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 Organic compounds are important constituents of many products eg., 
paints, drugs, plastics, food, explosives, petrochemicals etc. These 
molecules also exist in various natural products such as alkaloids and 
glycosides. Many of these organic compounds exhibit wide spectrum of 
biological activities such as antibacterial, antitubercular, anti HIV, 
anticancer, insecticidal, antiviral etc. These organic compounds can be 
aliphatic, biomolecules, polymers, heterocyclic etc.  
 Taking in view of the applicability of organic compounds, the present 
work was undertaken to synthesize some new heterocyclic compounds.   
The present work is divided into four chapters. 
Chapter-1 General Introduction 
Chapter-2 Synthesis and characterization 
 Section-I Synthesis of Azomethines 
 Section-II Synthesis of Benzothiazole derivatives 
 Section-III Synthesis of Dihydropyrimidinones 
 Section-IV Synthesis of Dihydropyrimidinthiones  
           Section-v       Synthesis of Thiazolidinones  
Chapter-3 Physico chemical properties 
Section-I Acoustical Properties 
Section-II Solubility 
Section-III Density and Refractive index 
Section-IV Dissociation Constants  
Section-V Thermal Properties 
Section-VI Conductance  
Chapter-4 Biological activities 
 
CHAPTER – 1: GENERAL INTRODUCTION 
 This chapter describes literature survey of synthesis, characterization, 
applications, physicochemical properties and antibacterial activities of 
heterocyclic compounds. 
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CHAPTER – 2: SYNTHESIS AND CHARACTERIZATION 
This chapter deals with synthesis and characterization of synthesized 
compounds. Characterization of these synthesized compounds was done by 
RI, Mass and NMR spectral data. 
 
Section-I Synthesis of Azomethines 
 
R = Functional group
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NCH
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Section-II Synthesis of Benzothiazole derivatives  
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Section-IV Synthesis of Dihydropyrimidinthiones  
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Section-v Synthesis of Thiazolidinones  
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CHAPTER – 3: PHYSICO-CHEMICAL PROPERTIES 
  
 Some physicochemical properties such as acoustical properties, 
solubility, density and refractive index, dissociation constants, thermal and 
conductance have also been studied in different solvents.  
These properties were studied for solutions of different concentrations 
of Dihydropyrimidinthiones derivatives (RAT series) in 
dimethylformamide and tetrahydrofuran at 308.15 K and are discussed in 
different sections as following: 
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Section-1 Acoustical Properties 
 In this section, density, viscosity and ultrasound velocity were 
measured for solutions of different concentrations in both the solvents,  DMF 
and THF.  From these experimental data, various acoustical parameters like 
specific acoustical impedance (Z), isentropic compressibility (κs), inter 
molecular free length (Lf), molar compressibility (W), Rao’s molar sound 
function (Rm), Vander Waals constant (b), relaxation strength (r), solvation 
number (Sn) apparent molar compressibility (φk) etc. were evaluated. The 
results are interpreted in terms of molecular interactions occurring in the 
solutions. 
 
Section-2 Solubility 
The solubility of various compounds of RAT series was determined at 
different temperatures (303.15-323.15 K) in dimethylformamide and 
tetrahydrofuran. Further, some thermodynamic parameters such as enthalpy, 
Gibb’s energy and entropy of different solutions have been evaluated from the 
experimental data. 
 
Section-3 Density and Refractive index 
Refractive index is a property of the material and is extremely useful in 
chemical analysis. In this section, the density and refractive index of solutions 
of different concentrations of compounds of RAT series were measured in 
dimethylformamide and tetrahydrofuran at 308.15 K. From the density of 
solutions, densities of synthesized compounds were evaluated. The density of 
compounds were also evaluated theoretically and were compared with those 
obtained from experimental data. 
Section-4 Dissociation Constants 
 This section deals with the dissociation constant of compounds of RAT 
series in DMF-water (60:40) system at different temperatures (298.15K, 
308.15K and 318.15K) by Calvin Bjerrum pH titration technique. From the 
experimental data, dissociation constant were evaluated by average and half-
integral method. 
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Further, some thermodynamic parameters such as enthalpy of solution, 
Gibb’s energy change and entropy of solution have been evaluated from the 
observed dissociation constants.  
Section-5 Thermal Properties 
 This section describes the thermal properties of RAT series 
compounds. The Thermo Gravimetric Analysis (TGA) and Differential Thermal 
Analysis (DSC) measurements were made. From these measurements, 
various kinetic parameters were evaluated. Further, thermal stability of 
various compounds were determined.  
 
Section-6 Conductance 
 This chapter deals with the conductance measurement of solutions of 
different concentrations of Dihydropyrimidinthiones derivatives (RAT series) in 
dimethylformamide and tetrahydrofuran at 308.15 K. From these experimental 
values, specific conductance and equivalent conductance were measured. 
 
 
CHAPTER – 4: BIOLOGICAL ACTIVITIES 
 In this chapter, antibacterial activity of synthesized compounds against 
some Gram positive and Gram negative bacteria in DMF and DMSO was 
studied. 
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 GENERAL INTRODUCTION 
The name organic was first used for all substances derived from living 
organisms i.e., plants and animals. Some of these substances are sugars, 
starches, oils, cellulose, fats, proteins, gums, dyes, alkaloids, fats, proteins, 
urea, gelatin etc. Such substances discovered and isolated from organic 
sources were studied under a branch of chemistry named organic chemistry.  
Organic chemistry plays an importance part in our daily life because 
food, clothes, paper, ink, rubber, soap, perfumes, medicines etc. are 
indispensable to us for proper living. Organic compounds are important 
constituents of many products eg., paint, food, plastic, explosive, medicine, 
petrochemical, pesticide etc1-5.  
The study of organic chemistry is of utmost importance for chemists in 
order to synthesize drugs for the alleviation of human sufferings, for a 
biologist to understand the processes undergoing in the bodies of animals and 
plants, for a pharmacist in order to prepare good medicines and for a 
chemical manufacturer for developing industries of dyes, drugs, plastics, 
rubber, textiles, rayon, etc.  
There are various types of organic compounds out of which 
heterocyclic compounds are one of the most important class. The study of 
heterocyclic compounds is of great interest both from the theoretical as well 
as practical point of view.  
Many workers have been reported the applicability of heterocyclic 
compounds6-15. These compounds have great applicability in pharmaceutics 
because they have specific chemical reactivity. They resemble essential 
metabolism and they fit biological receptors and block their normal working16. 
These compounds are useful in the field of medicine and are used as a 
starting material for the synthesis of new drugs17-25. Various drugs such as 
penicillin, rotenmone, strychnine, resepine, sulphamethoxazole, 
ciprofloxacine, etc and pigments such as indigo, hemoglobin, anthocin etc. 
contain heterocyclic ring26-28.  
Taking in view of the applicability of heterocyclic compounds, in the 
present work several entities containing heterocyclic nucleus have been 
selected. 
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AIM AND OBJECTIVES: 
 
? To synthesize some derivatives of 1-4-dihydropyrimidines, 
benzothaizole amine, thaizolidinones, sulphamethoxazole nucleus. 
? To characterize these synthesized compounds for structure elucidation 
by IR, 1H NMR and Mass spectral studies. 
? To study the physicochemical properties such as acoustical properties, 
density and refractive index, solubility, dissociation constant, thermal 
properties and conductance of some dihydropyrimidinones (RAT 
series) in different solvents. 
? To evaluated antibacterial activity of these synthesized compounds 
against different bacterial strains, in different solvents.          
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INTRODUCTION 
Azomethines are the compounds, which contain –C=N- group. These 
compounds are also known as imines or anils but most commonly, they are 
known as Schiff bases to honor Hugo Schiff1, who synthesized these 
compounds first. 
A lot of work has been done on this class of compounds due to its multi 
applicability. They are well known intermediate for the preparation of 
azetidinone2, thiazolidinone3, formazone4, arylacetamide5, metal complexes6-8 
and many other derivatives9,10.     
Further, these azomethines are known to be useful in complexing 
agent11, perfumery12, analytical reagent13, as corrosion inhibitor14, as a 
catalyst15 and polymerization process16. Further, many workers reported a 
wide range of biological activity17-19 of azomethines. Besides, several 
azomethines have been reported to possess remarkable antitumor20, 
antibacterial21, diuretic22, insecticidal23, anti-HIV24, antiparasitic25, anticancer26, 
antimicrobial27, antifunga28, and anti-inflammatory29 activities.  
Genaral account of the summary of reaction of aldehydes with amine 
(aromatic or aliphatic) has been reviewed by Murry30. Some azomethines from 
amphetine and procaine were reported by Giovambattista and Rabassa31. 
Savich32 at el. gave the detail study report of azomethines from 2-hydroxy-1-
napthaldehyde and arylamides. Takeo and Yuhi33 have been synthesized 
azomethines of 3,5-dibromosalicyladehyde. Some complexes of azomethines 
have also been synthesized from hetero aromatic amine and 
salicylaldehyde34. Sreenivasulu and Rao35 have studied the characterization 
of azomethines and its ability of complexing with cadmium(II) by polaography. 
Electrochemical behavior of platinum complexes of azomethines has also 
been reported by Shagisultanova at el36. Parra at el37. have studied the 
mesomorphic properties of some azomethines compounds derived from 
phenyl and thienyl-1,3,4,-thiadiazole. Some other azomethines have also 
been synthesized by Hussain and Shaukat from p-dimethylamino 
cinnamaldehyde38. 
Recently, Tian at el. have synthesized and characterized 2-(3,4,5-tri 
methoxybenzylidenamino)ethanol azomethines39 Yu and coworkers40 studied 
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the synthesis of 3,3'-[α,ω alkanediylbis(nitrilomethylidyne)]bis[2-hydroxy-5-
meth- ylbenzoic acid derivatives. Some novel azomethines derivatives of 2-
aminobenzothiazole41 and 4-methyl pyridine-2-amine42 have also been 
reported. The spectral studied of azomethines have also been studied by 
various workers43,44.  
Sulfonamides have been used as antibacterial agents for last 60 years. 
Sulfamethoxazole (4-amino-N-(5-methylisoxazol-3-yl)-benzenesulfonamide), 
one of the sulfonamides is a class of drugs whose molecular structure contain 
the sulfanilamide analog45. Sulfamethoxazole is most often used as part of 
combination with Trimethoprim46, which act synergistically against a wide 
variety of bacteria47-49, although other combinations of sulfonamides are also 
available. It has found widespread use in animal husbandry50 and, to a lesser 
extent51, in the treatment of human infections such as bronchitis and urinary 
tract infections52. It is also applicable for antiseptique53, atituberculr54 and anti-
inflammatory agent55. 
Thus, significant biological properties associated with azomethines 
derivatives have aroused considerable interest to design the compounds in 
which therapeutically active Sulfamethoxazole nucleus. 
 In the present section, some new azomethines have been synthesized 
containing Sulfamethoxazole nucleus. 
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EXPERIMENTAL 
 
Synthesis: 
 
To an ethanolic solution of aldehydes (0.01mole). 0.01 mole of 
sulfamethoxazole and 1 ml of ethanolic phenol solution (0.1 moles) was 
added (drop wise). The mixture was stirred for 15 minutes and then was 
refluxed in water bath for 1.5 hours at 80-85 oC. 
The resulting solution was cooled to room temperature and allowed to 
freeze for 30 minutes. The product was isolated by filtration and was 
recrystallized from ethanol.     
 
 
 
REACTION SCHEME 
 
 
NH2 S
O
O
NH
N
O CH3
N S
O
O
NH
N
O CH3
CH
R
+
O H
Phenol
1.5 hours
80-85 
o
C
R=Funcational group
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The following azomethines have been synthesized from sulfamethoxazole. 
 
1. RSA-1: 4-[(4-methoxybenzylidene)amino]-N-(5-methyl-1,2-oxazol                       
                                 -3-yl)benzenesulfonamide 
2. RSA-2 : 4-{[4-(dimethylamino)benzylidene]amino}-N-(5-methyl-1,2  
                                 -oxazol-3-yl)benzenesulfonamide 
3. RSA-3 : 4-[(4-fluorobenzylidene)amino]-N-(5-methyl-1,2-oxazol-3- 
                                 yl)benzenesulfonamide 
4. RSA-4 : 4-[(4-chlorobenzylidene)amino]-N-(5-methyl-1,2-oxazol-3- 
                                 yl)benzenesulfonamide 
5. RSA-5 : N-(5-methyl-1,2-oxazol-3-yl)-4-[(3-nitrobenzylidene)amino  
                                 ]benzenesulfonamide 
6. RSA-6 : N-(5-methyl-1,2-oxazol-3-yl)-4-[(2-nitrobenzylidene)amino  
                                 ]benzenesulfonamide 
7. RSA-7 : 4-(benzylideneamino)-N-(5-methyl-1,2-oxazol-3-yl)benze      
                                 nesulfonamide 
8. RSA-8 : 4-[(2-chlorobenzylidene)amino]-N-(5-methyl-1,2-oxazol-3- 
                                 yl)benzenesulfonamide 
9. RSA-9 : 4-[(3-chlorobenzylidene)amino]-N-(5-methyl-1,2-oxazol-3- 
                                 yl)benzenesulfonamide 
10. RSA-10: 4-[(3-bromobenzylidene)amino]-N-(5-methyl-1,2-oxazol-3- 
                                 yl)benzenesulfonamide 
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The various physical constants such as Rf value, melting point and 
percentage of yield for all synthesized Azomethiens are given in Table 1. The 
melting point was taken by open capillary method.  
 The characterization was done by IR, mass spectra and 1H NMR. 
 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. The IR spectra and data for RSA-1 is given in Figure 2.1.1 and Table 
2.1.2 respectively. The spectral data for all other compounds are reported in 
Table 2.1.3. 
 
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. 
Figure 2.1.2 shows mass spectra of RSA-1. The proposed mass 
fragmentation of RSA-1 is given in Scheme 2.1.1. The mass fragmentations of 
other compounds are also given separately.  
 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figure 2.1.3 shows 
NMR spectra of RSA-2. The spectral data for RSA-2 is given in Table 2.1.4.  
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Table 2.1.1: Physical constants of azomethines. 
  
 
Sr. 
No. 
Code R M.F. 
M. Wt. 
(g/mol)
Rf* 
Value 
M.P. 
oC 
Yield 
% 
1 RSA-1 4-OCH3 C18H17N3O4S 371 0.42 171 86 
2 RSA-2 4-N(CH3)2 C19H20N4O3S 384 0.48 202 92 
3 RSA-3 4-F C17H14FN3O3S 359 0.43 159 83 
4 RSA-4 4-Cl C17H14ClN3O3S 375 0.53 185 88 
5 RSA-5 3-NO2 C17H14N4O5S 386 0.58 211 90 
6 RSA-6 2-NO2 C17H14N4O5S 386 0.52 234 92 
7 RSA-7 -H C17H15N3O3S 341 0.61 131 80 
8 RSA-8 2-Cl C17H14ClN3O3S 375 0.67 241 84 
9 RSA-9 3-Cl C17H14ClN3O3S 375 0.60 238 80 
10 RSA-10 3-Br C17H14BrN3O3S 420 0.52 192 82 
 
 
       * Ethyl acetate: Hexane: 3:7 
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Figure 2.1.1:  IR spectra of 4-{[(E)-(4-methoxyphenyl)methylidene]amino}  
                       -N-(5-methylisoxazol-3-yl)benzenesulfonamide (RSA-1). 
 
 
 
 
 
Table 2.1.2: IR spectral data of 4-{[(E)-(4-ethoxyphenyl)methylidene]ami-  
                    no}-N- (5-methylisoxazol-3-yl)benzenesulfonamide (RSA-1). 
 
Frequency in cm-1 Type Vibration mode 
Observed Reported56,57 
C-H str. (asym.) 2941.54 2975-2920 
C-H str. (sym.) 2872.10 2880-2860 
C-H def. (asym.) 1460.16 1500-1435 
Alkane 
 
C-H def.(sym.) 1388.79 1400-1370 
C-H str. 3022.55 3200-3000 
C=C str. 1508.38 1585-1480 
C-H i.p. def. 1016.52 1125-1090 
Aromatic 
C-H o.o.p. def. 844.85 860-810 
Azomethine C=N str. 1658.84 1690-1640 
SO2-NH (sym.) 1168.90 1180-1140 Sulfonamide 
SO2-NH (asym.) 1327.07 1350-1300 
N-H (asym.) 3423.76 3500-3310 Secondary 
amine   N-H ben. 1593.25 1650-1550 
ether C-O-C str. (asym.) 1276.92 1300-1200 
 N-O str. 1327.07 1400-1000 
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Table 2.1.3: IR spectral data of synthesized azomethines  
                    (RSA-3 to RSA-10). 
 
IR ν, (cm-1)  
Compounds 
C=C  
(asym.)
N-O  
Str. 
C=N  
Str. 
R 
RSA-2 1498.88 1037.74 1653.05 - 
RSA-3 1538.16 1183.42 1673.45 1320.83 
RSA-4 1489.10 1087.89 1656.91 700.18 
RSA-5 1516.10 1109.11 1674.27 1340.57 
RSA-6 1501.84 1112.53 1682.42 1358.73 
RSA-7 1500.67 1203.84 1672.73 - 
RSA-8 1534.37 1154.31 1679.54 732.15 
RSA-9 1520.63 1167.50 1653.30 768.20 
RSA-10 1532.54 1101.91 1666.89 553.08 
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Figure 2.1.2: Mass spectra of 4-{[(E)-(4-ethoxyphenyl)methylidene]amino}-N- (5-methylisoxazol-3-yl)benzenesulfonamide 
                (RSA-1). 
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Scheme 2.1.1: Proposed mass fragmentation of 4-{[(E)-(4-ethoxyphenyl)methylidene]amino}-N- (5-methylisoxazol-3-     
 14 
                         yl)benzenesulfonamide (RSA-1). 
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Mass fragments (m/z value) of synthesized azomethiens  
(RSA-2  to RSA-10). 
 
RSA-2: 371, 303, 271, 239, 223, 207, 189, 156, 148, 132, 119, 92.   
RSA-3: 359, 317, 268, 246, 225, 198, 174, 156, 151, 140, 119, 108, 92. 
RSA-4: 375, 360, 339, 293, 278, 262, 251, 214, 200, 161, 138, 113, 97,   
RSA-5: 386, 370, 325, 304, 264, 251, 243, 237, 179, 155, 135, 122, 97.  
RSA-6: 386, 371, 324, 304, 290, 250, 237, 225, 146, 133, 120, 97. 
RSA-7: 341, 326, 301, 264, 259, 237, 155, 140, 104, 91, 77, 57. 
RSA-8: 375, 360, 335, 293, 258, 237, 182, 161, 145, 138, 112, 91. 
RSA-9: 375, 335, 294, 258, 239, 180, 162, 145, 111, 91. 
RSA-10: 420, 405, 382, 340, 307, 260, 251, 237, 182, 161, 133, 91,  
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Figure 2.1.3: 1H NMR spectra of 4-{[4-(dimethylamino)benzylidene] 
                       amino}-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide  
                       (RSA-2). 
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Table 2.1.4: 1H NMR spectral data of 4-{[4-(dimethylamino)benzylidene]  
                      amino}-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide  
                      (RSA-2). 
 
 
 
 
a
b
c
d
g
e
e'
f
f'
CH
N S
O
O
NH
N
O CH3
N
CH3
CH3
b'
d'
g'
h
i
 
 
 
 
 
 
 
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No.
of Protons 
Multiplicity Inference J 
(Hz) 
1 2.30 3 singlet -CH3 (a)   - 
2 3.09 6 singlet N-(CH3)2 (bb’)    - 
3 6.05 1 singlet -NH (c) - 
4 6.73-6.75 Ar-H (dd’) 8.96 
5 6.76-6.77 
4 
double 
doublet Ar-H (ee’) 6.48 
6 7.55-7.57 2 doublet Ar-H (ff’) 6.96 
7 7.66-7.67 2 doublet Ar-H (gg’) 4.68 
8 9.08 1 singlet N=CH (h) - 
9 9.67 1 singlet H (i) - 
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INTRODUCTION 
 
The Benzothiazole is sulfur and nitrogen containing bicyclic ring system 
fused with phenyl ring. The study of benzothiazole derivatives is of 
considerable current interest due to their important biological and biophysical 
properties. 
 
N
S
1
2
34
5
6
7
8
9
 
 
Benzothiazoles are a class of high production volume chemicals with 
various applications in industry1,2. The largest amount of benzothiazoles are 
used as vulcanization accelerators3, such as 2-morpholinothiobenzothiazole in 
rubber production4. 2-Mercaptobenzothiazole is used in paper production as 
corrosion inhibittor5, and 2-thiocyanomethylthiobenzothiazole is used as a 
substitute for chlorophenols in wood preservation and leather production6. 
Benzothiazoles are also added as antifreeze7 and cooling liquids8.   
 Further, Benzothiazole derivatives show a wide range of 
chemotherapeutic activity9-11. Many of the benzothiazole derivatives are used 
as antibacterial12-15 and antifungal16-19 agents. Substituted benzothaizols have 
been found to exhibit diverse biological activities such as antitumor20,21, 
antimicrobial22,23, anti-inflammatory24,25, anthelmintic26,27 antileishmanial28,29 
anticonvulsant30, anti-HIV31, antiviral32, diuretics33,34 etc. 
 One of the earliest and most valuable method for the synthesis of 
benzothiazole is the reaction of an o-amino thiaphenol with a carboxylic acid, 
its derivatives35-38 or aldehydes39-41. The reaction of aldehydes and ketones 
has also been reported42-44.  
Further, literature survey shows that 2-aminobenzothiazole and some 
of its derivatives have been synthesized by many workers45-50. Davies and 
Sexton51 have studied the synthesis of 1-thiolbenzothiazoles and its 
interaction with alcohols. Efros and Davidenkov52 have reported the 
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preparation of 1-benzothiazolyl-3-methyl-5(4H)-pyrazolone. Bhargava and 
Baliga53 have also synthesized some new 2-aminobenzothiazoles. Jenkins 
and coworkers54 have synthesized the benzothiazole and benzoxazole rings. 
The Synthesis of 2-[2-(5-nitro-2-furyl)ethynyl] benzothiazole has also been 
reported by Yoshina et al.55  Kim56 has studied the thermostable copolymers 
of methyl methacrylate with 2-thiobenzothiazolethyl methacrylate. Halgas et 
al.57 synthesized 3, 4, 6-substituted benzothiazolium salts and studied its 
antimicrobial activity. Maksimova and coworkers58 have prepared the 
benzothiazole dye. Syntheses of 4-nitrophenyl benzothiazol-6-ylsulfides and 
4-nitrophenyl benzothiazol-6-ylsulfones has been given by Kandeel59. Some 
complexes have also been synthesized by Mandal and coworkers from 2-(2'-
pyridyl) benzothiazole60. Borisov et al.61 have prepared (1E,3E)-1,4-diphenyl-
1,3-butadiene by cycloaddition of 1,3- benzothiaz- ole-2-sulfenyl chloride. 
Some new benzothiazole derivatives of pyrimidines, acrylonitriles, coumarins 
have been synthesized62 and studied their biological activities. Preparation of 
benzo[c]thiophene compounds containing benzimidazole, benzothiazole, and 
oxazole have reported by Clemen63. 
Thus, the important role displayed by benzothiazole and its derivatives 
for various therapeutic and biological activities encouraged to synthesize 
some new derivatives of benzothiazole.  
In this section, some derivatives of benzothiazoles have been 
synthesized and their characterization was done by IR, NMR and mass 
spectra.  
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EXPERIMENTAL 
 
Synthesis of 6-methoxy-N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-
1,3-benzothiazol-2-amine (RBT-1). 
 
[A] Synthesis of 2-amino benzothiazole derivatives. 
 A solution of substituted aniline (1 mole) in chloro benzene was 
prepared in a three-necked, round-bottom flask fitted with a stirrer, reflux 
condenser, thermometer, and dropping funnel. Over a period of 5 minutes, 
0.55 mole of concentrated sulfuric acid was added drop wise. To the finely 
divided suspension of substituted aniline sulfate, 1.1 moles of sodium 
thiocyanate was added and the mixture was heated for 3 hours at 100° (inside 
temperature) in an oil bath. The solution, which now contains the thio urea, 
was cooled to room temperature. To this mixture, 1.34 moles of sulfuryl 
chloride was added over a period of 15 minutes. Care was taken to avoid 
increase of temperature above 50°C. The mixture was kept at 50°C for 2 
hours to remove all the evolved hydrogen chloride. The reaction mixture was 
then filtered to remove chloro benzene. The solid residue was then dissolved 
in hot water, and the remaining solvent (chloro benzene) was removed by a 
current of steam. The aqueous solution was filtered and was made alkaline by 
adding concentrated ammonium hydroxide. The precipitated substituted 2-
amino benzothiazole was filtered and washed with water. The crude product 
was isolated and crystallized from absolute ethanol. 
 
[B] Synthesis of 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine. 
 The solution of (4-methoxy-3,5-dimethylpyridin-2-yl)methanol (o.1 
mole) in 50 ml of toluene was stirred for 10 minutes at room temperature. The 
reaction mixture was then cooled at 5-10oC. To this mixture, thionyl chloride 
(0.1 mole) was added drop wise ( the temperature dose not exceed 40oC) and 
the mixture was stirred for 20 minutes at room temperature. The product was 
filtered and washed with toluene.      
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[C] Synthesis of 6-methoxy-N-[(4-methoxy-3,5-dimethylpyridin-2-
 yl)methyl]-1,3-benzothiazol-2-amine (RBT-1). 
 0.5 gm of sodium hydroxide was dissolved in 15 ml of methanol in a 
water bath. To this alkaline solution, 6-methoxy-1,3-benzothiazol-2-amine 
(0.01 mole) and 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine (0.01 mole) 
was added and was refluxed at 70oC in water bath for 2 hours. The reaction 
mixture was then cooled at room temperature and poured in ice water. The 
solid product was filtered, washed with water and crystallized from ethanol.     
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REACTION SCHEME 
 
[A] Synthesis of 2-amino benzothiazole derivatives. 
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[B] Synthesis of 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine. 
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[C] Synthesis of 6-methoxy-N-[(4-methoxy-3,5-dimethylpyridin-2-
 yl)methyl]-1,3-benzothiazol-2-amine (RBT-1). 
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The following benzothiazole derivatives have been synthesized. 
 
1. RBT-1: 6-methoxy-N-[(4-methoxy-3,5-dimethylpyridin-2-yl) methyl  
                                 ]-1,3-benzothiazol-2-amine 
2. RBT-2: 6-chloro-N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]- 
                                1,3-benzothiazol-2-amine 
3. RBT-3: 6-fluoro-N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]- 
                                1,3-benzothiazol-2-amine 
4. RBT-4: N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-6-nitro- 
                                1,3-benzothiazol-2-amine 
5. RBT-5: N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-6-methyl- 
                                1,3-benzothiazol-2-amine 
6. RBT-6: 4-chloro-N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]- 
                                1,3-benzothiazol-2-amine 
7. RBT-7: 4-bromo-N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]- 
                                1,3-benzothiazol-2-amine 
8. RBT-8: 6-bromo-N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]- 
                                1,3-benzothiazol-2-amine 
9. RBT-9: N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-1,3-benzot 
                                hiazol-2-amine 
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The various physical constants such as Rf value, melting point and 
percentage of yield for all synthesized benzothiazole derivatives are given in 
Table 2.2.1. All the melting point was taken by open capillary method.  
 The characterization was done by IR, mass spectra and 1H NMR. 
 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. The IR spectra and data for RBT-1 is given in Figure 2.2.1 and Table 
2.2.2 respectively. The spectral data for all other compounds are reported in 
Table 2.2.3. 
 
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. 
Figure 2.2.2 shows mass spectra of RBT-2. The proposed mass 
fragmentation of RBT-2 is given in Scheme 2.2.1. The mass fragmentations of 
other compounds are also given separately.  
 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figure 2.2.3 shows 
NMR spectra of RBT-2. The spectral data for RBT-2 is given in Table 2.2.4.  
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Table 2.2.1: Physical constants of Benzothiazole derivatives. 
  
 
 
Sr. 
No. 
Code R M.F. 
M. Wt. 
(g/mol)
Rf* 
Value 
M.P. 
oC 
Yield
% 
1 RBT-1 4-OCH3 C17H19N3O2S 329 0.50 212 60 
2 RBT-2 4-Cl C16H16ClN3OS 333 0.61 181 72 
3 RBT-3 4-F C16H16FN3OS 317 0.54 196 50 
4 RBT-4 4-NO2 C16H16N4O3S 344 0.48 233 42 
5 RBT-5 4-CH3 C17H19N3OS 313 0.57 204 78 
6 RBT-6 2-Cl C16H16ClN3OS 333 0.46 228 56 
7 RBT-7 2-Br C18H22BrN3OS 378 0.38 178 62 
8 RBT-8 4-Br C16H16BrN3OS 378 0.40 207 38 
9 RBT-9 -H C16H17N3OS 299 0.66 215 68 
 
 
                                                                     * Methanol: Chloroform: 1.5:8.5 
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Figure 2.2.1:  IR spectra of 6-methoxy-N-[(4-methoxy-3,5-dimethylpyridin  
                       -2-yl)methyl]-1,3-benzothiazol-2-amine (RBT-1). 
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Table 2.2.2: IR spectral data of 6-methoxy-N-[(4-methoxy-3,5-dimethyl  
                     pyridine- 2-yl)methyl]-1,3-benzothiazol-2-amine (RBT-1). 
  
Frequency in cm-1 Type Vibration mode 
Observed Reported64,65 
C-H str. (asym.) 2972.40 2975-2920 
C-H str. (sym.) 2875.96 2880-2860 
C-H def. (asym.) 1489.10 1500-1435 
Alkane 
 
C-H def.(sym.) 1402.30 1400-1370 
C-H str. 3198.09 3200-3000 
C=C str. 1562.39 1585-1480 
C-H i.p. def. 1155.40 1125-1090 
Aromatic 
C-H o.o.p. def. 813.99 860-810 
-N-H (asym.) 3335.03 3500-3310 Secondary 
amine -N-H (sym) 1591.33 1650-1550 
C-S-C (sym.) 1031.95 1250-1010 Thaizole 
C-S-C o.o.p.def. 688.68 700-600 
ether C-O-C str. (asym.) 1298.14 1300-1200 
 C-O-C str. (sym.) 1091.75 1100-1050 
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Table 2.2.3: IR spectral data of synthesized benzothaizole derivatives 
                     (RBT-2  to RBT-9). 
 
IR ν, (cm-1)  
Compounds C=C  
str. 
-N-H  
(asym) 
C-S-C 
(sym.) 
C-O-C  
(asym.)  
R 
RAT-2 1562.39 3335.03 1103.32 1278.85 777.34 
RBT-3 1560.00 3300.12 1188.19 1257.63 1327.07 
RBT-4 1573.97 3342.72 1118.75 1290.42 1344.43 
RBT-5 1533.46 3337.08 1122.61 1280.61 - 
RBT-6 1542.81 3321.50 1085.34 1264.74 532.05 
RBT-7 1554.64 3365.71 1165.48 1279.09 632.70 
RBT-8 1549.05 3311.76 1132.80 1284.00 650.87 
RBT-9 1513.94 3350.09 1096.07 1260.40 - 
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Figure 2.2.2: Mass spectra of 6-chloro-N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-1,3-benzothiazol-2-amine (RBT-2). 
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Scheme 2.2.1: Proposed mass fragmentation of 6-chloro-N-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-1,3-benzothiazol- 
 33 
                         2-amine (RBT-2).  
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Mass fragments (m/z value) of synthesized benzothiazole derivatives.  
(RBT-1 and RBT-3 to RBT-9). 
 
RBT-1: 329, 314, 267, 225, 195, 164, 133, 107, 77.   
RBT-3: 317, 301, 286, 255, 226, 180, 151, 122, 92.  
RBT-4: 344, 299, 243, 231, 209, 180, 160, 134, 112, 77.   
RBT-5: 313, 282, 256, 228, 200, 168, 136, 108, 91.  
RBT-6: 333, 318, 298, 256, 232, 199, 164, 137, 109, 77. 
RBT-7: 378, 342,m 312, 280, 266, 241, 217, 168, 152, 130, 109. 
RBT-8: 378, 348, 324, 278, 254, 212, 190, 167, 138, 116, 91. 
RBT-9: 299, 284, 253, 163, 134, 121, 105, 91,77. 
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Figure 2.2.3: 1H NMR spectra of 6-chloro-N-[(4-methoxy-3,5-dimethylpyri  
                        din-2-yl)methyl]-1,3-benzothiazol-2-amine (RBT-2). 
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Table 2.2.4: 1H NMR spectral data of 6-chloro-N-[(4-methoxy-3,5-dimethyl          
                      pyridin-2-yl)methyl]-1,3-benzothiazol-2-amine (RBT-2). 
 
 
ab
c
d
ge
f
h
i
N
O
CH3
CH3 CH3
N
S
NH CH2
Cl
 
 
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No.
of Protons 
Multiplicity Inference J 
(Hz) 
1 2.34 3 singlet -CH3 (a)   - 
2 2.52 3 singlet -CH3 (b)   - 
3 3.80 3 singlet -OCH3 (c)   - 
4 4.76 2 singlet -CH2 (d)   - 
7.15-7.16 doublet 2.12  
5 7.17-1.18 
1 
doublet 
Ar-H (e) 
2.08 
6 7.30-7.32 1 doublet Ar-H (f) 8.56 
7 7.40 1 singlet -NH (g) - 
8 7.55-7.56 1 doublet Ar-H (h) 2.08 
9 7.93 1 singlet -H (i) - 
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INTRODUCTION 
Dihydropyrimidinones consists of a six membered heterocyclic ring 
having two nitrogen atoms at one and three positions. These compounds are 
synthesized by the most important multi-component reactions, known as 
Biginelli reaction. Biginelli reported the synthesis of functionalized 3,4-
dihydropyrimidin-(1H)-ones (DHPMs) via three-component one-port, condens- 
ation reaction of an aromatic aldehyde, urea, and ethyl acetoacetate1.  
There are several methods used for the synthesis of 
dihydropyrimidinones2-6. Dihydropyrimidinones are synthesized by using 
Lewis acids as well as protic acid under classical reflux7-10, solvent-free 
conditions11-14, by microwave15-18 or by ultrasound irradiation19-22. Recently, 
these methods are improved by using various catalyst such as indium(III) 
chloride23, bismuth(III)24, CoCl2 6H2O or LaCl3 7H2O25, silcasulfuric acid26, 
clay-SmCl3 6H2O27, ferrous chloride or nickel chloride28, zinc perchlorate29, 
NaIO430 and ionic liquids31. However, in spite of their potential utility, many of 
these methods involve low yields, long reaction times, high temperature and 
expensive reagents. 
 Dihydropyrimidinones have been subjected to a large number of 
different modifications in order to obtain derivatives having different biological 
properties32-36. Several groups have studied the chemistry and 
pharmacological properties of dihydropyrimidinones derivatives. Dihydropyri- 
midinones are known to exhibit a wide range of biological activities such as 
antiviral37, antitumour38,39, antibacterial40,41, and anti-inflammatory42-44 propert-
ies. In addition, these compounds have emerged as potential calcium channel 
blockers45, antihypertensive46, α1a–adrenergic antagonists47 and neuropeptide 
antagonists48. Recently, these types of compounds have been isolated from 
marine alkaloids with interesting biological activities49-51. 
 Janion and Shugard52 have studied the effect of dihydropyrimidinones 
on some enzymes. Hardtmann and Kathawala53 have studied of 4,6-Diaryl 
pyrimidin-2(1H)-ones as tranquilizers. The relation between the structure and 
cardiovascular activity of some dihydropyrimidinones have also been reported 
by Gitlina et al.54 Vedernikova and coworkers55 have studied the 
pharmacological applications of 4-oxo-1,4-dihydropyrimidines. Ziegler et al.56 
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have been synthesized 3-benzyloxy-6-hydroxy-3, 4-dihydro-4-pyrimidinones. 
Some 9-(aminoalkyl)-6,7-dihydropyrimido[2,1-f]purine-2,4,8 (1H,3H,9H)triones 
have been sythesised by Pawlowski and coworkers57. Lu et al.58 have 
reported the synthesis of 3,4-dihydropyrimidin-2(1H)-ones using lanthanum 
chloride. Some 3,4-dihydropyrimidinones have been synthesized by using 
different methods59-61. Recently, synthesis of 4-(4-Cyano-2-thioaryl)-dihydro 
pyrimidinones and their uses in diseases of lung and cardiovascular systems 
have been reported by Nussbaum and coworkers62. Fustero et al.63 have 
reported the new method for the synthesis of fluorinated 3,4-dihydro 
pyrimidinones. 
With a view to getting better therapeutic agent, it was contemplated to 
synthesize some dihydropyrimidinones derivatives to enhance the overall 
activity of resulting compounds, which have been described in this section. 
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EXPERIMENTAL 
 
Synthesis of N-(4-methoxyphenyl)-4-(4-methoxy-3,5-dimethylpyridin-2-yl) 
-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide (RAU-1). 
 
[A] Synthesis of substituted 3-oxo-N-phenylbutanamide. 
 A mixture of substituted aniline (0.01 M) and ethyl aceto acetate (0.012 
M) in 25 ml toluene was refluxed for 12 hours in presence of few drops of 
slurry of NaOH in water. The excess of toluene was distilled out and the 
reaction mixture was taken in hexane and stirred with glass rod. The product 
was isolated in hexane and filtered. The crude product was dried. This 
product was taken in aqueous NaOH solution and neutralized with dilute HCl. 
The recrystalisation was done in ethanol.  
 
[B] Synthesis of 4-methoxy-3,5-dimethylpyridine-2-carbaldehyde. 
10 gm of (4-methoxy-3,5-dimethylpyridin-2-yl)methanol was taken in 60 
ml of dichloromethane (MDC) in stopper flask and stirred. The mixture was 
heated at 30-35o C. Then, 35 gm of MnO2 was added over a period of 15 
minutes. The reaction mixture was again stirred at 30-35o C for 2 hours. The 
excess of toluene was distilled out and the liquid product of 4-methoxy-3,5-
dimethylpyridine-2-carbaldehyde was isolated.     
 
 [C] Synthesis of N-(4-methoxyphenyl)-4-(4-methoxy-3,5-dimethylpyri- 
din-2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox 
amide (RAU-1). 
A solution of 4-methoxy-3,5-dimethylpyridine-2-carbaldehyde (0.01 M), 
substituted 3-oxo-N-phenylbutanamide (0.01 M) and urea (0.012 M) in 
methanol was refluxed for 12 hours in presence of few drops of concentrated 
HCl as catalyst. The product was isolated and recrystallized from DMF.  
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REACTION SCHEME 
 
[A] Synthesis of substituted 3-oxo-N-phenylbutanamide. 
 
NH2
+ CH3 O CH3
O O
NH
CH3
O
O
Toluene
NaOH
120 
o
C
R
R
 
 
 
[B] Synthesis of 4-methoxy-3,5-dimethylpyridine-2-carbaldehyde. 
 
N
O
CH3
CH3 CH3
OH
MnO 2
Dichloromethane
2 hrs.
30-35 
o
C N
O
CH3
CH3 CH3
O
H  
 
 
[C] Synthesis of N-(4-methoxyphenyl)-4-(4-methoxy-3,5-dimethylpyri- 
din2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox 
amide ( RAU-1). 
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The following dihydropyrimidinones have been synthesized. 
 
1. RAU-1: N-(4-methoxyphenyl)-4-(4-methoxy-3,5-dimethylpyridin-2-            
                                yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox  
                                 amide 
2. RAU-2: N-(4-chlorophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2- 
                                yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox  
                                amide 
3. RAU-3: N-(3-chlorophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2- 
                                yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox  
                                amide 
4. RAU-4: N-(4-hydroxyphenyl)-4-(4-methoxy-3,5-dimethylpyridin-2- 
                                yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox  
                                amide  
5. RAU-5: N-(2,5-dichlorophenyl)-4-(4-methoxy-3,5-dimethylpyridin- 
                                2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carb     
                                oxamide 
6. RAU-6: N-(4-florophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2-yl)- 
                                6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox  
                                amide 
7. RAU-7: N-(4-nitrophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2-yl)- 
                                6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox 
                                amide 
8. RAU-8: 4-(4-methoxy-3,5-dimethylpyridin-2-yl)-6-methyl-2-oxo-N- 
                                phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
9. RAU-9: N-(4-methylphenyl)-4-(4-methoxy-3,5-dimethylpyridin-2- 
                                yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox  
                                amide 
10. RAU-10: N-(4-bromophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2- 
                                yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carbox  
                                amide 
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The various physical constants such as Rf value, melting point and 
percentage of yield for all synthesized dihydropyrimidinones derivatives are 
given in Table 2.3.1. All the melting point was taken by open capillary method.  
 The characterization was done by IR, mass spectra and 1H NMR. 
 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. The IR spectra and data for RAU-1 is given in Figure 2.3.1 and Table 
2.3.2 respectively. The spectral data for all other compounds are reported in 
Table 2.3.3. 
 
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. 
Figure 2.3.2 shows mass spectra of RAU-2. The proposed mass 
fragmentation of RAU-2 is given in Scheme 2.3.1. The mass fragmentations 
of other compounds are also given separately.  
 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figure 2.3.3 shows 
NMR spectra of RAU-1. The spectral data for RAU-1 is given in Table 2.3.4.  
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Table 2.3.1: Physical constants of dihydropyrimidinones. 
  
 
 
Sr. 
No. 
Code R M.F. 
M. Wt. 
(g/mol)
Rf* 
Value 
M.P. 
oC 
Yield
% 
1 RAU-1 4-OCH3 C21H24N4O4 396 0.52 218 46 
2 RAU-2 4-Cl  C20H21ClN4O3 400 0.43 254 45 
3 RAU-3 3-Cl C20H21ClN4O3 400 0.46 262 35 
4 RAU-4 4-OH C20H22N4O4 382 0.56 193 31 
5 RAU-5 2,5-Dichloro C20H20Cl2N4O3 435 0.61 234 40 
6 RAU-6 4-F C20H21FN4O3 384 0.63 222 39 
7 RAU-7 4-NO2 C20H21N5O5 411 0.48 240 34 
8 RAU-8 4-H C20H22N4O3 366 0.37 206 56 
9 RAU-9 4-CH3 C21H24N4O3 380 0.46 187 53 
10 RAU-10 4-Br C20H21BrN4O3 445 0.54 267 44 
 
                                                              
                                                                          * Methanol: Chloroform  2.5:7.5 
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Figure 2.3.1:  IR spectra of N-(4-methoxyphenyl)-4-(4-methoxy-3,5-dimeth 
                       ylpyridin-2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-            
                       5-carboxamide (RAU-1). 
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Table 2.3.2: IR spectral data of N-(4-methoxyphenyl)-4-(4-methoxy-3,5- 
                     dimethylpyridin-2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrim  
                     idine-5-carboxamide (RAU-1). 
 
Frequency in cm-1 Type Vibration mode 
Observed Reported64,65 
C-H str. (asym.) 2962.76 2975-2920 
C-H str. (sym.) 2841.24 2880-2860 Alkane  
C-H def. (asym.) 1464.02 1500-1435 
C-H str. 3155.65 3200-3000 
C=C str. 1508.38 1585-1480 
C-H i.p. def. 1109.11 1125-1090 
Aromatic 
C-H o.o.p. def. 831.35 860-810 
C=O str.(cyclic) 1660.77 1740-1650 Ketones 
C=O str. (alip.) 1597.11 1710-1550 
-N-H (asym.) 3296.64 3500-3300 Secondary 
amine -N-H (sym) 1560.46 1650-1550 
C-O-C str. (asym.) 1298.14 1400-1000  
Ether C-O-C str. (sym.) 1091.75 1075-1020 
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Table 2.3.3: IR spectral data of synthesized dihydropyrimidinones  
                     (RAU-2 to RAU-10). 
 
IR ν, (cm-1)  
Compounds
C=C str. -N-H (sym) R 
RAU-2 1520 1590 752 
RAU-3 1532 1591 764 
RAU-4 1509 1610 3476 
RAU-5 1512 1618 772 
RAU-6 1524 1620 1188 
RAU-7 1527 1609 1342 
RAU-8 1521 1619 - 
RAU-9 1508 1598 - 
RAU-10 1510 1625 562 
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Figure 2.3.2: Mass spectra of N-(4-chlorophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydro  
                      pyrimidine-5-carboxamide (RAU-2). 
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                          -1,2,3,4- tetrahydro pyrimidine-5-carboxamide (RAU-2). 
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Mass fragment (m/z value) of other synthesized dihydropyrimidinones 
(RAU-1 and RAU-3 to RAU-10). 
 
 
RAU-1: 396, 381, 365, 334, 319, 304, 260, 232, 203, 183, 164, 153.  
RAU-3: 400, 356, 336, 308, 290, 276, 253, 232, 215, 186, 155, 138. 
RAU-4: 382, 365, 334, 321, 304, 289, 259, 246, 186, 170, 155, 136. 
RAU-5: 435, 420, 404, 368, 374, 303, 352, 299, 274, 246, 263, 228. 
RAU-6: 384, 369, 353, 338, 304, 289, 246, 231, 200, 248. 
RAU-7: 411, 296, 380, 365, 364, 342, 332, 304, 290, 275, 240. 
RAU-8: 366, 351, 335, 305, 289, 252, 230, 228, 243. 
RAU-9: 380, 365, 349, 334, 304, 289, 246, 216, 170. 
RAU-10: 445, 430, 414, 384, 365, 304, 309, 289, 274, 246.     
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Figure 2.3.3: 1H NMR spectra of N-(4-methoxyphenyl)-4-(4-methoxy-3,5-di  
                        methylpyridin-2-yl)-6-methyl-2-oxo-1,2,3,4-trahydropyrimid  
                        ine-5-carboxamide (RAU-1). 
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Table 2.3.4: 1H NMR spectral data of N-(4-methoxyphenyl)-4-(4-methoxy- 
                      3,5-dimethylpyridin-2-yl)-6-methyl-2-oxo-1,2,3,4-trahydropy  
                      rimidine-5-carboxamide (RAU-1). 
 
 
 
a
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CH3
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O
CH3
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k
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Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No.
of Protons 
Multiplicity Inference J 
(Hz) 
1 1.99 3 singlet -CH3 (a)   - 
2 2.20 3 singlet -CH3 (b)   - 
3 2.21 3 singlet -CH3 (c)   - 
4 3.64 3 singlet -OCH3 (d)   - 
5 3.68 3 singlet  -OCH3 (e)  - 
6 5.64 1 singlet -CH (f) - 
7 6.73-6.74 2 doublet Ar-H (gg’) 5.28 
8 7.37-7.38 2 doublet Ar-H (hh’) 5.2 
9 8.16 1 singlet Ar-H (i) - 
10 8.50 1 singlet -NH (j) - 
11 9.39 1 singlet -NH (k) - 
12 9.97 1 singlet -NH (l) - 
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INTRODUCTION 
 Dihydropyrimidinthiones and their derivatives are important classes of 
compounds in Dihydropyrimidine group. Dihydropyrimidinthiones consists of a 
six membered heterocyclic ring having two nitrogen atoms at one and three 
positions and also containing sulfur at second carbon. Biginelli reported the 
synthesis of 3,4-dihydropyrimidin-(1H)-thiones1.  
Over the past decade, dihydropyrimidin-2(1H)-thiones and their 
derivatives have attracted considerable attention in organic and medicinal 
chemistry as the dihydropyrimidine scaffold displays a fascinating array of 
pharmacological and therapeutic properties2. Thiourea itself was one of the 
first new drug employed to depress, the clinically over active thyroid in 
thyrotoxicosis3 but some of the cyclic thiourea have been found better suited. 
All of these are prone of produce adverse reduction in susceptible patients 
and found more potent and less likely to produce side effect and is being used 
widely4. These dihydropyrimidinthiones compounds exist in a variety of natural 
and synthetic organic compounds and are known to possess a wide spectrum 
of biological and therapeutic properties5-7 such as antibacterial8, anti-viral9, 
anti-tumor10,11, anti-inflammatory12, anti-fungal13, antihypertensive14, anti-
HIV15, as well as α1a-antagonists16,17, neuropeptide Y (NPY) antagonists18, 
aggregation inhibitory activity22 and anticarcinogencic19 activity. These 
compounds are also used as analgesic20, blood platelet21 and calcium 
channel blockers23. The stereo chemical relationship between the aryl group 
and the dihydropyrimidine ring was found to be one of the factors having a 
pronounced effect on the biological activity24,25. Lukacs et al.26 have reported 
the synthesis libraries of dihydropyrimidinone, dihydropyrimidinethione, 
dihydropyrimidothiazine and its biological activity. Shahrokni and coworkers27 
have reported the toxicity and efficacy of 5-fluorouracil. The photophysical of 
5-ethoxycarbonyl-4-cinnamyl-6-methyl-3,4- dihydropyrimidine -2(1H)-thiones 
has also been reported28.  
Multicomponent reactions (MCRs) are of increasing importance in 
organic and medicinal chemistry for various reasons29,30 In times where a 
premium is put on speed, diversity, and efficiency in the drug discovery 
process31,32 , MCR strategies offer significant advantages over conventional 
 
Studies on some bio-active……. 
 
                                                                       Section-IV Synthesis of Dihydropyrimidinthiones 
 62 
linear-type syntheses. MCR condensations involve three or more compounds 
reacting in a single event, but consecutively to form a new product, which 
contains the essential parts of all the starting materials. 
In recent years, many workers have reported improvements in the 
Biginelli reaction include several methods and reagents33-37, such as 
H2SO438, zirconium(IV) chloride39, samarium chloride40, boric acid41, 
ytterbium(III) resin42, 12-molybdophosphoric acid43, silica triflate44, covalently 
anchored sulfonic acid45, phosphonic acid anhydride46, trichloroisocyanuric 
acid47 and N-butyl-N,N-dimethyl-α-phenyl ethyl ammonium bromide48. Most 
reported methods have shortcomings due to expensive reagents, long 
reaction times and unsatisfactory yields. 
Recently, Hitchings et al.49 have reported the synthesis of 2,6-diamino 
and 2-amino-6-hydroxy derivatives of 5-aryl-4,5-dihydropyrimidines. 
Konyukhov and coworkers50 have synthesized 3,4-dihydropyrimidinethiones 
derivatives and studied their biological activity. Some compounds have also 
synthesized by Sammour et al.51. Vasudeva and coworkers52 have also 
synthesized derivatives of benzopyrimidothiadiazines. Spectroscopic studies 
of the pyrimidine-2(1H)thione derivatives have been given by Al-Hajjar et al.53. 
Singh and Kumar54 have studied the synthesis of 1,4-dihydropyrimidine-
2(3H)-thiones/-ones with 1,2- and 1,3-binucleophiles. Postnov et al55. have 
used α,β-unsaturated ferrocenyl ketones in the synthesis of 4,6-disubstituted 
dihydropyrimidinethiones. Ultrasonic synthesis of 3,4-dihydropyrimidin-2(1H)-
thiones have been reported by Gholap and coworkers56. Some new 
dihydropyrimidinones and their serivatives have also been synthesized by 
some workers57-59. 
In this section, the methods for the synthesis of 3,4-dihydropyrimidin-
2(1H)-thiones by the one-pot three component condensation of aromatic 
aldehy- des, β-keto esterand thiourea in the presence of phenol are reported. 
Furher, the characterization of synthesized compounds are done by IR, NMR 
and mass spectral studies. 
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EXPERIMENTAL 
 
Synthesis of RAT series: 
 
Synthesis of N-(2,5-dichlorophenyl)-4-(4-methoxyphenyl)-6-methyl-2-
thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide (RAT-1): 
  
[A] Synthesis of N-(2,5-dichlorophenyl)-3-oxobutanamide. 
 
 A mixture of 2,5-dichloro aniline (0.01 M) and ethyl acetoacetate (0.012 
M) in 25 ml toluene was refluxed for 12 hours in presence of few drops of 
slurry of NaOH in water. The excess of toluene was distilled out and the 
reaction mixture was taken in hexane and was stirred with glass rod. The 
product was isolated in hexane and filtered. It was dried and dissolved in 
aqueous NaOH solution. On neutralization of this solution with dilute HCl, 
product was precipitated. The recrystalisation was done in ethanol.  
 
[B]  Synthesis of N-(2,5-dichlorophenyl)-4-(4-methoxyphenyl)-6-methyl    
           l-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide (RAT-1). 
 
A solution of substituted benzaldehyde (0.01 M), N-(2,5-dichlorophenyl)-
3-oxobutanamide (0.01 M) and thiaourea (0.012 M) in methanol was refluxed 
for 10 hours in presence of few drops of phenol as catalyst. The product was 
isolated and recrystallized from DMF.  
 
 
 
 
 
 
 
 
 
 
 
 
Studies on some bio-active……. 
 
                                                                       Section-IV Synthesis of Dihydropyrimidinthiones 
 64 
REACTION SCHEME 
 RAT series 
 
 [A] Synthesis of N-(2,5-dichlorophenyl)-3-oxobutanamide. 
 
 
 
NH2
Cl
Cl
+ CH3 O CH3
O O
NH
CH3
O
O
Cl
Cl
Toluene
NaOH
120 
o
C
 
 
[B]  Synthesis of N-(2,5-dichlorophenyl)-4-(4-methoxyphenyl)-6-methyl  
            -2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide (RAT-1). 
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Synthesis of RAB series: 
 
Synthesis of 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N-(4-methoxyphenyl)-
6-methyl-N-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
( RAB-1). 
 
[C] Synthesis of substituted 3-oxo-N-phenylbutanamide. 
  
 As per section-III, experiment [A].   
 
[D] Synthesis of 4-methoxy-3,5-dimethylpyridine-2-carbaldehyde. 
 
 As per section-III, experiment [B]. 
 
 [E] Synthesis of 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N-(4-methoxy  
           phenyl)-6-methyl-N-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine- 
           5-carboxamide (RAB-1). 
A solution of 4-methoxy-3,5-dimethylpyridine-2-carbaldehyde (0.01 M), 
substituted 3-oxo-N-phenylbutanamide (0.01 M) and thiaourea (0.012 M) in 
methanol was refluxed for 12 hours in presence of few drops of concentrated 
HCl as catalyst. The product was isolated and recrystallized from DMF.  
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REACTION SCHEME  
RAB series 
[C] Synthesis of substituted 3-oxo-N-phenylbutanamide. 
 
As per section-III, reaction scheme [A] 
 
[D] Synthesis of 4-methoxy-3,5-dimethylpyridine-2-carbaldehyde. 
 
As per section-III, reaction scheme [B] 
 
[E] Synthesis of 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N-(4-methoxy  
           phenyl)-6-methyl-N-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine- 
           5-carboxamide (RAB-1). 
 
NH
CH3
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N
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CH3 CH3
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The following dihydropyrimidinthiones have been synthesized. 
 
1. RAT-1: N-(2,5-dichlorophenyl)-4-(4-methoxyphenyl)-6-methyl-2-       
                                 thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
2. RAT-2 : N-(2,5-dichlorophenyl)-6-methyl-4-phenyl-2-thioxo- 
                                1,2,3,4-tetrahydropyrimidine-5-carboxamide 
3. RAT-3 : N-(2,5-dichlorophenyl)-6-methyl-4-(4-methylphenyl)-2- 
                                thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
4. RAT-4 : N-(2,5-dichlorophenyl)-4-(4-fluorophenyl)-6-methyl-2- 
                                thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide. 5.
 RAT-5 : N-(2,5-dichlorophenyl)-4-(4-hydroxyphenyl)-6-methyl-2- 
                                thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
6. RAT-6 : 4-(3-chlorophenyl)-N-(2,5-dichlorophenyl)-6-methyl-2- 
                                thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
7. RAT-7 : N-(2,5-dichlorophenyl)-6-methyl-4-(3-nitrophenyl)-2- 
                                thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
8. RAT-8 : 4-(2-chlorophenyl)-N-(2,5-dichlorophenyl)-6-methyl-2- 
                                thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
9. RAT-9 : N-(2,5-dichlorophenyl)-6-methyl-4-(2-nitrophenyl)-2- 
                                thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
10. RAT-10: N-(2,5-dichlorophenyl)-4-(2-hydroxyphenyl)-6-methyl-2- 
                                thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
11.  RAB-1: 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N-(4-methoxy  
                                 phenyl)-6-methyl-N-phenyl-2-thioxo-1,2,3,4-tetrahydro  
                                 pyrimidine-5-carboxamide  
12. RAB-2 : N-(4-chlorophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2-    
                                 yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5- 
                                 carboxamide 
13. RAB-3 : N-(3-chlorophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2- 
                                 yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5- 
                                 carboxamide 
14. RAB-4 : N-(4-hydroxyphenyl)-4-(4-methoxy-3,5-dimethylpyridin-2- 
                                 yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5- 
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                                 carboxamide 
15. RAB-5 : N-(2,5-dichlorophenyl)-4-(4-methoxy-3,5-dimethylpyridin- 
                                2-yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5- 
                                carboxamide 
16. RAB-6 : N-(4-fluorophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2-yl)- 
                                 6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5- 
                                 carboxamide 
17. RAB-7 : N-(4-nitrophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2-yl)- 
                                 6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5- 
                                 carboxamide 
18. RAB-8 : 4-(4-methoxy-3,5-dimethylpyridin-2-yl)-6-methyl-N-phenyl 
                                 -2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 
19. RAB-9 : N-(4-methylphenyl)-4-(4-methoxy-3,5-dimethylpyridin-2- 
                                 yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5- 
                                 carboxamide 
20. RAB-10: N-(4-bromophenyl)-4-(4-methoxy-3,5-dimethylpyridin-2- 
                                 yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5- 
                                 carboxamide 
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The various physical constants such as Rf value, melting point and 
percentage of yield for all synthesized dihydropyrimidinthiones are given in 
Table 2.4.1. The melting point was taken by open capillary method.  
 The characterization was done by IR, mass spectra and 1H NMR. 
 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. The IR spectra of RAT-1 and RAB-1 are given in Figures 2.4.1 and 
2.4.2. IR spectral data are given in Tables 2.4.2 and 2.4.3 respectively. The 
spectral data for all other compounds are reported in Table 4. 
 
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. 
Figures 2.4.3 and 2.4.4 shows mass spectra of RAT-2 and RAB-1 
respectively and the proposed mass fragmentation of RAT-2 and RAB-1 are 
given in Schemes 2.4.1 and 2.4.2 respectively. The mass fragmentations of 
other compounds are also given separately.  
 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figures 2.4.3 and 
2.4.4 shows NMR spectra of RAT-1 and RAB-1respectively. The spectral data 
for RAT-1 and RAB-1 are given in Tables 2.3.4 and 2.4.5.  
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Table 2.4.1: Physical constants of dihydropyrimidinthiones. 
  
 
Sr. 
No. 
Code R M.F. 
M. Wt. 
(g/mol)
Rf* 
Value 
M.P. 
oC 
Yield
% 
1 RAT-1 4-OCH3 C19H17Cl2N3O2S 422 0.51 180 56 
2 RAT-2 -H C18H15Cl2N3OS 392 0.62 194 61 
3 RAT-3 4-CH3 C19H17Cl2N3OS 406 0.42 211 53 
4 RAT-4 4-F C18H14Cl2N3OS 410 0.46 254 62 
5 RAT-5 4-OH C18H15Cl2N3O2S 408 0.43 194 57 
6 RAT-6 3-Cl C18H14Cl3N3OS 426 0.46 167 60 
7 RAT-7 3-NO2 C18H14Cl2N4O3S 437 0.57 235 48 
8 RAT-8 2-Cl C18H14Cl3N3OS 426 0.61 247 41 
9 RAT-9 2-NO2 C18H14Cl2N4O3S 437 0.58 238 63 
10 RAT-10 2-OH C18H15Cl2N3O2S 408 0.53 208 60 
11 RAB-1 4-OCH3 C21H24N4O3S 412 0.61 182 52 
12 RAB-2 4-Cl C20H21ClN4O2S 416 0.51 240 41 
13 RAB-3 3-Cl C20H21ClN4O2S 416 0.48 237 35 
14 RAB-4 4-OH C20H22N4O3S 398 0.43 175 48 
15 RAB-5 2,5-Dichloro C20H20Cl2N4O2S 451 0.58 186 40 
16 RAB-6 4-F C20H21FN4O2S 400 0.61 231 36 
17 RAB-7 4-NO2 C20H21N5O4S 427 0.57 210 49 
18 RAB-8 -H C20H22N4O2S 382 0.53 196 43 
19 RAB-9 4-CH3 C21H24N4O2S 396 0.50 208 52 
20 RAB-10 4-Br C20H21BrN4O2S 461 0.43 219 46 
 
                                                                                            
                                                                                                 * Methanol: Chloroform  2:8 
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Figure 2.4.1:  IR spectra of N-(2,5-dichlorophenyl)-4-(4-methoxyphenyl)- 
                       6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbox  
                       Amide (RAT-1). 
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Table 2.4.2: IR spectral data of N-(2,5-dichlorophenyl)-4-(4-methoxyphe  
                     nyl)-6-methyl-2- thioxo-1,2,3,4-tetrahydropyrimidine-5-carb 
                     oxamide (RAT-1). 
 
Frequency in cm-1 Type Vibration mode 
Observed Reported60,61 
C-H str. (asym.) 2964.69 2975-2920 
C-H str. (sym.) 2835.45 2880-2860 
C-H def. (asym.) 1465.96 1500-1435 
Alkane 
 
C-H def.(sym.) 1408.08 1400-1370 
C-H str. 3007.12 3200-3000 
C=C str. 1554.68 1585-1480 
C-H i.p. def. 1116.82 1125-1090 
Aromatic 
C-H o.o.p. def. 815.92 860-810 
Ketones C=O str.  1674.27 1710-1550 
N-H (asym.) 3281.02 3400-3200 Secondary 
amine   N-H (sym) 1554.68 1650-1550 
C-O-C str. (asym.) 1247.99 1400-1000 Ether 
C-O-C str. (sym.) 1028.09 1075-1020 
Sulfur C=S str. 1180.47 1200-1050 
Chlorine C-Cl str. 673.18 600-800 
 
Studies on some bio-active……. 
 
                                                                       Section-IV Synthesis of Dihydropyrimidinthiones 
 72 
Figure 2.4.2:  IR spectra of 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N-(4- 
                       methoxyphenyl)-6-methyl-N-phenyl-2-thioxo-1,2,3,4-tetra  
                       hydropyrimidine-5-carboxamide (RAB-1). 
 
 
 
Table 2.4.3: IR spectral data of 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N- 
                     (4-methoxyphenyl)-6-methyl-N-phenyl-2-thioxo-1,2,3,4-tetra   
                     hydropyrimidine-5-carboxamide (RAB-1). 
 
Frequency in cm-1 Type Vibration mode 
Observed Reported60,61 
C-H str. (asym.) 2961.29 2975-2920 
C-H str. (sym.) 2872.10 2880-2860 
C-H def. (asym.) 1402.30 1500-1435 
Alkane 
 
C-H def.(sym.) 1323.21 1400-1370 
C-H str. 3099.92 3200-3000 
C=C str. 1514.17 1585-1480 
C-H i.p. def. 1105.25 1125-1090 
Aromatic 
C-H o.o.p. def. 850.64 860-810 
Ketones C=O str.  1681.98 1710-1550 
N-H (asym.) 3273.31 3500-3310 Secondary 
amine   N-H (syn.) 1566.25 1650-1550 
C-O-C str. (asym.) 1201.69 1300-1200 Ether 
C-O-C str. (sym.) 1045.45 1075-1020 
Sulfur C=S str. 1105.25 1200-1050 
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Table 2.4.4: IR spectral data of synthesized dihydropyrimidinthaiones 
                     (RAT-2 to RAT-10 and RAB-2 to RAB-10). 
 
IR ν, (cm-1)   
Compounds 
C=C 
str. 
C=S  
 str. 
C=O 
 str. 
  
N-H  
(sym.)
R 
RAT-2 1491 1188  1680 1577 - 
RAT-3 1521 1188 1672 1566 - 
RAT-4 1514 1105 1681 1566 1193 
RAT-5 1508 1099 1681 1575 3282  
RAT-6 1520 1164 1685 1572 771 
RAT-7 1509 1142 1676 1581 1532 
RAT-8 1511 1183 1680 1564 790 
RAT-9 1524 1154 1681 1584 1521 
RAT-10 1507 1114 1691 1570 3295  
RAB-2 1537 1134 1682 1588 752 
RAB-3 1524 1151 1710 1573 761 
RAB-4 1555 1164 1723 1610 3310 
RAB-5 1534 1142 1698 1594 782 
RAB-6 1504 1124 1672 1620 1125 
RAB-7 1564 1107 1691 1576 1534 
RAB-8 1554 1131 1705 1610 - 
RAB-9 1543 1146 1710 1587 - 
RAB-10 1540 1151 1716 1593 663 
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Figure 2.4.3: Mass spectra of N-(2,5-dichlorophenyl)-6-methyl-4-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5- 
                      Carboxamide (RAT-2). 
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Scheme 2.4.1: Proposed mass fragmentation of N-(2,5-dichlorophenyl)-6-methyl-4-phenyl-2-thioxo-1,2,3,4-tetrahydro pyri  
                         midine-5-carboxamide (RAT-2). 
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Figure 2.4.4: Mass spectra of 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N-(4-methoxyphenyl)-6-methyl-N-phenyl-2-thioxo-1,2, 
                      3,4-tetrahydropyrimidine-5-carboxamide (RAB-1). 
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Scheme 2.4.2: Proposed mass fragmentation of 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N-(4-methoxyphenyl)-6-methyl-N- 
 77 
                         phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide (RAB-1). 
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Mass fragment (m/z value) of synthesizes dihydropyrimidinthiones. 
 
RAT-1: 422, 379, 351, 345, 317, 303, 271, 261, 245, 231, 212, 202.  
RAT-3: 406, 386, 245, 225, 211, 199, 187, 169, 161, 145, 126, 109. 
RAT-4: 410, 394, 374, 354, 344, 328, 315, 293, 276, 249, 237, 221. 
RAT-5: 408, 407, 391, 314, 289, 262, 245, 230, 221, 218, 202. 
RAT-6: 426, 412, 390, 374, 360, 331, 314, 284, 267, 265, 239, 229.  
RAT-7: 437, 421, 419, 401, 389, 314, 288, 276, 258, 248, 228, 217. 
RAT-8: 426, 392, 374, 355, 336, 315, 289, 263, 241, 230, 207. 
RAT-9: 437, 420, 395, 377, 356, 340, 316, 301, 283, 276, 254, 211. 
RAT-10: 408, 407, 390, 356, 324, 305, 260, 246, 230, 218, 200. 
RAB-2: 416, 401, 370, 335, 321, 318, 305, 278, 262, 245.  
RAB-3: 416, 373, 355, 320, 337, 310, 303, 281, 232. 
RAB-4: 398, 380, 365, 348, 318, 300, 288, 261, 245. 
RAB-5: 451, 420, 403, 372, 366, 350, 315, 307, 274, 262, 231. 
RAB-6: 400, 386, 370, 336, 303, 274, 264, 248, 220. 
RAB-7: 427, 411, 395, 381, 365, 341, 320, 281, 244, 212. 
RAB-8: 382, 350, 337, 320, 289, 247, 218. 
RAB-9: 396, 350, 336, 304, 290, 261, 244, 226. 
RAB-10: 461, 429, 401, 380, 351, 336, 302, 289, 262. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Studies on some bio-active……. 
 
                                                                       Section-IV Synthesis of Dihydropyrimidinthiones 
 79 
Figure 2.4.5: 1H NMR spectra 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N-(4- 
                       methoxyphenyl)-6-methyl-N-phenyl-2-thioxo-1,2,3,4-tetra             
                       hydropyramidin e-5-carboxamide (RAT-1). 
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Table 2.4.4: 1H NMR spectral data of 4-(4-methoxy-3,5-dimethylpyridin-2- 
                      yl)N-(4-methoxyphenyl)-6-methyl-N-phenyl-2-thioxo-1,2,3,4- 
                      tetrahydropyrimidine-5-carboxamide (RAT-1). 
 
 
 
 
a
b
c
d
iNH
N
H
NH
O
CH3 S
O
H
CH3
Cl
Cl j
k
d'
e e'
f
g
h
 
 
 
 
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No.
of Protons 
Multiplicity Inference J 
(Hz) 
1 2.35 3 singlet -CH3 (a)   - 
2 3.82 3 singlet -OCH3 (b)   - 
3 5.29 1 singlet -CH (c)   - 
4 6.89-6.91 2 doublet Ar-H (dd’) 8.64 
5 6.97-6.98 2 doublet Ar-H (ee’) 8.12 
6 7.22-7.24 1 doublet Ar-H (f) 8.56 
7 7.34-7.36 1 doublet Ar-H (g) 8.68 
8 7.90 1 singlet Ar-H (h) - 
9 8.15 1 singlet -NH (j) - 
10 9.19 1 singlet -NH (j) - 
11 9.86      1 singlet -NH (k) - 
some bio-active……. 
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Figure 2.4.6: 1H NMR spectra of 4-(4-methoxy-3,5-dimethylpyridin-2-yl)N-(4-methoxyphenyl)-6-methyl-N-phenyl-2-thioxo- 
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                       1,2,3,4-tetrahydropyrimidine-5-carboxamide (RAB-1). 
 
 
 
 
Studies on 
 
Studies on some bio-active……. 
 
                                                                       Section-IV Synthesis of Dihydropyrimidinthiones 
 82 
Table 2.4.5: 1H NMR spectral data of 4-(4-methoxy-3,5-dimethylpyridin-2- 
                      yl)N-(4-methoxyphenyl)-6-methyl-N-phenyl-2-thioxo-1,2,3,4- 
                      tetrahydropyrimidine-5-carboxamide (RAB-1). 
 
 
 
 
 
a
b
c
d
i
N
NH
N
H
NH
O
CH3 S
CH3
H
O
CH3
CH3O
CH3
j
k
e
f
g
h
g'
h'
l  
 
 
 
 
 
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative No.
of Protons 
Multiplicity Inference J 
(Hz) 
1 2.13 3 singlet -CH3 (a)   - 
2 2.30 3 singlet -CH3 (b)   - 
3 2.60 3 singlet -CH3 (c)   - 
4 3.66 3 singlet -OCH3 (d)   - 
5 3.80 3 singlet -OCH3 (e)   - 
6 5.68 1 singlet -CH (f) - 
7 6.76-6.78 2 doublet Ar-H (gg’) 6.8 
8 7.12-7.14 2 doublet Ar-H (hh’) 7.16 
9 7.16 1 singlet -H (i) - 
10 8.10 1 singlet -NH (j) - 
11 9.10 1 singlet -NH (k) - 
12 9.74 1 singlet -NH (l)  
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INTRODUCTION 
Thiazolidinones are the derivatives of thiazolidine which belong to an 
important group of heterocyclic compounds containing sulfur and nitrogen in a 
five member ring. 4-Thiazolidinones are containing carbonyl group at 4-
position1. Substituent in the 2, 3 and 5 position may be varied, but greatest 
difference in structure and properties is exerted by the groups attached to 
carbon atom in the 2-position and to nitrogen atom in the 3- position. General 
structure of 4-Thiazolidinones is given below:  
 
NH
S
O
1 2
3
4
5
 
 
A number of 4-thiazolidinone derivatives have been reported to 
possess diversified activities including hypoglycemic action2-8. Thiazolidinone 
ring is a main pharamacophoric group responsible for antidiabetic activity9-11. 
Compounds carrying the thiazolidinone ring have been reported to 
demonstrate a wide range of pharmacological activities which include 
anticonvulsant12, antimicrobial13,14, antiinflammatory15, hypnotic16, anti-
hypertensive17, antitumer18 and antihistaminic19 activities. Further, Singh20 
have reported the fungicidal activity of 5-methyl-3-aryl-2-arylimino-4-
thiazolidinones and their acetoxymercuri derivatives. Pande and Saxena21 
have been measured the antiviral activity of 3-(substituted aminomethyl)-5-
(nitrobenzylidene)- 4-thiazolidinone -2-thiones. 
A lot of research work on thiazolidinones has been done in the past. 
The ucleus is also known as wonder nucleus because it gives out different 
derivatives with all different types of biological activities. Considerable 
confusion concerning the structure of 4-thiazolidinones exist in the early 
literature and noncyclic formulas were at first proposed for pseudothiohy- 
dantoin and for rhodanine22. Various optical and geometrical isomers are 
reported in the references23. A series of regioselective isomers has been 
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reported in someworks24,25. The carbonyl group of 4-thiazolidinone is highly 
unreactive. But in few cases 4-thiazolidinone on reaction with Lawesson’s 
reagent gives corresponding 4-thione derivatives26. A detail study of 
tautomerism in 2-imnothiazolidine-4-one has been done by Akerblom27. 
 Different methods for preparation of 4-thiazolidinone are available in 
literature. Kinetics of formation of 4-thiazolidinones by cyclocondensation 
reaction is given by Lawande and Arbad28. Ishimaru et al. have been used 
DBFOX-Ph/metal complexes as catalysts for enantioselective fluorination of 
3-(2-arylacetyl)-2- thiazolidinones29. 4-thiazolidinones have been synthesized 
by using Phosphine was reported by Gabillet and coworkers30. Many workers 
have been reported the synthesis of 4-thiazolidinones under microwave 
irradiation31,32. 
Literature survey shows that, 4-thaizolidinone are synthesized by many 
workers33-36. Ram and coworkers37 have been synthesized some 3-aryl-2-
arylimino-4-thiazolidinones. Mane and Ingle38 have reported the synthesis of 
3-hydroxy-2-(substituted thiazolyl)-4-thiazolidinones. Roda et al.39 have given 
the preparation of 2-aryl-3-[2'-isopropyl-5'-methylphenoxyacetylamino]-5H-
methyl-4-thiazolidinones. Synthesis 2-aryl/alkyl-3-benzhydryl-4-thiazolidinone- 
s of have reported by Padia and Patel40. Solankee and coworkers41 have 
synthesized 2-(phenylimino)-5-(ω -carboxyhexyl)-4-thiazolidinones. Shi and 
Wang42 have studied the on synthesis of 3-aryl-5-benzoyl-2-thioxo- 4-thiazoli- 
dinones. Upma and Manrao43 have studied the effect of chloro group on 
fungus with 4-thaizolidinone. Lata and Prakash44 have reported the synthesis 
and biological evaluation of 4-thiazolidinones and their ketoazomethines. 
Synthesis of some novel bis-1,2,4-triazolo[3, 4 -b]-1,3, 4-thiadiazoles and bis-
4-thiazolidinone derivatives from terephthalic dihydrazide have been reported 
by Palekar45. 
In this section, some derivatives of 4-thaizolidinones have been 
synthesized and their characterization was done by IR, NMR and mass 
spectra.  
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EXPERIMENTAL 
 
Synthesis of 4-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N-(5-meth  
ylisoxazol-3-yl)benzenesulfonamide (RSAT-1). 
 
 
[A] Synthesis of 4-[(4-methoxybenzylidene)amino]-N-(5-methyl-1,2- 
           oxazol-3-yl)benzenesulfonamide (RSA-1). 
     
           As per section-I.  
 
 
[B] Synthesis of 4-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N- 
           (5-methylisoxazol-3-yl)benzenesulfonamide (RSAT-1). 
 
A mixture of 4-[(4-methoxybenzylidene)amino]-N-(5-methyl-1,2-oxazol-
3-yl)be nzenesulfonamide (RSA-1)  (0.01M) and thioglycolic acid 0.01M was 
heated at 120°C for 10-12 hrs. The reaction mixture was cooled and treated 
with 10% sodium bicarbonate solution. The solid product was thus separated, 
filtered and washed with water and crystallized from absolute ethanol.  
Similarly other Schiff bases were condensed with thioglycolic acid. 
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REACTION SCHEME 
 
[A] Synthesis of 4-[(4-methoxybenzylidene)amino]-N-(5-methyl-1,2- 
           oxazol-3-yl)benzenesulfonamide (RSA-1). 
            
           As per section-I.  
 
 
[B] Synthesis of 4-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N- 
           (5-methylisoxazol-3-yl)benzenesulfonamide (RSAT-1). 
 
 
 
S
O
O
NH
N
O
N
S
O
R
S
O
O
NH
N
O
NCH
SH
OHO
10-12 hrs.
R= Functional group
Reflux
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o
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The following thiazolidinones have been synthesized from sulfamethoxazole. 
 
1. RSAT-1: 4-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N-(5-  
                                 methylisoxazol-3-yl)benzenesulfonamide 
2. RSAT-2: 4-{2-[4-(dimethylamino)phenyl]-4-oxo-1,3-thiazolidin-3-yl}-  
                                 N-(5-methylisoxazol-3-yl)benzenesulfonamide 
3. RSAT-3: 4-[2-(4-fluorophenyl)-4-oxo-1,3-thiazolidin-3-yl]-N-(5- 
                                methylisoxazol-3-yl)benzenesulfonamide 
4. RSAT-4: 4-[2-(4-chlorophenyl)-4-oxo-1,3-thiazolidin-3-yl]-N-(5- 
                                methylisoxazol-3-yl)benzenesulfonamide 
5. RSAT-5: N-(5-methylisoxazol-3-yl)-4-[2-(3-nitrophenyl)-4-oxo-1,3- 
                                 thiazolidin-3-yl]benzenesulfonamide 
6. RSAT-6: N-(5-methylisoxazol-3-yl)-4-[2-(2-nitrophenyl)-4-oxo-1,3- 
                                 thiazolidin-3-yl]benzenesulfonamide 
7. RSAT-7: N-(5-methylisoxazol-3-yl)-4-(4-oxo-2-phenyl-1,3- 
                                 thiazolidin-3-yl)benzenesulfonamide 
8. RSAT-8: 4-[2-(2-chlorophenyl)-4-oxo-1,3-thiazolidin-3-yl]-N-(5- 
                                methylisoxazol-3-yl)benzenesulfonamide 
9. RSAT-9: 4-[2-(3-chlorophenyl)-4-oxo-1,3-thiazolidin-3-yl]-N-(5- 
                                methylisoxazol-3-yl)benzenesulfonamide 
10. RSAT-10: 4-[2-(4-bromophenyl)-4-oxo-1,3-thiazolidin-3-yl]-N-(5- 
                                methylisoxazol-3-yl)benzenesulfonamide 
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The various physical constants such as Rf value, melting point and 
percentage of yield for all synthesized Thiazolidinones are given in Table 
2.5.1. The melting point was taken by open capillary method.  
 The characterization was done by IR, mass spectra and 1H NMR. 
 
Infrared spectra: 
The IR spectra were recorded by SHIMADZU-FTIR-8400 
spectrophotometer in the frequency range of 4000-400 cm-1 by KBr powder 
method. The IR spectra and data for RSAT-1 is given in Figure 2.5.1 and 
Table 2.5.2 respectively. The spectral data for all other compounds are 
reported in Table 2.5.3. 
 
Mass spectra: 
The Mass spectra were recorded by GCMS-SHIMADZU-QP2010. 
Figure 2.5.2 shows mass spectra of RSAT-1. The proposed mass 
fragmentation of RSAT-1 is given in Scheme 2.5.1. The mass fragmentations 
of other compounds are also given separately.  
 
1H NMR Spectra: 
The NMR spectra were recorded by BRUKER Spectrometer (400 MHz) 
using internal reference TMS and solvent CDCl3/DMSO. Figure 2.5.3 shows 
NMR spectra of RSAT-2. The spectral data for RSAT-1 is given in Table 
2.5.4.  
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Table 2.5.1: Physical constants of thaizolidinones. 
 
 
 
Sr. 
No. 
Code R M.F. 
M. Wt. 
(g/mol)
Rf* 
Value 
M.P. 
oC 
Yield
% 
1 RSAT-1 4-OCH3 C20H19N3O5S2 445 0.53 193 31 
2 RSAT-2 4-N(CH3)2 C21H22N4O4S2 458 0.42 274 24 
3 RSAT-3 4-F C19H16FN3O4S2 433 0.61 234 29 
4 RSAT-4 4-Cl C19H16ClN3O4S2 449 0.42 203 30 
5 RSAT-5 3-NO2 C19H16N4O6S2 460 0.43 259 37 
6 RSAT-6 2-NO2 C19H16N4O6S2 460 0.38 184 28 
7 RSAT-7 H C19H17N3O4S2 415 0.46 238 23 
8 RSAT-8 2-Cl C19H16ClN3O4S2 449 0.57 250 35 
9 RSAT-9 3-Cl C19H16ClN3O4S2 449 0.40 286 34 
10 RSAT-10 3-Br C19H16BrN3O4S2 494 0.52 281 28 
 
 
 
                                                                                       * Hexene: Toluene: 7:3 
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Figure 2.5.1:  IR spectra of 4-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin- 
                       3-yl]-N-(5-methylisoxazol-3-yl)benzenesulfonamide  
                       (RSAT-1). 
 
 
 
 
Table 2.5.2: IR spectral data of 4-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazo  
                     lidin-3-yl]-N-(5-methylisoxazol-3-yl)benzenesulfonamide  
                     (RSAT-1). 
 
Frequency in cm-1 Type Vibration mode 
Observed Reported46,47 
C-H str. (sym.) 2895.25 2880-2860 
C-H def. (asym.) 1455.00 1500-1435 Alkane 
C-H def.(sym.) 1400.30 1400-1370 
C-H str. 3005.20 3200-3000 
C=C str. 1577.82 1585-1480 
C-H i.p. def. 1093.67 1125-1090 
Aromatic 
C-H o.o.p. def. 806.27 860-810 
C=O str. 1660.05 1760-1655 
C-N str. 1188.19 1220-1020 Thaizolidinone 
C-S-N str. 644.25 700-600 
Sulfonamide SO2-NH (asym.) 1319.35 1350-1300 
Secondary 
amine N-H (asym.) 3410.00 3500-3310 
ether C-O-C str. (asym.) 1236.41 1300-1200 
 N-O str. 1047.38 1400-1000 
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Table 2.5.3: IR spectral data of synthesized thiazolidinones  
                    (RSAT-2 to RSAT-10). 
 
IR ν, (cm-1)  
Compounds 
C=C str. N-O str. C=N (asym.)  R 
RSAT-2 1564 1064 3425 - 
RSAT-3    1524 1058 3411 1326 
RSAT-4 1532 1100 3464 709 
RSAT-5 1548 1121 3436 1321 
RSAT-6 1564 1092 3434 1342 
RSAT-7 1524 1086 3451 - 
RSAT-8 1560 1134 3427 740 
RSAT-9 1532 1127 3467 761 
RSAT-10 1544 1108 3472 569 
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Figure 2.5.3: Mass spectra 4-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N-(5-methylisoxazol-3-yl)benzenesulfon  
                      amide (RSAT-1). 
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Scheme 2.5.1: Proposed mass fragmentation of 4-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N-(5-methylisoxazol-3- 
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                         yl)benzenesulfonamide (RSAT-1). 
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Mass fragments (m/z value) of synthesized thiazolidinones  
(RSAT- 2 to RSAT-9). 
 
RSAT-2: 458, 443, 428, 414, 376, 361, 352, 338, 320, 315, 292. 
RSAT-3: 433, 418, 414, 400, 388, 351, 338, 317, 304, 272, 253, 237. 
RSAT-4: 449, 434, 414, 400, 367, 352, 338, 290, 288, 254, 238. 
RSAT-5: 460, 444, 445, 414, 398, 378, 348, 318, 300, 276, 267. 
RSAT-6: 460, 441, 413, 390, 364, 350, 327, 302, 276, 268.   
RSAT-7: 415, 400, 372, 358, 338, 332, 317, 287, 254, 212. 
RSAT-8: 449, 432, 414, 399, 351, 328, 288, 244, 231.  
RSAT-9: 449, 430, 414, 384, 342, 338, 300, 276, 240, 228. 
RSAT-10:  494, 479, 464, 444, 432, 412, 400, 382, 361, 354, 344, 320. 
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Table 2.5.4: 1H NMR spectral data of 4-{2-[4-(dimethylamino)phenyl]-4- 
                      oxo-1,3-thiazolidin-3-yl}-N-(5-methylisoxazol-3-yl)benzene  
                      sulfonamide (RSAT-2). 
 
 
 
 
a
b
c
d
g
e
f
g'
h
i
S
O
O
NH
N
O
CH3
N
S
O
N
CH3
CH3
H
H
b'
h'
i'
j
j'
k
 
 
 
 
 
 
 
 
 
Singal 
No. 
Signal 
Position 
(δ ppm) 
Relative 
No. of 
Protons
Multiplicity Inference J 
(Hz) 
1 2.29 3 singlet -CH3 (a) - 
2 3.08 6 singlet N-(CH3)2 (bb’) - 
4.09-4.13 doublet 16.08 
3 
4.15-4.19 
2 
doublet 
-CH2 (cd) 
16.00 
4 6.04 1 singlet -NH (e) - 
5 6.63 1 singlet -H (f) - 
6 7.040-7.044 2 doublet Ar-H (gg’) 1.76 
7 7.05-7.06 2 doublet Ar-H (hh’) 1.84 
8 7.63-7.65 2 doublet Ar-H (ii’) 8.68 
9 7.84-7.85 2 doublet Ar-H (jj’) 2.00 
10 9.86 1 singlet -H (k) - 
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INTRODUCTION 
 Ultrasonics is the science of sound waves deals with mechanical 
vibrations in a solid or fluid at a frequency higher than the range audible to 
humans 20 KHz (20,000 cycles per sec). It is also known as silent waves 
because human beings cannot hear these sound waves. However, bats, 
dogs, whales etc can hear these sound waves so these waves have been 
used in animal communication1.  
 These ultrasonic vibrations have been used for a huge variety of 
applications. The industrial applications of ultrasound waves include welding 
of metals2 and plastics3, ultrasonic cleaning4, sono-chemistry5, polishing and 
cutting of mold steel6-8, non-destructive material testing9, thickness  
measurement10, fluid level measurement11 and medical imaging12, metal-
forming processes13, aircraft14 and drawing15 etc. For the extraction of various 
compounds also16-19, ultrasonic waves have been used.  
 Ultrasonic measurement techniques are familiar to most people from 
their medical applications, it is used for various diagnosis such as brain 
diseases20, dental disease21, vascular diseases22, in urology23, in cancer24 etc. 
It is also used in extraction of insulin25, blood flow estimation26, chemotherapy 
on rats27, combination therapy28 etc. This technique have also been used in 
herbal medicines29 and skin therapy treatment30. Further, it is also applicable 
for the fetus in the imaging tissue anomalies in order to detect defects such as 
tumors 31. 
 In recent years, ultrasonic waves have been applicable to process 
monitoring and control, analyzing of milk composition32, food processing33 etc. 
A number of other applications in food industry have also been reported34-38.  
 In materials science, these waves have been used for the 
determination of some properties of solids such as compressibility39,40, 
specific heat ratios41-43, elasticity44-46 etc. In addition to these, ultrasonic 
waves provide valuable information about the structure of solids47-49 and 
detecting effects in materials.   
 Now a days, lots of interest has been generated on the use of 
ultrasound radiation in synthetic organic chemistry, which includes decrease 
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of reaction time, increase of yield, lower reaction temperature, avoidance of 
phase transfer catalysis, nano particle synthesis etc50-57. 
 In addition to these, Ultrasonic velocity measurements are used to 
study molecular interactions in pure liquids and binary / ternary mixtures58-65 
such as molecular association, dissociation etc. Further, equilibrium constant 
and some thermodynamic properties66-69 of liquids and liquid mixtures can 
also be evaluated by ultrasonic measurements. It provides a powerful, 
effective and reliable tool to investigate the properties of solutions of 
polymers, carbohydrates, amino acids and organic and inorganic compounds.   
 Thus, in the present section, acoustical velocity studies of some 
dihydripirimidinones derivatives (RAT series) in N, N-dimethylformamide 
(DMF) and tetrahydrofuran (THF) solutions were done at 308.15K over a wide 
range of concentrations with a view to understand the molecular interactions 
in these solutions. 
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EXPERIMENTAL 
 The selected solvents, DMF and THF for the present study were 
distilled by the reported procedure70. The synthesized dihydropyrimidin 
thiones derivatives (RAT series)  were recrystallized before use. 
 The densities, viscosities and ultrasonic velocities of pure solvents and 
solutions of diydropyririmidinthiones derivatives (RAT series) of different 
concentrations were measured at 308.15 K by using pyknometer, an 
Ubbelohde suspended level viscometer and single frequency ultrasonic 
interferometer operating at 2 MHz, with the uncertainties of 0.0001 g/cm3, + 
0.06 % and 0.01% respectively. 
Density measurements: 
              The weight of distilled water, pure solvents and solutions of 
synthesized compounds were measured by using pyknometer. The densities 
(ρ) were evaluated by using following equation: 
( ) ( )( )( )3 wt. of solvent or solution density of waterρ g cm = wt. of water                … (3.1.1) 
Viscosity Measurements: 
           To determine the viscosity of solution, Ubbelohde viscometer71 was 
used, which obeys Stoke’s low72. The measured quantity of the distilled water 
/ solvent / solution was placed in the viscometer, which was suspended in a 
thermostat at 308.15 K. The digital stopwatch, with an accuracy of + 0.01 sec 
was used to determine flow time of solutions. Using the flow times (t) and 
known viscosity of standard water sample, the viscosity of solvent (η1) and 
solutions (η2) were determined according to equation: 
                 1 1 1
2 2
t
t 2
η ρ
η ρ=                                      ... 
(3.1.2) 
Sound velocity measurement: 
          Ultrasonic interferometer, (Mittal Enterprise, New Delhi, Model No.      
F-81) working at frequency of 2 MHz was used to determine sound velocity. 
         The solvent / solution were filled in the measuring cell with quartz 
crystal and then micrometer was fixed. The circulation of water from the 
thermostat at 308.15 K was started and test solvent / solution in the cell is 
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allowed to thermally equilibrate. The micrometer was rotated very slowly so as 
to obtain a maximum or minimum of anode current (n). A number of maximum 
reading of anode current were counted. The total distntde (d) travel by the 
micrometer for n=10, was read. The wave length (λ) was determined by the 
equation: 
                                           2d
n
λ =          … (3.1.3) 
 and sound velocity (U) of solvent and solutions were calculated by the 
equation: 
                                                U Fλ=               ... (3.1.4) 
where F is the frequency, which is equal to 2 x 106 Hertz. 
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RESULTS AND DISCUSSION 
         Table 3.1.1 shows the experimental data of density (ρ), viscosity (η) and 
sound velocity (U) of pure solvents and solutions of compounds (RAT series) 
at 308.15 K.  
         From these experimental data, various acoustical parameters like 
specific acoustical impedance (Z), isentropic compressibility (κs), inter molecu 
-lar free length (Lf), molar compressibility (W), Rao’s molar sound function 
(Rm), Vander Waals constant (b), relaxation strength (r), relative association 
(RA), internal pressure (π ), apparent molar compressibility (φk) etc., were 
evaluated using the following equations: 
1.  Specific acoustical impedance: 
          Specific acoustical impedance (Z) can be calculated as: 
    Z U ρ=        ... (3.1.5) 
2.  Isentropic compressibility: 
         Isentropic compressibility ( sκ ) can be evaluated by the equation73:  
     2
1
s U
κ ρ=      … (3.1.6) 
3.  Intermolecular free path length: 
 Jacobson74 proposed an equation to calculate the intermolecular free 
path length (Lf), which is given below: 
     1 2f j sL K κ=        … (3.1.7) 
where KJ is Jacobson constant (=2.0965 X 10
-6)   
4.  Molar compressibility: 
          Molar compressibility (W) can be calculated by the following equation
75
: 
     1 7s
MW κρ
−⎛ ⎞= ⎜ ⎟⎝ ⎠
              … (3.1.8) 
The apparent molecular weight (M) of the solution can be calculated 
according to following equation: 
     1 1 2 2M MW M W= +     … (3.1.9) 
 
where W1 and W2 are weight fractions of solvent and solute respectively. M1 
and M2 are the molecular weights of the solvent and compounds respectively. 
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Table 3.1.1: The density (ρ), ultrasonic velocity (U) and viscosity (η) of  
                     RAT series in DMF and THF at 308.15 K. 
Conc. 
M 
 
 
Density 
ρ 
g.cm-3 
Velocity 
U. 10-5 
cm.s-1 
 
Viscosity
η.103 
poise 
 
Density 
ρ 
g.cm-3 
Velocity 
U. 10-5 
cm.s-1 
 
Viscosity
η.103 
poise 
 
 DMF THF 
 RAT-1 
0.00 0.9338 1.4280 7.4521 0.8798 1.2152 4.7004 
0.01 0.9413 1.4288 7.5964 0.8832 1.2172 4.8664 
0.02 0.9433 1.4296 7.6368 0.8868 1.2232 4.9670 
0.04 0.9470 1.4304 7.6961 0.8898 1.2268 5.1842 
0.06 0.9481 1.4316 7.7658 0.8941 1.2300 5.3508 
0.08 0.9523 1.4336 8.0506 0.8972 1.2336 5.4109 
0.10 0.9569 1.4360 8.5263 0.9005 1.2384 5.6361 
 RAT-2 
0.01 0.9427 1.4312 7.5886 0.8822 1.2196 4.9138 
0.02 0.9447 1.4344 7.6723 0.8843 1.2252 5.0558 
0.04 0.9453 1.4376 7.7378 0.8863 1.2336 5.1527 
0.06 0.9466 1.4408 7.8234 0.8891 1.2380 5.3055 
0.08 0.9485 1.4436 7.9607 0.8925 1.2448 5.4265 
0.10 0.9494 1.4460 8.1469 0.8962 1.2616 5.6246 
 RAT-3 
0.01 0.9409 1.4296 7.5822 0.884 1.2172 4.8685 
0.02 0.9418 1.4328 7.6589 0.8864 1.2208 5.0264 
0.04 0.9462 1.4352 7.7068 0.8886 1.2272 5.1773 
0.06 0.9484 1.4368 7.9183 0.8917 1.2348 5.1542 
0.08 0.9495 1.4400 8.1305 0.8941 1.2368 5.3098 
0.10 0.9553 1.4424 8.6519 0.8978 1.2536 5.4791 
 RAT-4 
0.01 0.9434 1.4272 7.9905 0.8832 1.2044 5.0384 
0.02 0.9457 1.4284 8.3062 0.8861 1.2080 5.1401 
0.04 0.9471 1.4340 8.5554 0.8900 1.2112 5.2127 
0.06 0.9485 1.4460 8.8266 0.8948 1.2224 5.3405 
0.08 0.9504 1.4516 9.1002 0.8981 1.2256 5.4700 
0.10 0.9527 1.4568 9.4756 0.9002 1.2348 5.7679 
 RAT-5 
0.01 0.9421 1.4344 7.8053 0.8845 1.2064 4.9954 
0.02 0.9438 1.4364 8.0776 0.8872 1.2104 4.9499 
0.04 0.9468 1.4412 8.3665 0.8898 1.2136 5.2735 
0.06 0.9479 1.4500 8.6629 0.8925 1.2184 5.4307 
0.08 0.9494 1.4568 8.8725 0.8960 1.2228 5.6706 
0.10 0.9512 1.4668 9.1587 0.8991 1.2288 6.2512 
                                                                                                       Continue….. 
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….. Continue 
Conc. 
M 
 
 
Density 
ρ 
g.cm-3 
Velocity 
U. 10-5 
cm.s-1 
 
Viscosity
η.103 
poise 
 
Density 
ρ 
g.cm-3 
Velocity 
U. 10-5 
cm.s-1 
 
Viscosity
η.103 
poise 
 
 DMF THF 
 RAT-6 
0.00 0.9338 1.4280 7.4521 0.8798 1.2152 4.7004 
0.01 0.9431 1.4316 7.9467 0.8812 1.2244 4.9210 
0.02 0.9448 1.4364 8.2397 0.8862 1.2316 5.1213 
0.04 0.9454 1.4396 8.4966 0.8904 1.2380 5.2640 
0.06 0.9481 1.4424 8.7833 0.8935 1.2428 5.5166 
0.08 0.9521 1.4472 8.9578 0.8962 1.2500 5.7070 
0.10 0.9574 1.4524 9.3023 0.8992 1.2572 5.8350 
 RAT-7 
0.01 0.9431 1.4304 7.7128 0.8836 1.2172 4.9131 
0.02 0.9454 1.4336 7.8145 0.8865 1.2232 5.0543 
0.04 0.9471 1.4364 8.0239 0.8905 1.2276 5.1458 
0.06 0.9489 1.4396 8.2055 0.8954 1.2332 5.2776 
0.08 0.9506 1.4428 8.3513 0.8982 1.2376 5.5031 
0.10 0.9514 1.4452 8.5413 0.9022 1.2420 5.7295 
 RAT-8 
0.01 0.9413 1.4320 7.9164 0.8871 1.2192 4.8951 
0.02 0.9437 1.4344 8.2130 0.8894 1.2256 4.9685 
0.04 0.9450 1.4376 8.4718 0.8924 1.2292 5.0520 
0.06 0.9486 1.4416 8.7180 0.8947 1.2352 5.2114 
0.08 0.9533 1.4460 8.9762 0.8981 1.2368 5.3635 
0.10 0.9552 1.4516 9.3024 0.9002 1.2396 5.5506 
 RAT-9 
0.01 0.9420 1.4224 7.7340 0.8864 1.2184 4.9594 
0.02 0.9456 1.4276 7.8505 0.8892 1.2236 5.1027 
0.04 0.9482 1.4312 8.0585 0.8942 1.2292 5.2084 
0.06 0.9512 1.4336 8.2477 0.8974 1.2356 5.4578 
0.08 0.9532 1.4368 8.4036 0.9005 1.2424 5.5669 
0.10 0.9563 1.4408 8.6078 0.9044 1.2472 5.7197 
 RAT-10 
0.01 0.9442 1.4332 7.8025 0.8933 1.2112 4.9095 
0.02 0.9445 1.4364 8.0634 0.8956 1.2136 5.0260 
0.04 0.9452 1.4408 8.2816 0.8975 1.2184 5.1541 
0.06 0.9493 1.4460 8.6128 0.8991 1.2232 5.2992 
0.08 0.9513 1.4496 8.8516 0.9015 1.2252 5.5001 
0.10 0.9535 1.4552 9.1483 0.9026 1.2288 5.6154 
 
 
 
 
 
Studies on some bio-active……. 
 
                                                                                                     Section-I Acoustical Properties 
 113 
 
5.  Rao’s molar sound function: 
          Rao’s molar sound function (Rm) can be evaluated by an equation 
given by Bagchi et al.
76
. 
             1 3m
MR Uρ
⎛ ⎞= ⎜ ⎟⎝ ⎠
                                  … (3.1.10) 
 
6.  Van der Waals Constant: 
          Van der Waals constant (b) can be calculated as follows77: 
           
2
21 1 3
M RT MUb
MU RTρ
⎧ ⎫
1
⎡ ⎤⎪ ⎛ ⎞= − + − ⎪⎢ ⎥⎨ ⎜ ⎟⎝ ⎠ ⎬⎢ ⎥⎪ ⎪⎣ ⎦⎩ ⎭
   ... (3.1.11) 
where R is the gas constant (=8.3143 JK-1 mol-1) and T is the absolute 
temperature. 
7.  Relaxation Strength: 
          The relaxation strength (r) can be calculated as follows78: 
    
2
1r U
U
= −
∞
⎡ ⎤⎢ ⎥⎣ ⎦
                                   … (3.1.12) 
where  = 1.6 x 105 cm .sec-1.  ∞U
8. Relative Association (RA): 
   
1 3
0
0
A
UR
U
ρ
ρ
⎛ ⎞= ⎜ ⎟⎝ ⎠
             …  (3.1.13) 
where U,  and ,  are ultrasonic velocities and densities of solution and 
solvent respectively. 
0U ρ 0ρ
9.  Internal Pressure: 
          Suryanarayana and Kuppuswamy
79 gave the following equation for 
evaluating internal pressure:  
   
1 2 2 3
7 6
K
bRT
U M
η ρπ ⎡ ⎤= ⎢ ⎥⎣ ⎦
             … (3.1.14) 
where b is the packing factor (= 2). K is a constant (=4.28 X 109).  The 
internal pressure (π ) depends on temperature, density, ultrasonic velocity 
and specific heat at constant pressure. 
10.    Free Volume: 
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   Free volume80 can be calculated according to equation (3.1.15): 
   
3 2
f
n
MUV
K
⎡ ⎤= ⎢ ⎥⎣ ⎦
             …  (3.1.15) 
 
11. Apparent Molar Compressibility (φk): 
The apparent molar compressibility ( Kφ ) of the solutions was calculated 
by the following equation: 
( )0 00 2
0 0
1000s s s
K
M
c
ρ κ ρκ κφ ρ ρ
−= +              … (3.1.16) 
where ρ0 and 0sκ  are density and isentropic compressibility of pure solvent 
respectively, c is the concentration of the solution and M2 is the molecular 
weight of the compound.  
 
12. Solvation number:  
                                    02
1
1 100
s
s
n
M XS
M
κ
κ
⎡ ⎤− −
X
⎡ ⎤= ⎢ ⎥ ⎢ ⎥⎣ ⎦⎢ ⎥⎣ ⎦  
                                   … (3.1.17) 
where X is the number of grams of solute in 100 gm of the solution. M1 and M2 
are the molecular weights of solvent and solute respectively.  
Some of the calculated acoustical parameters are given in Tables 3.1.2 
and 3.1.3 for compounds in DMF and THF solutions respectively.  
Figure 3.1.1 shows the variation of ultrasound velocity (U) with 
concentration in DMF and THF. It is observed that overall ultrasonic velocity 
(U) increases with concentration for all the compounds in both the solvents. 
The velocity depends on intermolecular free length (Lf). Comparison of 
ultrasonic velocity and intermolecular free length (Tables 3.1.2 and 3.1.3) 
shows these two parameters are inversely related. Decrease in the free length 
causes velocity to increase or vice versa. It is evident from Tables 3.1.2 and 
3.1.3 that Lf decrease continuously which is due to strong interaction between 
solvents and compound molecules. This causes velocity to increase. 
The isentropic compressibility (κs) of the solutions in both the solvents 
is also found to decrease with increase of concentration, as shown in Figure 
3.1.2. This phenomenon can be explained by assuming that the solvated  
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Table 3.1.2: Some acoustical parameters of RAT series in DMF at  
                     308.15 K.   
 
Conc. 
M 
Z .10-5 
g.cm-2 
Lf 
Ao 
Rm.10-3 
cm-8/3.s-1/3 
b 
cm3.mol-1 
r RA 
RAT-1 
0.00 1.3335 0.1519 4.0912 78.2697 0.2034 1.0000 
0.01 1.3449 0.1512 4.1462 79.3078 0.2026 1.0078 
0.02 1.3485 0.1509 4.2245 80.7909 0.2017 1.0098 
0.04 1.3546 0.1506 4.3799 83.7459 0.2008 1.0136 
0.06 1.3573 0.1504 4.5470 86.9172 0.1994 1.0145 
0.08 1.3652 0.1498 4.6967 89.7378 0.1972 1.0185 
0.10 1.3741 0.1492 4.8419 92.4603 0.1945 1.0228 
RAT-2 
0.01 1.3492 0.1508 4.1291 78.9375 0.1999 1.0088 
0.02 1.3551 0.1503 4.1966 80.1681 0.1963 1.0102 
0.04 1.3590 0.1499 4.3436 82.9134 0.1927 1.0101 
0.06 1.3639 0.1495 4.4867 85.5822 0.1891 1.0107 
0.08 1.3693 0.1491 4.6255 88.1731 0.1859 1.0121 
0.10 1.3728 0.1488 4.7687 90.8528 0.1832 1.0125 
RAT-2 
0.01 1.3451 0.1511 4.1416 79.2058 0.2017 1.0072 
0.02 1.3494 0.1507 4.2204 80.6525 0.1981 1.0074 
0.04 1.3580 0.1501 4.3605 83.2827 0.1954 1.0116 
0.06 1.3627 0.1498 4.5087 86.0808 0.1936 1.0136 
0.08 1.3673 0.1494 4.6634 88.9691 0.1900 1.0140 
0.10 1.3779 0.1487 4.7892 91.3186 0.1873 1.0196 
RAT-4 
0.01 1.3464 0.1512 4.1299 79.0253 0.2043 1.0105 
0.02 1.3508 0.1509 4.2015 80.3738 0.2030 1.0126 
0.04 1.3581 0.1502 4.3618 83.3303 0.1967 1.0128 
0.06 1.3715 0.1488 4.5281 86.2690 0.1832 1.0115 
0.08 1.3796 0.1481 4.6847 89.1367 0.1769 1.0122 
0.10 1.3879 0.1474 4.8376 91.9358 0.1710 1.0135 
RAT-5 
0.01 1.3513 0.1505 4.2040 80.3085 0.1963 1.0074 
0.02 1.3557 0.1502 4.3405 82.8776 0.1940 1.0087 
0.04 1.3645 0.1495 4.6139 88.0005 0.1886 1.0108 
0.06 1.3745 0.1485 4.9004 93.2761 0.1787 1.0099 
0.08 1.3831 0.1477 5.1817 98.4765 0.1710 1.0100 
0.10 1.3952 0.1465 5.4639 103.6024 0.1596 1.0096 
                             Continue….. 
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    ….. Continue       
Conc. 
M 
Z .10-5 
g.cm-2 
L  f
Ao 
R .10-3 m
cm-8/3.s-1/3 
b 
cm3.mol-1 
r RA 
RAT-6 
0.00 1.3501 0.1519 4.1426 79.1881 0.2034 1.0000 
0.01 1.3571 0.1508 4.2279 80.7268 0.1994 1.0091 
0.02 1.3610 0.1501 4.4045 84.0375 0.1940 1.0098 
0.04 1.3675 0.1497 4.5692 87.1241 0.1904 1.0097 
0.06 1.3779 0.1492 4.7270 90.0330 0.1873 1.0119 
0.08 1.3905 0.1484 4.8751 92.7418 0.1819 1.0151 
0.10 1.3501 0.1.475 4.1426 79.1881 0.1760 1.0195 
RAT-7 
0.01 1.3490 0.1509 4.1466 79.2858 0.2008 1.0094 
0.02 1.3553 0.1504 4.2325 80.8679 0.1972 1.0111 
0.04 1.3604 0.1499 4.4130 84.2621 0.1940 1.0123 
0.06 1.3660 0.1495 4.5923 87.6211 0.1904 1.0134 
0.08 1.3715 0.1490 4.7711 90.9652 0.1868 1.0145 
0.10 1.3750 0.1487 4.9535 94.3907 0.1841 1.0148 
RAT-8 
0.01 1.3479 0.1509 4.1511 79.3428 0.1990 1.0071 
0.02 1.3536 0.1504 4.2310 80.8248 0.1963 1.0091 
0.04 1.3585 0.1500 4.4045 84.0759 0.1927 1.0097 
0.06 1.3675 0.1493 4.5657 87.0729 0.1882 1.0126 
0.08 1.3785 0.1484 4.7189 89.9030 0.1832 1.0166 
0.10 1.3866 0.1477 4.8874 92.9933 0.1769 1.0173 
RAT-9 
0.01 1.3399 0.1518 4.1438 79.3805 0.1972 1.0101 
0.02 1.3499 0.1510 4.2256 80.8500 0.1949 1.0127 
0.04 1.3571 0.1504 4.4021 84.1561 0.1922 1.0147 
0.06 1.3636 0.1499 4.5735 87.3837 0.1859 1.0173 
0.08 1.3696 0.1494 4.7495 90.6788 0.1832 1.0187 
0.10 1.3778 0.1488 4.9184 93.8175 0.1742 1.0211 
RAT-10 
0.01 1.3532 0.1505 4.1312 78.9403 0.1976 1.0099 
0.02 1.3567 0.1.501 4.2132 80.4465 0.1940 1.0095 
0.04 1.3618 0.1496 4.3746 83.4435 0.1891 1.0092 
0.06 1.3727 0.1488 4.5187 86.0894 0.1832 1.0124 
0.08 1.3790 0.1482 4.6706 88.9091 0.1792 1.0137 
0.10 1.3875 0.1475 4.8225 91.6820 0.1728 1.0147 
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Table 3.1.3: Some acoustical parameters of RAT series in THF at  
                     308.15 K.   
 
Conc. 
M 
Z .10-5 
g.cm-2 
Lf 
Ao 
Rm.10-3 
cm-8/3.s-1/3 
b 
cm3.mol-1 
r RA 
RAT-1 
0.00 1.0691 0.1839 4.0591 81.9481 0.4232 1.0000 
0.01 1.0750 0.1833 4.1395 83.5256 0.4213 1.0033 
0.02 1.0847 0.1820 4.2223 85.0564 0.4155 1.0058 
0.04 1.0916 0.1812 4.3969 88.4869 0.4121 1.0082 
0.06 1.0997 0.1803 4.5615 91.7198 0.4090 1.0122 
0.08 1.1068 0.1794 4.7309 95.0333 0.4056 1.0147 
0.10 1.1152 0.1784 4.8985 98.2733 0.4009 1.0171 
RAT-2 
0.01 1.0759 0.1830 4.1329 83.3364 0.4190 1.0015 
0.02 1.0834 0.1820 4.2088 84.7383 0.4136 1.0024 
0.04 1.0933 0.1805 4.3675 87.7326 0.4056 1.0024 
0.06 1.1007 0.1796 4.5160 90.6090 0.4013 1.0043 
0.08 1.1110 0.1783 4.6624 93.3762 0.3947 1.0063 
0.10 1.1306 0.1755 4.8180 96.0615 0.3783 1.0060 
RAT-3 
0.01 1.0760 0.1832 4.1280 83.2935 0.4213 1.0042 
0.02 1.0821 0.1824 4.2063 84.7887 0.4178 1.0060 
0.04 1.0905 0.1812 4.3734 88.0039 0.4117 1.0067 
0.06 1.1011 0.1798 4.5358 91.0839 0.4044 1.0081 
0.08 1.1058 0.1793 4.6937 94.2036 0.4025 1.0103 
0.10 1.1255 0.1765 4.8609 97.1233 0.3861 1.0099 
RAT-4 
0.01 1.0740 0.1835 4.1324 83.4087 0.4224 1.0036 
0.02 1.0793 0.1829 4.2083 84.8943 0.4205 1.0064 
0.04 1.0865 0.1820 4.3658 88.0049 0.4178 1.0100 
0.06 1.0938 0.1813 4.5142 90.9560 0.4163 1.0150 
0.08 1.1007 0.1805 4.6703 94.0190 0.4132 1.0179 
0.10 1.1116 0.1789 4.8397 97.1868 0.4044 1.0177 
RAT-5 
0.01 1.0752 0.1834 4.1917 84.6147 0.4228 1.0052 
0.02 1.0792 0.1830 4.3321 87.4309 0.4220 1.0081 
0.04 1.0848 0.1823 4.6259 93.2879 0.4194 1.0103 
0.06 1.0896 0.1818 4.9144 99.0620 0.4178 1.0129 
0.08 1.0956 0.1811 5.1944 104.6497 0.4159 1.0163 
0.10 1.1048 0.1799 5.4793 110.2100 0.4102 1.0182 
   Continue….. 
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    ….. Continue         
Conc. 
M 
Z .10-5 
g.cm-2 
L  f
Ao 
R .10-3 m
cm-8/3.s-1/3 
b 
cm3.mol-1 
r RA 
RAT-6 
0.00 1.0691 0.1839 4.0591 81.9481 0.4232 1.0000 
0.01 1.0789 0.1824 4.1593 83.7594 0.4144 1.0011 
0.02 1.0914 0.1808 4.2389 85.1956 0.4075 1.0028 
0.04 1.1023 0.1795 4.4148 88.5789 0.4013 1.0058 
0.06 1.1104 0.1785 4.5924 92.0221 0.3967 1.0080 
0.08 1.1203 0.1772 4.7734 95.4649 0.3896 1.0091 
0.10 1.1305 0.1759 4.9509 98.8256 0.3826 1.0105 
RAT-7 
0.01 1.0755 0.1832 4.1451 83.6381 0.4213 1.0038 
0.02 1.0844 0.1820 4.2387 85.3869 0.4155 1.0054 
0.04 1.0932 0.1810 4.4237 89.0069 0.4113 1.0087 
0.06 1.1042 0.1797 4.6020 92.4539 0.4059 1.0128 
0.08 1.1116 0.1787 4.7883 96.0817 0.4017 1.0147 
0.10 1.1205 0.1777 4.9647 99.5040 0.3974 1.0180 
RAT-8 
0.01 1.0816 0.1826 4.1251 83.1895 0.4194 1.0072 
0.02 1.0900 0.1814 4.2161 84.8753 0.4132 1.0080 
0.04 1.0969 0.1805 4.3936 88.3634 0.4098 1.0105 
0.06 1.1051 0.1794 4.5761 91.8835 0.4040 1.0114 
0.08 1.1108 0.1789 4.7449 95.2312 0.4025 1.0148 
0.10 1.1159 0.1783 4.9212 98.6951 0.3998 1.0164 
RAT-9 
0.01 1.0800 0.1828 4.1331 83.3675 0.4201 1.0066 
0.02 1.0880 0.1817 4.2257 85.1153 0.4152 1.0084 
0.04 1.0992 0.1804 4.4057 88.6055 0.4098 1.0125 
0.06 1.1088 0.1791 4.5934 92.2213 0.4036 1.0144 
0.08 1.1188 0.1778 4.7802 95.7960 0.3970 1.0160 
0.10 1.1280 0.1768 4.9571 99.2144 0.3924 1.0191 
RAT-10 
0.01 1.0820 0.1831 4.0784 82.4271 0.4270 1.0165 
0.02 1.0869 0.1825 4.1550 83.9196 0.4247 1.0184 
0.04 1.0935 0.1816 4.3200 87.1374 0.4201 1.0192 
0.06 1.0998 0.1808 4.4856 90.3609 0.4155 1.0197 
0.08 1.1045 0.1802 4.6423 93.4659 0.4136 1.0219 
0.10 1.1091 0.1796 4.8076 96.7000 0.4102 1.0221 
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molecules are fully compressed by the electrical forces of the ions81. The 
compressibility of the solution is mainly due to the free solvent molecules. Due 
to solute-solvent interactions in the system, compressibility of the solution 
decreases with the increase in solute concentration. This is further confirmed 
by decrease of relaxation strength (r) and increase in specific impedance (Z) 
values (as reported in Tables 3.1.2 and 3.1.3). The increase in viscosity in 
both solvents also confirms the same. The association between solute and 
solvent molecules is further confirmed by relative association (RA) values, 
which are found to increase continuously with concentration for all the 
compounds in both the solvents.  
Further, Figure 3.1.3 shows variation of molar compressibility (W) with 
concentration for all the derivatives. There is linear increase in molar 
compressibility. Tables 3.1.2 and 3.1.3 shows that Vander Waal’s constant (b) 
and Rao’s molar sound function (Rm) also increases linearly with 
concentration for all the derivatives. The correlation coefficients for these 
parameters are in the range of 0.9800- 0.9979. The linear increase of these 
parameters suggests the absence of complex formation in these systems.  
The interactions in a solution can also be confirmed by the solvation 
number, which is a measure of structure forming or structure breaking 
tendency of a solute in a solution. Figure 3.1.4 shows that for all the 
compounds, solvation number (Sn) increases with concentration. Further, 
these Sn values are positive for all the compounds in both the solvents. The 
positive Sn values suggest structure forming tendency of compounds in 
solution.  This further confirms that there exist strong solute-solvent 
interactions in studied solutions.  
The isentropic compressibility of all the solutions were also fitted to the 
following Bachem’s relation82: 
        0 3 2s s AC BCκ κ= + +                        … (3.1.18) 
From the plot of ( )0 /s s Cκ κ−
0
 verses √C, values of A and B were 
evaluated from the intercept and slope respectively. sκ  is the isentropic 
compressibility of pure solvent.     
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Figure 3.1.1: Variation of ultrasonic velocity (U) of RAT series with concentration in [A] DMF and [B] THF at 308.15 K. 
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Figure 3.1.2: Variation of Isentropic compressibility (κs) of RAT series with concentration in [A] DMF and [B] THF at  
                      308.15 K. 
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Figure 3.1.3: Variation of Molar compressibility (W) of RAT with concentration in [A] DMF and [B] THF at 308.15 K. 
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Further, the apparent molar compressibility (φk) of the solutions is fitted 
to Gucker’s relation83. 
                                              φk = φok + Sk √C                   … (3.1.19) 
From the plot of φk verses √C, φok and Sk values are evaluated from the 
intercept and slope.  
 The apparent molar volumes ΦV of the solutions were calculated by the 
following equation: 
   Φv = M/ρ-[1000(ρ-ρ0)/ρc]                                                          …. (3.1.20) 
and were fitted in the relation: 
    ΦV = ΦVo +Sv C                                 …. (3.1.21) 
From the plot of ΦV verses C, ΦVo and Sv values were calculated from 
the intercept and slope respectively. Sv is the measure of solute-solvent 
interaction. All these values are given in Table 3.1.4. 
It is evident from Table 3.1.4 that in DMF solutions, A, φok, and ΦV
o
 
values are negative whereas B and φok values are positive for all the 
compounds. The negative A, φok , ΦV
o
 and positive B values indicate solute-
solvent interactions in studied systems.  This is again confirmed by the 
positive and higher Sk and Sv values, which are known as interaction 
parameters.  
Thus, in the studied systems, solute-solvent interactions dominate in 
both DMF and THF solutions. 
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Figure 3.1.4: Variation of Solvation Number (Sn) of RAT series with concentration in [A] DMF and [B] THF at 308.15 K. 
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Table 3.1.4: Bachem’s constants A and B, φok and Sk, ΦVo and Sv of RAT         
                     series DMF and THF at 308.15 K.  
 
 
Comp. 
A X 1011 
dyn-1. cm3 
mol-1 
B X 1011 
dyn-1.cm-1/2 
mol-3/2 
φok X 108 
dyn-1.mol-1 
Sk X 108 
dyn-1cm-3/2 
mol-3/2 
ΦVo Sv 
DMF 
RAT-1 -5.38 12.96 -3.15 6.19 -721.00 10115.25 
RAT-2 -8.83 23.16 -12.6 41.10 -782.20 9917.54 
RAT-3 -6.07 13.63 -8.23 25.30 -407.32 3764.68 
RAT-4 -4.70 5.68 -8.83 24.64 -618.00 6772.78 
RAT-5 -10.02 23.14 -12.55 38.99 -521.00 5602.04 
RAT-6 -9.27 22.64 -5.13 7.65 -537.65 5560.84 
RAT-7 -8.42 21.43 -12.22 39.82 -545.71 5104.91 
RAT-8 -8.02 18.61 -10.48 31.55 -466.93 4365.00 
RAT-9 -3.83 5.83 -6.01 17.29 -608.97 6180.61 
RAT-10 -10.76 27.60 -14.97 49.91 -524.55 5334.67 
THF 
RAT-1 -20.24 51.44 -33.04 99.86 -1098.06 11063.82 
RAT-2 -14.38 28.22 -15.25 32.44 -531.96 4487.24 
RAT-3 -8.42 3.43 -9.46 7.03 -491.67 1562.06 
RAT-4 -4.77 1.77 -22.44 73.84 -1094.05 10218.58 
RAT-5 -28.8 0.18 -16.59 40.80 -1785.39 10025.34 
RAT-6 -20.34 37.15 -18.27 25.61 -960.14 5218.38 
RAT-7 -14.23 28.05 -19.27 45.73 -766.20 5187.94 
RAT-8 -14.56 32.95 -18.31 52.85 -690.00 6086.35 
RAT-9 -12.06 18.41 -15.44 33.50 -663.37 4796.00 
RAT-10 -3.31 1.52 -2.55 6.97 -317.46 2664.52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Studies on some bio-active……. 
 
                                                                                                     Section-I Acoustical Properties 
 126 
LITERATURE CITED 
1. J. J. Vatine, A. Ratner, M. Dvorkin and Z. Seltzer; A novel computerized system for 
analyzing motor and social behavior in groups of animals, J. Neurosci. Meth., 85, 1-
11 (1998). 
2. B. Langenecker; Metal deformation in macrosonic field, SAE transactions, 74, 499-
505 (1966). 
3. I. Petrov, G. Bakharov and G. arag'ozov; Plasticity of zinc after treatment with 
ultrasound during solidification, Metalurgiya, 40, 24-26 (1985). 
4. H. Lee; Sterilizing system for food, which comprises air droplet washing unit, 
chemical sterilizing unit, ultrasonic wave washing unit, drying unit and cleaning unit, 
Kon. Tae. Kon., 4, 215-218  (2006),    
5. L. Cui, J. Shao, J. Wang, J. Bai and Y. Zhang; Ultrasound elastography of ethanol-
induced hepatic lesions: in vitro Study, J. Chin. Med. Sci., 24, 81-85 (2009). 
6. A. V. Markov, B. G. Kuznetsov, M. L. Tsvetkov, N. A. Tkachenko and G. G. Gulei; 
Continuous casting of Kh18N10T steel under ultrasound vibration of the mold walls, 
Stal, 6, 32-34 (1990). 
7. Y. S. Ushakov, A. A. Kudinov, I. M. Knyazev, E. S. Tret'yakova and G. A. Kozlova; 
Method for manufacture of powder-metallurgical articles from matrix high-speed 
steels. Russ. (2002).  
8. J. Schneider, A. Kienzler, M. Deuchert, V. Schulze, J. Kotschenreuther, K. H. Zum  
Gahr, D. Loehe and J. Fleischer; Mechanical structuring, surface treatment and     
tribological characterization steel mould inserts for micro powder injection moulding      
Microsystem,Technologies, 14, 1797-1803 (2008). 
9. B. H. Hanson; Present and future uses of titanium in engineering, Materials and 
design, 7, 301-307 (1986).  
10. Fleischmann and Bernhard; Ultrasonic determination of the residual wall thickness of 
glass furnace refractories, Glass Sci. Tech., 70, 1-7 (1997). 
11. Y. Ding, Q. Qiu, Z. Cui, Q. Li and L. Liu. Study of extracting the volatile components 
in roots from Homalomena occulta (Lour.) Schott. by supercritical fluid extraction and 
ultrasonic solvent extraction, Shizhen Guoyi Guoyao, 17, 533-536 (2006). 
12. Y. Nishikubo, K. Morita and K. Fukusaka; Organic piezoelectric film, method of 
forming the same, and, fabricated using the film, ultrasonic oscillator, ultrasonic probe  
and ultrasonic medical imaging diagnostic apparatus, PCT Int. Appl., 20, 47-52 
(2009). 
13. M. Geiger, U. Engel, S. Niederkorn and M. Pfestorf; Experimental methods to 
measure contact mechanisms in metal forming processes, Tribologie und Schmi., 43, 
113-119 (1996). 
14. A. I. Bykov, S. N. Shestukhina, D. V. Motorin, N. V. Mukhin, N. V. Vymorkov, B. V. 
Chernyshov and B. T. Fedotov; Production of improved quality fibrous prepregs by 
two step ultrasonic impregnation for use in air and space crafts, Russ., 7pp (2008). 
 
Studies on some bio-active……. 
 
                                                                                                     Section-I Acoustical Properties 
 127 
15. K. Sato, M. Tanaka and T. Ishikawa; The ultrasonic probe cable and its 
manufacturing method, Jpn. Kokai Tokkyo Koho , 7pp (2009),  
16. K. M. Sadeghi, M. A. Sadeghi, G. V. Chilingarian and T. F. Yen; Development of a 
new method for extraction of bitumen from bituminous sands using ultrasound and 
sodium silicate, Geolo. Nei J. Gaza, 8, 53-57 (1988). 
17. H. Huang and S. Yang; Toward efficient synthesis of endohedral metallofullerenes by 
arc discharge of carbon rods containing encapsulated rare earth carbides and 
ultrasonic soxhlet extraction, Chem. Mate., 12, 2715-2720 (2000). 
18. H. Lu, J. Zhao, L. Li, S. Huang, W. Li and W. Yang; Ultrasonic extraction and 
identification of total flavanone from longan leaves, Weili. Yua. Yu Jian. Yan., 24, 48-
49 (2007). 
19. H. Li, W. Hu, Y. Li, Z. Zhang, H. Lei, Y. Zhang and L. Liu; HPLC determination of 
homoharringtonine in Cephalotaxus sinesis with ultrasonic extraction, Hua. Fen., 45, 
466-467 (2009). 
20. K. T. Dussik; Additional results of ultrasonic investigation of brain diseases, Acta 
neuro., 2, 379-401 (1952). 
21. D. Zietowska, M. Zietek and B. Plonka; Ultrasonic application in the dental prosthetic 
laboratory, Protetyka stomatologiczna, 26, 39-44 (1976). 
22. K. H. Vogelberg, M. Muhl and M. Kohler; Doppler ultrasound determination of 
maximal blood flow velocity in the diagnosis of peripheral arterial occlusive diseases      
in diabetes mellitus, Klinische Wochenschrift, 65, 713-718 (1987).  
23. H. Knonagel; Interventional sonography in urology. What makes ultrasound so useful    
?, Urol.  Inter., 45, 241-250 (1990).  
24. S. Liu, Y. Yang and T. Yu; The use of ultrasound to synergize the effect of taxol 
against human ovarian cancer cells HO-8910PM, Chongqing Yike Daxue Xuebao, 
33, 1437-1439 (2008).  
25. J. Zayas; Effect of ultrasound treatment on the extraction of insulin, Biotech Bioengin.   
, 27, 1223-1228 (1985). 
26. D. Vray, A. Needles, V. X. D. Yang and F. S. Foster; High-frequency B-mode ultra 
sound blood flow estimation in the microvasculature, IEEE Ultrasonics Symposium, 1, 
466-469 (2004).  
27. B. J. Staples, B. L. Roeder, G. A. Husseini, O. Badamjav, G. B. Schaalje and W. G. 
Pitt; Role of frequency and mechanical index in ultrasonic enhanced chemotherapy in 
rats, Cancer Chemo. Pharmac., 64, 593-600 (2009). 
28. D. Harri; Combination ztherapy, PCT Int. Appl. 11pp (2009). 
29. X. Xu; Application of ultrasonic technology in Chinese herbal medicine extraction, 
Zhon. Yaof., 18, 1426-1429 (2007). 
30. N. B. Smith; Applications of ultrasonic skin permeation in transdermal drug delivery, 
Expert Opinion on Drug Delivery, 5, 1107-1120 (2008). 
 
Studies on some bio-active……. 
 
                                                                                                     Section-I Acoustical Properties 
 128 
31. H. Qi, S. Tan, Y. Ma and C. Song; Synergistic effects of focus ultrasound with 
different frequency and hematoporphyrin on human tumor cells, Life Sci., 41, 520-524 
(1998).  
32. D. Liu, X. Ye and M. Guo; Ultrasonic wave milk composition analyzer, Faming Zhuanli 
Shenqing Gongkai Shuomingshu, 11pp (2003). 
33. S. C. Lee, and B. Y. Cha; Method for processing egg laid by hen fed with maggot 
growing in snake corpse, Korean Kongkae Taeho Kongbo, 8pp (2009). 
34. L. Vaverka, J. Skalsky, L. Jaeger, F. Markalous, M. Bulicka and S. Tesar. Workup of 
sludges containing calcium sulfate dihydrate. Czech., 5, 2-10 (1975).  
35. E. Acton and G. J. Morris; Controlling solidification of foodstuffs and emulsions at or       
near the freezing point using ultrasound, PCT Int. Appl. 48pp (1992).  
36. A. N. Baklanov, F. A. Chmilenko and V. T. Chuiko; Photometric determination of  
boron in cooking salt and brines with use of ultrasound, J. Khimicheskoi Tekhnologii, 
97, 99-103 (1992).  
37. A. Brogna, R. Ferrara, A. M. Bucceri, F. Catalano, G. Natoli and V. Locata; Gastric 
emptying rates of solid food in relation to body mass index: an ultrasonographic and 
scintigraphic study, Euro. J. adiology, 27, 258-263 (1998).  
38. Y. Sahi and B. Sun; The effects of ultrasonic wave on oil adsorption of alcohol 
precipitated soy protein concentrate, Shipin Gongye Keji, 26, 84-86 (2005).  
39. M. Burstein and S. Lewi; The physical properties of the plasma clot; compressibility 
and retraction by ultrasonics, Soc. Biol. Fil., 146, 1544-1546 (1952). 
40. K. K. Shung and J. M. Reid; Ultrasound velocity in major bovine blood vessel walls, J. 
Acoust. Soc., 64, 692-694 (1978). 
41. M. Nikoonahad and M. V. Iravani; Focusing ultrasound in biological media, IEEE,       
36, 209-215 (1989). 
42. S. Halstenberg, T. Heimburg, T. Hianik, U. Kaatze and R. Krivanek; Cholesterol-
induced variations in the volume and enthalpy fluctuations of lipid bilayers, J. Biophys 
, 75, 264-271 (1998). 
43. W. L. Lin, C. T. Liauh, Y. Y. Chen, H. C. Liu and M. J. Shieh; Theoretical study of 
temperature elevation at muscle/bone interface during ultrasound hyperthermia, Med. 
Phys., 27, 1131-1140 (2000). 
44. R. Cadossi, F. Terlizzi, V. Cane, M. Fini and C. Wüster; Assessment of bone 
architecture with ultrasonometry: experimental and clinical experience, Horm Res.,     
54, 9-18 (2000). 
45. A. Achiron, S. Edelstein, Y. Ziev-Ner, U. Givon, Z. Rotstein and  Y. Barak; Bone  
strength in multiple sclerosis: cortical midtibial speed-of-sound assessment, Mult 
Scler., 10, 488-493 (2004). 
46. M. Fahey, H. H. Ko, S. Srivastava, W. W. Lai, S. Chatterjee, I. A. Parness and I. D. 
Lytrivi; A comparison of echocardiographic techniques in determination of arterial 
elasticity in the pediatric population, Echocardiography, 26, 567-573 (2009). 
 
Studies on some bio-active……. 
 
                                                                                                     Section-I Acoustical Properties 
 129 
47. E. R. Fuller, A. V. Granato, J. Holder and E. R. Naimon; Ultrasonic studies of the 
properties of solids, Methods Exp. Phy., 11, 371-441 (1974). 
48. J. M. Baud, P. Lemasle, C. Gras, C. B. De and J. F. Tricot; Doppler ultrasonic                       
evaluation of the embolism-causing potential of carotid artery plaques apropos of                  
113 macroscopic findings, J. des maladies vasculaires, 13, 33-40 (1988). 
49. W. Cai and V. Yang; Transient combustion response of AP/HTPB composite solid 
propellant to acoustic oscillations in a rocket motor, CPIA Publication, 701, 759-786 
(2000). 
50. J. R.Guest, C. W. Helleiner, M. J. Cross and D. D. Woods; Cobalamin and the  
synthesis  of methionine by ultrasonic extracts of Escherichia coli, Biochemi. J., 76, 
396-405 (1960). 
51. M. Cruceanu, E. Popovici and I. Nicolaescu; Synthesis of the molecular sieves in 
ultrasonic field, Chimie, 20, 223-229 (1974).     
52. J. L. Luche, C. Petrier and C. Dupuy; Ultrasound in organic synthesis: Preparation 
and some reactions of colloidal potassium, Tetra. Lett., 25, 753-756 (1984). 
53. O. D. Lucchi and G. Delogu; Inducing reactivity in organic synthesis by means of   
special techniques, Semin. Org. Synth., Summer Sch. "A. Corbella", 17th, 287-312 
(1992). 
54. U. Kunz, U. Hoffmann, A. Rosenplaenter and C. Horst; Use of ultrasonics for solid/ 
liquid reaction, Ger. 20pp (1999).  
55. Y. J. Bian, J. T. Li, T. S. Li; Applications of ultrasound in organic synthesis using 
metal reagents, Youji Huaxue, 22, 227-232 (2002).  
56. C. Amiens and B. Chaudret; Organometallic; synthesis of nanoparticles, Modern Phy. 
Lett., 21, 1133-1141 (2007). 
57. C. Wei, Y. Zhang, Z. Jia, L. Zhang and J. Zhou; Method for increasing the yield of p-
nitrotoluene by using ultrasonic wave technology, Faming Zhuanli Shenqing Gongkai 
Shuomingshu, 10pp (2009).  
58. S. Sternberg and V. Vasilescu; Ultrasonic velocity compressibility, and excess volume 
for binary mixtures of molten salts magnesium chloride + barium chloride, magnesium 
chloride + potassium chloride, J. Chem. Thermo., 1, 595-606 (1969).  
59. A. Sivaraman, M. K. Tiwari, P. E. S. Kartha and P. Chandrasekhar; High pressure 
ultrasonic velocity measurements in critical binary liquid system cyclohexane + acetic 
anhydride, Proceedings of the Nuclear Physics and Solid State Physics Symposium. 
19, 494-497 (1976).  
60. H. Tanaka, H. Nakajima and Y. Wada; Sound velocity in critical binary mixtures,   
Jap. J. Appl. Phy., 21, 89-91 (1982). 
61. S. S. Bhatti, K. P. Prabhakar and D. P. Singh; Acoustical and optical investigations of 
a ternary liquid mixture at its miscibility point, Ind. J. Phy., 69, 389-398 (1995). 
62. K. Vijayalakshmi, V. Lalitha and R. Gandhimathi; Acoustic and excess parameter 
studies on interaction in ternary liquid mixtures, J. Pure and Appl. Ultraso., 28, 154-
 
Studies on some bio-active……. 
 
                                                                                                     Section-I Acoustical Properties 
 130 
156 (2006). 
63. V. K. Syal and S. Chauhan; Physico-chemical investigations of some solutes in binary 
non-aqueous solvent mixtures, J. Ind. Council of Chemists, 11, 53-58 (1995).    
64. G. V. Rao, S. A. Rama, R. C. Viswanatha and D. R. Ramachandran; Excess 
transport properties of binary mixtures of methanol and pyridine through ultrasonic 
measurements at different temperatures, Ind. J. Chem., 46, 1972-1978 (2007). 
65. S. Azhagiri, S. Jayakumar, R. Padmanaban, S. Gunasekaran and S. Srinivasan; 
Acoustic and Thermodynamic Properties of Binary Liquid Mixtures of Benzaldehyde 
in Hexane and Cyclohexane, J. Sol. Chem., 38, 441-448 (2009). 
66. R. T. Jacobsen and R. B. Stewart; Thermodynamic properties of nitrogen including 
liquid and vapor phases from 63 to 2000.deg. K with pressures to 10,000 bar, J. Phy. 
Chemi. Refe. Data, 2, 757-922 (1973). 
67. D. P. Singh and B. Singh; On the acoustical and thermodynamical investigations of 
molten alkali metals, Acta Ciencia Indica, 21, 65-68 (1995). 
68. J. L. Daridon, B. Lagourette and A. Lagrabette; Acoustic determination of 
thermodynamic properties of ternary liquid mixtures up to 150 MPa, Phy. and Chemi. 
Liq., 37, 137-160 (1999). 
69. R. M. Nath, A. Banerjee and A. Choudhury; Theological, thermodynamic and       
 ultrasonic study of binary mixtures containing 2-methoxyethanol and some alkan-1-ol,     
             Phy. Chemi. Liq., 47, 412-436 (2009). 
70.   J. A. Riddick, W. B. Bunger and T. Sakano; Organic Solvents: Physical Properties 
and methods of purification, Fourth Edition., Techniques of Chemistry, II, A Wiley-
Interscience Publication, John Wiley, New York (1986). 
71. L. Ubbelhode; Theory of the Friction of Lubricated Machine Parts, Petroleum., 7, 882- 
89 (1912). 
72. R. A. Robinson and R. H. Stokes; "Electrolyte Solutions", Butterworths Scientific 
Publications, London (1955). 
73. G. L. Sastry, V. K. S. Sastry and B. Krishnamurty; Ultrasonic parameters in mixed salt 
solutions, Ind. J. Pure Appl. Phy., 6, 637-38 (1968).  
74. B. Jacobson, W. A. Anderson and J. T. Arnold; A proton magnetic resonance study of 
the hydration of deoxyribonucleic acid, Nature, 173, 772-773 (1954). 
75. Y. Wada; The relation between compressibility and molal volume of organic liquids, J. 
Phy. Soci. Jap., 4, 280-83 (1949).   
76. S. Sendhilnathan, S. Bagchi, S. K. Nema and R. P. Singh; Ultrasonic and rheological 
investigations of solid propellant binders, Euro. Poly. J., 25, 441-44 (1989).   
77. P. Vigoureux, "Ultrasonics", Chapman and Hall, London (1952). 
78. G. K. Johri and R. C. Misra; Phase-transition study and ultrasonic investigations in 
 tert-butyl alcohol (TBA), Ind. J. Phy., 59, 482-488 (1985). 
79. C. V. Suryanarayana and J. Kuppuswamy, J. Acoust. Soc., 9, 4 (1981). 
 
 
Studies on some bio-active……. 
 
                                                                                                     Section-I Acoustical Properties 
 131 
80. D. Subramanian, N. Karunanidhi and P. Aruna, J. Pure Appl. Ultrason., 21, 5 (1999). 
81. S. P. Yawale, S. V. Pakade and C. S. Adagonkar. Solid state variable frequenncy 
pulser-receiver system. For ultrasonic mesurements. Ind. J. Pure and App. Phy., 33, 
638-642 (1995). 
82. H. Falkenhagen and C. Bachem; The compressibility of strong electrolytes, Zeit. fuer 
Elektro. Ange. Physi. Che., 41, 570-575  (1935).. 
83. F.T. Gucker (Jr.), Chem. Rev., 64, 111 (1993). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Studies on some bio-active……. 
 
                                                                                                                       Section-II Solubility 
 132 
INTRODUCTION 
 Chemical such as trade-sales coating, pharmaceuticals, cosmetics and 
foodstuffs are produced as multicomponent chemical mixture. Often these 
mixtures or formulations include polymers and low molecular components of 
high and low boiling points. Basic knowledge of the miscibility of the various 
components is required to meet environmental, shelf life and product quality 
specifications. In this regard, solubility has played an important role in the 
development of stable commercial chemical formulation as well as for 
assessing phase segregation during product synthesis. 
  In 1936, Joel Hildebrand proposed1 a simple definition for a “solubility” 
that would provide a systemic description of the miscibility behavior of 
solvents. The solubility of drug is essential information in drug discovery and 
is important in the preparation of drug formulation stages in the 
pharmaceutical industry. There are many methods for solubilization of drugs 
including cosolvency, surface active agents, salt information, complexation, 
hydrotropism, crystal engineering and preparation of soluble prodrug, and 
more recently, the addition of ionic liquids2-9. 
 The extensive information on the thermodynamic properties of organic 
compounds is needed not only their use in many industrial processes but also 
for the advancement of theoretical developments through an understanding of 
the intermolecular forces in solution for structure-property relationship. 
 The process of dissolving is a process which involves the breaking 
and making of bonds and that involves energy which is in the form of heat. 
Thus, the process of dissolution is accompanied by the heat change i.e., 
enthalpy change (ΔHsol). The interpretation of these heat transfer found in the 
literature,10–15 may not be sufficient to provide a realistic picture of the 
interactions in solution. In most cases, the small values of the heat transfer 
results from the approximate cancellation of the component entropy and 
enthalpy contributions. These separate contributions can be calculated, if 
precise solubility data at different temperatures are available. 
From the solubility measurements, melting temperature of a substance 
can also be determined16. Literature serve, shows that many researchers 
have been worked on solubility of some gases17, organic compounds18-20, 
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amino acids 21,22,  polymers23-25, ionic liquids26,27, inorganic compounds28-31, 
drugs32-35, etc. In our laboratory, heat of solution of some synthesized 
heterocyclic compounds and drugs has also been determined36,37. From the 
solubility data, some thermodynamic parameters have also been reported38-45.  
In the present work, the solubility for some dihydropyrimidinthiones 
derivatives (RAT series) was determined in N, N-dimethylformamide (DMF) 
and tetrahyrofuran (THF) at different temperatures (303.15 to 323.15 K). 
Further, some thermodynamic parameters such as enthalpy, Gibb’s energy 
and entropy have also been evaluated from the solubility data. 
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EXPERIMENTAL 
           The solubility of Dihydropyrimidinthiones derivatives (RAT series) has 
been studied in DMF and THF. These solvents were purified and fractionally 
distilled prior to use by the reported method46.  
 The solubilities were measured by a gravimetric method47. For each 
measurement, an excess mass of dihydropyrimidinthiones was added to a 
known mass of solvent. Then, the equilibrium cell was heated to a constant 
temperature with continuous stirring. After few hours when the temperature of 
the water bath approached constant value, the actual value of the 
temperature was recorded. The stirring was stopped and the solution was 
kept still for 2 h. A portion of this solution was filtered and by a preheated 
injector, 2 ml of this clear solution was taken in another weighted measuring 
vial (m0). The vial was quickly and tightly closed and weighted (m1) to 
determine the mass of the sample (m1- m0). Then, the vial was covered with a 
piece of filter paper to prevent dust contamination. Then, the vial was kept at 
room temperature to evaporate the solvent. After the solvent in the vial had 
completely evaporated, the vial was dried and reweighed (m2) to determine 
the mass of the constant residue solid (m2- m0). All the weights were taken 
using an electronic balance (Mettler Toledo AB204-S, Switzerland) with an 
accuracy of ± 0.0001 g. Thus, the solid concentration of the sample solution of 
mole fraction, x, could be determined from equation 3.2.1.  
                 2 0 1
2 0 1 1 2
( ) /
( ) / ( ) /
m m Mx
m m M m m M 2
−= − + −       .. (3.2.1) 
where M1 is the molar mass of dihydropyrimidinthiones and M2 is the molar 
mass of the solvent. 
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RESULTS AND DISCUSSION 
Tables 3.2.1 and 3.2.2 shows, the solubility (x) of synthesized 
compounds in the DMF and THF respectively. It is evident from these Tables 
that the solubility increases with temperature in both the solvents. Comparison 
of solubility of these compounds in DMF and THF shows that overall solubility 
is greater in DMF than that in THF. The dielectric constant and dipole moment 
of DMF (36.71, 3.86) are greater than that of THF (7.58, 1.75). Thus, these 
properties of solvent play an important role on the solubility. Figure 3.2.1 
shows the variation of mole fraction solubility (x) against temperature for RAT-
1 in DMF and THF. 
The temperature dependence solubility in solvents is described by the 
modified Apelblat equation48, 49    
    ln x A BT= +                          ….. (3.2.2) 
where x is the mass fraction solubility of compounds; T is the absolute 
temperature and A, and B are the coefficients. The values of these 
coefficients are given in Table 3.2.3. Using these values of A and B, 
calculated solubilities xc were evaluated and are reported in Tables 3.2.1 and 
3.2.2.  
The percentage relative deviations (%RD) between the experimental 
and calculated values of solubilities are also calculated by equation 3.2.3 and 
are given in Tables 3.2.1 and 3.2.2.  
  % Relative Deviation  ⎛⎜⎝ ⎠
c ⎞⎟x - x= x
. 100           ….. (3.2.3) 
Using these solubility values at different temperature in both the 
solvents, some thermodynamic parameter such as enthalpy, Gibb’s energy 
and entropy have also been calculated. 
According to van’t Hoff equation50, the standard enthalpy change of 
solution is obtained from the slope the ln x versus 1/T plot. However, in recent 
thermodynamic treatments, some modifications have been introduced in the 
van’t Hoff equation to diminish the propagation of errors and consequently to 
separate the chemical effects from those due to statistical treatment used 
when enthalpy-entropy compensation plots are developed51. For this reason,  
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Table 3.2.1: The experimental solubility (x), calculated solubility (xc) and  
                     % relative deviation (RD) of RAT series in DMF at different        
                     temperatures. 
 
Temp. 
K 
x. 102 xc.102 % RD x. 102 xc.102 %RD 
 RAT-1 RAT-6 
303.15 3.1033 3.3084 -6.6070 2.8855 2.8470 1.3346 
308.15 4.1796 4.0387 3.3707 3.5512 3.5921 -1.1524 
313.15 5.3378 4.9302 7.6361 4.4767 4.5321 -1.2373 
318.15 6.1341 6.0186 1.8834 5.6319 5.7182 -1.5315 
323.15 6.9475 7.3472 -5.7535 7.2467 7.2146 0.4425 
 RAT-2 RAT-7 
303.15 3.5019 3.4570 1.2828 3.0000 3.2309 -7.6979 
308.15 4.4062 4.2264 4.0789 4.0419 3.9461 2.3691 
313.15 5.3104 5.1672 2.6971 5.1641 4.8197 6.6693 
318.15 6.4375 6.3173 1.8679 5.9361 5.8866 0.8340 
323.15 7.6503 7.7234 -0.9549 6.7250 7.1896 -6.9082 
 RAT-3 RAT-8 
303.15 2.9576 2.8728 2.8692 3.1007 2.9877 3.6445 
308.15 3.2212 3.2487 -0.8535 3.7634 3.7116 1.3766 
313.15 3.6787 3.6739 0.1329 4.4530 4.6109 -3.5460 
318.15 4.1851 4.1546 0.7291 5.8554 5.7281 2.1745 
323.15 4.6965 4.6983 -0.0393 7.3654 7.1160 3.3853 
 RAT-4 RAT-9 
303.15 2.9652 2.8622 3.3075 2.2067 2.2680 -2.7804 
308.15 3.1794 3.2684 -2.8006 3.0681 2.9194 4.8472 
313.15 3.7468 3.7258 0.5612 3.9468 3.7578 4.7900 
318.15 4.0482 4.2472 -4.9150 4.9705 4.8369 2.6876 
323.15 4.9589 4.8413 2.3662 6.0478 6.2260 -2.9465 
 RAT-5 RAT-10 
303.15 3.3579 3.4195 -1.8338 3.1697 3.3657 -6.1808 
308.15 4.2091 4.2079 0.0303 4.0114 3.9436 1.6889 
313.15 5.1011 5.1780 -1.5073 4.8826 4.6208 5.3608 
318.15 6.4807 6.3718 1.6796 5.4430 5.4143 0.5281 
323.15 7.6321 7.8409 -2.7352 6.0075 6.3440 -5.6018 
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Table 3.2.2: The experimental solubility (x), calculated solubility (xc) and  
                      % relative deviation (RD) of RAT series in THF at different  
                       temperatures. 
 
Temp. 
K 
x. 102 xc.102 %RD x. 102 xc.102 % RD 
 RAT-1 RAT-6 
303.15 3.8427 3.8944 -1.3459 7.9882 7.9987 -0.1321 
308.15 4.6809 4.5700 2.3688 9.1685 8.8575 3.3923 
313.15 5.5446 5.3626 3.2792 10.3143 9.8084 4.9048 
318.15 6.4393 6.2931 2.2701 11.0636 10.8615 1.8270 
323.15 7.2983 7.3849 -1.1855 11.4847 12.0276 -4.7277 
 RAT-2 RAT-7 
303.15 3.8905 3.9590 -1.7627 5.8449 5.8741 -0.4986 
308.15 4.9825 4.8451 2.7584 6.6823 6.5734 1.6302 
313.15 6.0185 5.9294 1.4792 7.3915 7.3559 0.4808 
318.15 7.4377 7.2565 2.4363 8.2394 8.2317 0.0937 
323.15 8.6098 8.8805 -3.1439 9.0926 9.2117 -1.3093 
 RAT-3 RAT-8 
303.15 4.7033 4.7055 -0.0468 2.1180 2.0995 0.8742 
308.15 5.7597 5.8486 -1.5435 2.8161 2.7187 3.4578 
313.15 7.1539 7.2693 -1.6126 3.6401 3.5205 3.2852 
318.15 9.0958 9.0352 0.6667 4.6049 4.5589 1.0008 
323.15 11.0525 11.2300 -1.6058 5.7744 5.9034 -2.2341 
 RAT-4 RAT-9 
303.15 2.9890 3.0323 -1.4477 3.2051 3.1260 2.4682 
308.15 3.8176 3.6832 3.5211 3.8546 3.7875 1.7394 
313.15 4.6254 4.4739 3.2763 4.7952 4.5891 4.2994 
318.15 5.4863 5.4342 0.9494 5.6862 5.5602 2.2148 
323.15 6.3585 6.6008 -3.8101 6.5467 6.7370 -2.9064 
 RAT-5 RAT-10 
303.15 4.9367 4.9918 -1.1175 4.2472 4.1582 2.0961 
308.15 5.7410 5.7047 0.6335 4.5860 4.6788 -2.0249 
313.15 6.6063 6.5193 1.3176 5.0537 5.2647 -4.1767 
318.15 7.4356 7.4502 -0.1962 5.8883 5.9240 -0.6057 
323.15 8.2244 8.5140 -3.5209 6.7587 6.6658 1.3749 
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Figure 3.2.1: The mole fraction solubility (x) against temperature (T/K) 
for RAT-1 in [A] DMF and [B] THF. 
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Table 3.2.3: Coefficient A and B of RAT series in DMF and THF from equation 
3.2.2. 
 
Compounds A B A B 
 DNF THF 
RAT-1 -15.5047 0.0399 -12.9472 0.0320 
RAT-2 -15.1075 0.0388 -15.2808 0.0398 
RAT-3 -10.7297 0.0237 -16.1934 0.0433 
RAT-4 -11.2465 0.0254 -14.8278 0.0374 
RAT-5 -15.9565 0.0415 -10.7493 0.0256 
RAT-6 -17.5209 0.0461 -8.0351 0.0183 
RAT-7 -15.5586 0.0400 -9.4557 0.0219 
RAT-8 -16.6677 0.0434 -18.9763 0.0500 
RAT-9 -18.9179 0.0500 -14.4467 0.0363 
RAT-10 -13.0020 0.0317 -10.3353 0.0236 
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the mean harmonic temperature (Thm) is used in the van’t Hoff analysis, 
which is calculated by the following equation. 
                                  ( )1hm n
i
nT
T
=
∑
                              ….. (3.2.4) 
where n is the number of temperatures studied and T is absolute temperature 
of the experiment. In the present case, the Thm value obtained is 308 K.  
So, the modified van’t Hoff equation is 52, 53. 
              ln
1 1
sol
hm P
Hx
R
T T
Δ∂ = −⎛ ⎞∂ −⎜ ⎟⎝ ⎠
                     ….. (3.2.5) 
where ∆Hsol is the heat of solution and R is the gas constant.  
 Figure 3.2.2 shows the van’t Hoff plots for RAT-1 in DMF and THF 
solutions. The slope of these linear plots gives the values of ∆Hsol whereas 
Gibb’s free energy of dissolution (ΔGsol) were evaluated from the intercept 
using the following equation53. 
ΔGsol = -RThm. intercept                          ….. (3.2.6) 
Using these evaluated ∆Hsol and ΔGsol values, the entropies of 
solutions ΔSsol were obtained from equation54 . 
   Δ ΔΔ sol solsol
hm
H - GS =
T
                                ….. (3.2.7) 
 All these thermodynamic parameters are given in Table 3.2.4.                       
 It is evident from Table 3.2.4 that for all the compounds ∆Hsol , ΔGsol 
and ∆Ssol values are positive.  The positive ∆Hsol is due to absorption of 
energy i.e. endothermic dissolution of compounds takes place. This causes 
decrease in solubility as evident by comparing theoretical and experimental 
values, which may be due to Van Der Waals and Lwis acid-base interactions 
between solute and solvent54. The positive ∆Hsol and ∆Ssol values in both 
solvents, suggest that solubility of compounds is entropy driving process55. 
Further, the positive values of ΔGsol indicate that the dissolution process is not 
spontaneous55. 
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Figure 3.2.2: van’t Hoff plots for for RAT-1 in [A] DMF and [B] THF. 
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Table 3.2.4: The thermodynamic parameters of compounds in DMF and 
THF. 
ΔHsol ΔGsol ΔSsol ΔHsol ΔGsol ΔSsol Compound 
code kJ.mol-1 kJ.mol-1 J.mol-1.K-1 kJ.mol-1 kJ.mol-1 J.mol-1.K-1 
 DMF THF 
RAT-1 7.7950 1.8702 18.9296 6.2451 1.8126 14.1619 
RAT-2 7.5655 1.8312 18.3208 7.7532 1.7546 19.1655 
RAT-3 4.6720 2.0621 8.3386 8.4288 1.6354 21.7049 
RAT-4 5.4745 2.0586 10.9139 7.3008 1.9288 17.1634 
RAT-5 8.0759 1.8466 19.9026 4.9875 1.7015 10.4988 
RAT-6 8.7445 1.9052 21.8517 3.5730 1.4371 6.8242 
RAT-7 7.8079 1.8908 18.9049 4.2591 1.6224 8.4242 
RAT-8 8.4443 1.9044 20.8950 9.7301 2.0731 24.4640 
RAT-9 9.7442 2.0320 24.6405 7.0814 1.9064 16.5343 
RAT-10 6.1875 1.9167 13.6451 4.5782 1.8349 8.7648 
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INTRODUCTION 
In 1621, Willebrord Snell, discovered the sinusoidal relationship 
between the angle of incidence and the angle of refraction when a light ray 
passes from one optically transparent medium to another. From that the 
refractive index of a medium is a measure of how much the speed of light is 
reduced inside the medium. It is a fundamental physical property of a 
substance, which depends upon temperature and the wavelength of the light 
used. 
 It is one of the physical constants that can be used to describe a 
chemical species. Further, it is useful for the identification of crystalline 
substance. Refractive index has used to measure solids, liquids, and gases. 
Most commonly it is used to measure the concentration of a solute in a 
solution. Specific and molar refractions have proved useful for analytical 
purposes since they are found to vary in a systematic way within homologous 
series of compounds. The molar refraction has been useful in structural 
studies. It is useful to identify a particular substance, purity of component and 
measurement of concentration. It also determines isotropic and anisotropic 
behavior of the crystal compounds. Various thermodynamic properties of 
chemical materials can be evaluated by refractive index. 
Literature survey shows that much work has been done in liquid 
mixtures1-15 and various polymers16-20. Many workers have been reported 
refractive index of amino acid21-24, vitamins25-27, medicine materials28,29,   
complex refractive index30-32, plant extracts33,34, organic and inorganic 
compounds35-38 etc. 
By using the refractive index, Rangappa studied the milk constant39. 
Masuko and Awaya have been reported simple method for assaying sugars of 
silage materials40. Kashmiri and co-workers41 studied the   physico-chemical 
analysis of different types of honey produced in Pakistan. Glucose and 
fructose levels of grape skin have been reported by Varandas et al.42.   
Further, Deich43 have been reported refractive index of C6H5X 
(X=halogen group). Kinart at al.44 studied the refractive index of 1-butyl-3-
methylimidazolium tetrafluoroborate and 1-butyl-2,3-dimethylimidazolium tetra 
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-fluoroborate. The refractive index of 1,4:3,6-Dianhydrohexitol-basedpolycarb 
-onate yhave been reported by Yamaoka and Nukui45.  
In the present section, the refractive indexes of solutions of RAT series 
have measured in N, N-dimethylformamide (DMF) and tetrahydrofuran (THF) 
at 308.15 K. 
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EXPERIMENTAL 
The solvents DMF and THF were purified by fractionally distillation by 
the reported method46. For each compound, a series of solutions of different 
concentrations were prepared in these solvents.   
  The density and refractive index of pure solvents and solutions were 
measured by using pycnometer and Abbe refrectometer respectively at 
308.15 K. The temperature was maintained by circulating water through jacket 
around the prisms of refractometer from an electronically controlled 
thermostatic water bath (NOVA NV-8550 E). The uncertainty of temperature 
was ± 0.1 oC. 
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RESULTS AND DISCUSSION 
 The density of solution (ρ12) is related to densities of the solvent, solute 
and their weight fractions g1 and g2 according to the equation: 
                           1
12 1 2
1 g g2
ρ ρ ρ= +         … (3.3.1) 
where ρ12 is the density of solution and ρ1 and ρ2 are the densities of solvent 
and solute respectively. Tables 3.3.1 and 3.3.2 shows the experimental 
values of densities and refractive index for all the studied solutions. 
The density of these compounds were determined from the slope of the 
plot of 1 121 g ρ verses 2 1g g . Figure 3.3.1 shows the plot of 1 121 g ρ  verses 
2 1g g  for RAT-1, in DMF and THF respectively at 308.15K. The inverse of 
slope gives 2ρ . The densities of all the compounds evaluated from such plots 
are given in Table 3.3.4 for all the compounds in DMF and THF. Further, the 
density of compounds were evaluated by using the following equation47:       
                            A iKM N Vρ = Δ∑                       … (3.3.2) 
where ρ is the density of the compound, K is packing fraction (0.599), M is the 
molecular weight of the compound, NA is the Avogadro’s number and ΔVi is 
the volume increment of the atoms and atomic groups present in the 
compound. The calculated volume increment ΔVi for different atomic groups 
are given in Table 3.3.3.The density of all the studied compounds have been 
evaluated from equation (3.3.2) and are reported in Table 3.3.4.  
Comparison of densities evaluated from graphs and those calculated 
from eq. (3.3.2) showed that calculated values are different from those 
evaluated graphically. Further, for the same compound, density in the two 
solvents is different. This suggests that solvent plays an important role. In 
solutions molecular interactions exist which differ in different solvents due to 
different substitutions in compounds. The presence of these interactions have 
also been observed in ultrasonic studies which are discussed in section I of 
chapter 2. Due to these interactions, there may be some changes in volume 
which affects density. 
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Table 3.3.1: The density (ρ12) and refractive index (n) of RAT series in 
DMF at 308.15K. 
 
Conc. 
M 
ρ12 
g.cm-3 g1 g2 n 
RAT-1 
0.00 0.9338 1.0000 0.0000 1.4239 
0.01 0.9413 0.9955 0.0045 1.4241 
0.02 0.9433 0.9910 0.0090 1.4249 
0.04 0.9470 0.9822 0.0178 1.4261 
0.06 0.9481 0.9733 0.0267 1.4275 
0.08 0.9523 0.9645 0.0355 1.4289 
0.10 0.9569 0.9559 0.0441 1.4313 
RAT-2 
0.01 0.9427 0.9958 0.0042 1.4242 
0.02 0.9447 0.9917 0.0083 1.4248 
0.04 0.9453 0.9834 0.0166 1.4259 
0.06 0.9466 0.9751 0.0249 1.4273 
0.08 0.9485 0.9669 0.0331 1.4291 
0.10 0.9494 0.9587 0.0413 1.4308 
RAT-3 
0.01 0.9409 0.9957 0.0043 1.4243 
0.02 0.9418 0.9914 0.0086 1.4248 
0.04 0.9462 0.9828 0.0172 1.4257 
0.06 0.9484 0.9743 0.0257 1.4268 
0.08 0.9495 0.9658 0.0342 1.4289 
0.10 0.9553 0.9575 0.0425 1.4292 
RAT-4 
0.01 0.9434 0.9957 0.0043 1.4247 
0.02 0.9457 0.9913 0.0087 1.4255 
0.04 0.9471 0.9827 0.0173 1.4265 
0.06 0.9485 0.9740 0.0260 1.4277 
0.08 0.9504 0.9655 0.0345 1.4286 
0.10 0.9527 0.9569 0.0431 1.4298 
RAT-5 
0.01 0.9421 0.9957 0.0043 1.4249 
0.02 0.9438 0.9913 0.0087 1.4256 
0.04 0.9468 0.9827 0.0173 1.4269 
0.06 0.9479 0.9742 0.0258 1.4289 
0.08 0.9494 0.9656 0.0344 1.4292 
0.10 0.9512 0.9571 0.0429 1.4311 
         Continue….. 
 
 
 
 
 
 
                                                                                      Section-III Density and Refractive Index 
   151
 
Studies on some bio-active……. 
….. Continue 
Conc. 
M 
ρ12 
g.cm-3 g1 g2 n 
RAT-6 
0.00 0.9338 1.0000 0.0000 1.4239 
0.01 0.9431 0.9955 0.0045 1.4250 
0.02 0.9448 0.9910 0.0090 1.4258 
0.04 0.9454 0.9820 0.0180 1.4270 
0.06 0.9481 0.9730 0.0270 1.4282 
0.08 0.9521 0.9642 0.0358 1.4291 
0.10 0.9574 0.9555 0.0445 1.4305 
RAT-7 
0.01 0.9431 0.9954 0.0046 1.4253 
0.02 0.9454 0.9907 0.0093 1.4264 
0.04 0.9471 0.9815 0.0185 1.4276 
0.06 0.9489 0.9723 0.0277 1.4290 
0.08 0.9506 0.9632 0.0368 1.4308 
0.10 0.9514 0.9540 0.0460 1.4320 
RAT-8 
0.01 0.9413 0.9955 0.0045 1.4242 
0.02 0.9437 0.9910 0.0090 1.4247 
0.04 0.9450 0.9820 0.0180 1.4269 
0.06 0.9486 0.9730 0.0270 1.4289 
0.08 0.9533 0.9642 0.0358 1.4295 
0.10 0.9552 0.9554 0.0446 1.4312 
RAT-9 
0.01 0.9420 0.9954 0.0046 1.4243 
0.02 0.9456 0.9907 0.0093 1.4269 
0.04 0.9482 0.9816 0.0184 1.4272 
0.06 0.9512 0.9724 0.0276 1.4281 
0.08 0.9532 0.9633 0.0367 1.4309 
0.10 0.9563 0.9543 0.0457 1.4320 
RAT-10 
0.01 0.9514 0.9957 0.0043 1.4245 
0.02 0.9536 0.9915 0.0085 1.4251 
0.04 0.9558 0.9830 0.0170 1.4255 
0.06 0.9578 0.9746 0.0254 1.4271 
0.08 0.9590 0.9662 0.0338 1.4289 
0.10 0.9602 0.9578 0.0422 1.4319 
 
 
 
                                                                                      Section-III Density and Refractive Index 
   152
 
Studies on some bio-active……. 
Table 3.3.2: The density (ρ12) and refractive index (n) of RAT series in 
THF at 308.15K. 
 
Conc. 
M 
ρ12 
g.cm-3 g1 g2 n 
RAT-1 
0.00 0.8798 1.0000 0.0000 1.4016 
0.01 0.8832 0.9953 0.0047 1.4038 
0.02 0.8868 0.9906 0.0094 1.4043 
0.04 0.8898 0.9813 0.0187 1.4059 
0.06 0.8941 0.9720 0.0280 1.4076 
0.08 0.8972 0.9628 0.0372 1.4082 
0.10 0.9005 0.9537 0.0463 1.4097 
RAT-2 
0.01 0.8822 0.9956 0.0044 1.4032 
0.02 0.8843 0.9912 0.0088 1.4041 
0.04 0.8863 0.9825 0.0175 1.4057 
0.06 0.8891 0.9739 0.0261 1.4063 
0.08 0.8925 0.9653 0.0347 1.4076 
0.10 0.8962 0.9568 0.0432 1.4082 
RAT-3 
0.01 0.8840 0.9955 0.0045 1.4035 
0.02 0.8864 0.9910 0.0090 1.4053 
0.04 0.8886 0.9820 0.0180 1.4069 
0.06 0.8917 0.9730 0.0270 1.4083 
0.08 0.8941 0.9641 0.0359 1.4098 
0.10 0.8978 0.9554 0.0446 1.4111 
RAT-4 
0.01 0.8832 0.9954 0.0046 1.4031 
0.02 0.8861 0.9909 0.0091 1.4044 
0.04 0.8900 0.9818 0.0182 1.4069 
0.06 0.8948 0.9729 0.0271 1.4087 
0.08 0.8981 0.9639 0.0361 1.4093 
0.10 0.9002 0.9550 0.0450 1.4118 
RAT-5 
0.01 0.8845 0.9954 0.0046 1.4056 
0.02 0.8872 0.9909 0.0091 1.4061 
0.04 0.8898 0.9819 0.0181 1.4082 
0.06 0.8925 0.9729 0.0271 1.4092 
0.08 0.8960 0.9640 0.0360 1.4122 
0.10 0.8991 0.9552 0.0448 1.4138 
               Continue….. 
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….. Continue 
Conc. 
M 
ρ12 
g.cm-3 g1 g2 n 
RAT-6 
0.00 0.8798 1.0000 0.0000 1.4016 
0.01 0.8812 0.9952 0.0048 1.4036 
0.02 0.8862 0.9905 0.0095 1.4052 
0.04 0.8904 0.9811 0.0189 1.4065 
0.06 0.8935 0.9718 0.0282 1.4079 
0.08 0.8962 0.9625 0.0375 1.4091 
0.10 0.8992 0.9532 0.0468 1.4108 
RAT-7 
0.01 0.8836 0.9951 0.0049 1.4034 
0.02 0.8865 0.9903 0.0097 1.4049 
0.04 0.8905 0.9806 0.0194 1.4059 
0.06 0.8954 0.9711 0.0289 1.4070 
0.08 0.8982 0.9616 0.0384 1.4082 
0.10 0.9022 0.9522 0.0478 1.4098 
RAT-8 
0.01 0.8871 0.9953 0.0047 1.4031 
0.02 0.8894 0.9905 0.0095 1.4046 
0.04 0.8924 0.9811 0.0189 1.4056 
0.06 0.8947 0.9718 0.0282 1.4079 
0.08 0.8981 0.9625 0.0375 1.4086 
0.10 0.9002 0.9533 0.0467 1.4112 
RAT-9 
0.01 0.8864 0.9951 0.0049 1.4034 
0.02 0.8892 0.9903 0.0097 1.4048 
0.04 0.8942 0.9807 0.0193 1.4058 
0.06 0.8974 0.9712 0.0288 1.4066 
0.08 0.9005 0.9617 0.0383 1.4079 
0.10 0.9044 0.9523 0.0477 1.4091 
RAT-10 
0.01 0.8933 0.9963 0.0037 1.4032 
0.02 0.8956 0.9926 0.0074 1.4038 
0.04 0.8975 0.9852 0.0148 1.4046 
0.06 0.8991 0.9779 0.0221 1.4061 
0.08 0.9015 0.9705 0.0295 1.4075 
0.10 0.9026 0.9631 0.0369 1.4082 
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Figure 3.3.1: The variation of 1/g1ρ12 with g2/g1 for RAT-1 in [A] DMF and  
                      [B] THF at 308.15 K. 
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Table 3.3.3: Volume increments of some atoms and groups of atoms. 
 
 
Atoms or 
Atomic group 
Volume 
Increments (Ao)3
Atoms or 
Atomic group 
Volume 
Increments (Ao)3
C
C
C
N
1 37. 1 4.
 
 
10.2 
 
C Cl
1 77.
 
 
19.35 
C
C
H
HH
1 541 54. .
 
 
 
23.5 C
O
H
HH
1 091 09. .
1 5.
 
 
 
26.3 
C
C
C
C
. 1 54.1 34
 
 
9.0 N
C
C
H
 
 
8.3 
C
C
N
H
1 00. 1 28.
1 48.
 
 
 
3.61 
 
C F
1 34.
 
 
 
9.2 
C
C
C
H
1 08. 1 48.
1 28.
 
 
 
11.36 
 
N
C
C
C 1 37.
1 37.
 
 
 
0.9 
C
O
N
C
1 54. 1 37.
1 28.
 
 
 
14.10 CH
C
C
1 4.
 
 
14.7 
C
C
C
F
 
 
11.40 C S
HN
HN  
 
3.44 
C Cl
C
C  
 
10.39 
 
Car O Cal
1 37.1 5.
 
 
2.67 
C
C
C
O
 
 
11.65 
SC
N
N  
 
3.35 
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Table 3.3.4: Experimental and calculated densities of RAT series in DMF 
and THF Solutions at 308.15 K. 
  
 
Density calculated from slope of 
Figure 3.3.1 
(g.cm-3)  Compounds 
DMF THF 
Density (g.cm-3) 
Calculated from 
Eqn. 3.3.2 
RAT-1 1.7358 1.6886 1.3512 
RAT-2 1.3335 1.4658 1.3682 
RAT-3 1.6717 1.4804 1.3782 
RAT-4 1.4420 1.7781 1.4649 
RAT-5 1.4205 1.5618 1.4731 
RAT-6 1.6642 1.6393 1.4689 
RAT-7 1.3714 1.7655 1.4689 
RAT-8 1.6753 1.5265 1.4714 
RAT-9 1.6554 1.8272 1.5120 
RAT-10 1.3767 1.8103 1.4732 
 
 
Further, The molar refraction of a pure liquid (MRD)1 were calculated 
by the following equation: 
( ) 221 11
n MMRD
n ρ
⎡ ⎤−= ⎢ ⎥+⎣ ⎦
                        … (3.3.3) 
where n, M and ρ are refractive index, molecular weight and density pure 
liquid respectively. 
 For solutions, the following equation was used to determining molar 
refraction: 
               ( ) 212 1 1 2 2212
12 12
1
1
n X M X MMRD
n ρ
⎡ ⎤ ⎡ ⎤− += ⎢ ⎥ ⎢ ⎥+⎣ ⎦ ⎣ ⎦
            … (3.3.4)     
 where n12 and ρ12 are refractive index and density of solution respectively. X1 
and X2 are the mole fractions and M1 and M2 are the molecular weight of the 
solvent and solute respectively.   
 The plots of (MRD)12 verses concentration for RAT series in DMF and 
THF are given in Figures 3.3.2 and 3.3.3. It is evident from these figures that 
(MRD)12 increase with the increase in concentration. From the values of the 
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molar refraction of solution and pure solvent, molar refraction of solid 
compounds were determined by following equation: 
                ( ) ( ) ( )1 212 1 2MRD X MRD X MRD= +             … (3.3.5)                       
 From the density and molar refraction data, the refractive indexes of all 
the compounds were calculated from eq. (3.3.3). The molar refraction (MRD)2 
and refractive index of all the compounds are reported in Table 3.3.5, for 0.1M 
solution.  
 It is evident from Table 3.3.5 that both (MRD)2 and refractive index of 
compounds are different in each solvent. This again proves that in different 
solvents, intermolecular interactions are different, which affect these 
parameters. In some solvents, there may be intraction between solute and 
solvent molecules where as in others breakage of bonds may take place. As 
refractive index and molar refraction depends not only upon atomic refraction 
but also upon single, double or triple bonds, these parameters are affected by 
the type of interactions taking place in solution. Further, bond polarity also 
causes change in molar refraction. Thus, type of solvent affects the refractive 
index and molar refraction of a solute. 
However, it is reported that bond refraction is more effective than 
atomic refraction. Further, bond polarity also causes change in molar 
refraction. Thus, type of solvent affects the refractive Index and molar 
refraction of a solute.   
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Figure 3.3.2: The plots of molar refraction (MRD)12 against concentration    
of RAT series in DMF solutions at 308.15 K. 
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Figure 3.3.3: The plots of molar refraction (MRD)12 against concentration  
of RAT series in THF solutions at 308.15 K. 
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Table 3.3.5: Molar refraction (MRD)2 and refractive index (n) of 0.1M   
                     solution of RAT series in DMF and THF at 308.15 K. 
 
Solvents 
DMF THF  Compounds (MRD2) n (MRD2) n 
RAT-1 91.0744 1.6724 102.4883 1.7566 
RAT-2 100.7345 1.6012 98.1486 1.6551 
RAT-3 80.0690 1.5734 113.1660 1.7628 
RAT-4 91.4046 1.5561 111.3178 1.9494 
RAT-5 101.7629 1.6267 124.5989 1.9328 
RAT-6 86.6130 1.5919 113.1603 1.8205 
RAT-7 113.8506 1.6333 102.4138 1.7656 
RAT-8 96.2845 1.6817 112.5131 1.7397 
RAT-9 100.4741 1.6862 92.4797 1.7004 
RAT-10 99.5083 1.5863 78.7481 1.6159 
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INTRODUCTION 
The term dissociation constant is used to measure the strength of acid 
and bases. This is also known as ionization or acidity constant. The 
dissociation constant deals with the tendency of a compound to dissociate. 
Dissociation is the process by which the compound or ion is split into two 
components that are also ions or compounds  
The dissociation constant of organic reagent plays a fundamental role 
in many analytical procedures such as acid- base titration, solvent extraction, 
complex formation, ion transport etc. It has been shown that the acid-base 
properties affect the toxicity1, chromatographic retention behavior, and 
pharmaceutical properties2 of organic acids and bases. Much of the 
theoretical foundation of modern organic chemistry is based on the 
observation of the effects on acid-base equilibrium of changing molecular 
structure3.  
For the measurement of dissociation constants, various methods have 
been reported. Mehrotra and Upadhyaya4 have used conductometric method 
for the determination of the dissociation constant. Uhrova et al.5 reported 
separation methods for the determination of dissociation constants. Tanaka et 
al.6 maasured the ionization constant of weak acids by feedback-based flow 
ratiometry method. Lebron-Paler7 reported the acid dissociation constant by 
Spectroscopic Method. Zevatskii8 and coworkers represent the calculations of 
dissociation constants by empirical and quantum-chemical DFT methods. 
Various workers have been determined the dissociation constant by capillary 
electrophoresis9, NMR methods10, potentiometric method11 etc. 
For very high or very low acid strengths, spectrophotometer method is 
considered to be an ideal method but this method is also more time 
consuming. It is applicable if at least one of the species at equilibrium absorbs 
characteristically in the ultraviolet or visible region and the relevant ionic 
species show absorption maxima at different wavelengths. 
 Potentiometry is mostly used for the determination of dissociation 
constant of acids because it is economical in time. Further, it can be used for 
acids of pKa range from 2 to 11 units12. For this measurement, glass and 
calomel electrodes have been used and carbonate free potassium hydroxide 
is the best alkali to use as a titrant. 
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 The potential generated by the hydrogen ions, in the solution of an acid 
in a given medium is measured by an electronic potentiometer assembly. The 
relationship between the potential of glass electrode and the pH of the 
solution has the general form: 
0log[ ]   at 25
0.0591
cE EH pH C+ −− = = o
 
 where E0 is the observed potential and Ec is the potential of the calomel 
electrode. The various terms in above equation change with time. So, this 
electrode cannot be used as a primary standard. However, it does provide a 
very convenient way of comparing the pH of a series of solutions. So, it is 
calibrated before and after use with a pair of known buffers, the pH of one of 
which must lie near to the pH region to be measured. The correctness of the 
results depends upon the exactness of the calibration of pH-meter.  
 Literature survey shows that different workers studied the dissociation 
constant of acids, bases, amino acids, cellulose derivatives, vitamins etc13-22. 
Bell et al.23 have studied the dissociation constant of formic acid. Ong et al.24 
have reported the dissociation constants of pyridine penta carboxylic acid. 
Perlmutter and Tapuhi25 have determined the acid constant of trichloroacetic 
acids. Corradini and coworkers26 have studied the ionization constant of picric 
acid. The dissociation constant of 1-hydroxy-2-pyridinone-6-carboxylic acid 
was studied by Thipyapong et al.27. 
 Some of the thermodynamic parameters have also been evaluated with 
the help of dissociation constant28-35. Boodts and Lison36 have studied new 
computerized method for the determination of thermodynamic dissociation 
constants from experimental data. Basaran and coworkers37 have reported 
the determination of the thermodynamic dissociation constant of chloroacetic 
acid. Sallam et al38 have also reported dissociation constants of some dyes 
with thermodynamic functions. Bari and coworkers39 measured dissociation 
constants and thermodynamic parameters of 8-aminoquinoline. El-Naggar40 
has determined the first and second dissociation constants and related 
thermodynamic functions of adipic acid. The thermodynamic properties of 
H3PO4 over a wide range of temperatures and pressures were studied by 
Ballerat-Busserolles et al.41. Versteeg and Geert42 studied the dissociation 
constants and thermodynamic properties of amines and alkanolamines.  
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 In the present work, the dissociation constant of all synthesized 
dihydropyrimidinthiones derivatives (RAT series) are studied in DMF at 
different temperatures (298.15 - 318.15 K) by Calvin Bjerrum pH titration 
technique. 
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EXPERIMENTAL 
All solutions used for the titration are prepared using distilled water. 
Following are the concentrations of the solutions used for the titration. The 
chemicals used were of B.D.H Analar grade.  
Solutions      Concentration (M) 
Nitric acid      1.0 
Sodium hydroxide      0.5 
Sodium nitrate     1.0 
Ligand (in DMF)                           0.1 
 Nitric acid and sodium hydroxide were standardized by titrating with 
0.1 N NaOH and 0.05 M succinic acid solution respectively. 
The buffer solutions used for the calibration of pH meter were 0.05 M 
potassium hydrogen phthalate and 0.01 M Borax buffer. 
A Systronic pH meter (Model No. EQ 664) was used for the pH 
determination. The Systronic glass electrode and a saturated calomel 
electrode were used as indicator and reference electrodes respectively. 
Before operation, the glass electrode was immersed in 0.1 M HCl for twenty 
minutes. Then, it was washed thoroughly with distilled water. The pH meter 
was calibrated with buffer solution of known pH.  A constant temperature was 
maintained to ± 0.05 K by using a digital controller Nova Inst. (Model No. NV 
8550 E).  
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Calvin Bjerrum pH titration: 
           The following sets of mixtures were prepared for titration: 
(I)   2 ml HNO3 (1.0M) + 4 ml water + 30 ml DMF + 4.0 ml NaNO3 (1.0 M).  
(ii)   2 ml HNO3 (1.0M) + 4 ml water + 28 ml DMF + 2.0 ml ligand solution 
(0.1M) + 4.0 ml NaNO3 (1.0 M).   
  Thus, total volumes (V0) in each set = 40.0 ml and Solvent : Water ratio  
60:40 (v/v). The solvent used for the study was DMF. 
          The above mentioned solutions were allowed to attain a definite 
temperature and then titrated against standard NaOH solution (0.5 M). The 
same experiment was repeated at different temperatures, i.e., at 298.15 K, 
308.15K and 318.15K. 
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THEORY 
 In the present work ligands are of HL type. Thus, the equilibria are, 
L H HL+ ↔  
In general, these equations can be represented as: 
1j jLH H LH− + ↔  
The thermodynamic proton-ligand stability constant ( HjTK ) is given by: 
                                      [ ]{ }1 jHj j
LH
TK
LH H−
⎡ ⎤⎣ ⎦= ⎡ ⎤⎣ ⎦
                             ... (3.4.1) 
TKjH is reciprocal of the thermodynamic dissociation constant of the acid LHj 
dissociating as: 
    1i iLH LH H−= +  
The overall thermodynamic proton-ligand stability constant βjH is given by: 
[ ][ ]
jH
j j
LH
T
L H
β ⎡ ⎤⎣ ⎦=                                           ... (3.4.2) 
and it refers to the reaction: 
jL JH LH+ ↔  
The stoichiometric proton-ligand stability constant is given by: 
[ ]{ }1 jHj j
LH
K
LH H−
⎡ ⎤⎣ ⎦= ⎡ ⎤⎣ ⎦
                                  ... (3.4.3) 
and 
                                                [ ][ ]
jH
j j
LH
L H
β ⎡ ⎤⎣ ⎦=                                        ... (3.4.4) 
          An inert electrolyte is used to determine the stability constant in a 
particular salt medium. Sodium nitrate is mostly preferred as supporting 
electrolyte, because of very slight complexing tendency of nitrate ion. 
Generally, the competition between nitrate ion and the ligand under study is 
minor importance. The molar concentrations are used in place of activities. 
         For the determination of dissociation constants, Bjerrum43 introduced a 
relation for the determination of Hn , which is defined as average number of 
hydrogen bound to each ligand. 
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Hn  = {K1H [H] + 2K1H K2H [H]2 + .....JK1H K2H [H] ... KjH [H]j} / {1 + K1H [H] + 
K1H    K2H [H]2.....K1HK2H.....KjH [H]j                                             ... (3.4.5) 
From equation (3.6.4), we can write 
                                   
[ ]
[ ]
1
1
jH
j
j
H
jH
j
j
j H
n
H
η
η
β
β
=
=
=
∑
∑
      :  ( )0 1Hβ =                       … (3.4.6) 
Equation (3.4.6) is called Bjerrum formation function of the system. 
         The determination of dissociation constants from experimental data 
comprises the following three steps: (i) evaluation of formation curve of the 
system (ii) calculation of stoichiometric K`s of the system by direct solution of 
the formation function and (iii) conversion of stoichiometric constants into 
thermodynamic constants. 
         When the system consists of a ligand, which is a conjugated base of a 
weak acid, the pH-metric method introduced by Bjerrum has been widely 
used. This method is known as "Bjerrum-Calvin pH titration technique".  
 In this technique, the concentration of H+ ions is measured. Thus, a 
large amount of data can be obtained in a short period of time. The Irving and 
Rossotti method44 has some advantages, such as:  
(i) valid for both pure water and for the mixed solvents.  
(ii) conversion of pH-meter reading in to stoichiometric hydrogen ion 
concentration is not necessary. 
(iii) not necessary to know the stoichiometric concentration of neutral salt 
added to maintain the ionic strength constant.  
Due to these advantages, this method is used in the present work. The 
pH-meter is standardized using an aqueous buffer. The pH is measured for 
two solutions: 
(1) A mixture containing a mineral acid, a chelating agent and a neutral 
electrolyte to keep ionic strength constant and 
(2) A mixture same as above but without the chelating agent, when titrated 
against an alkali solution.  
  After each addition of standard alkali, the pH meter reading is noted 
using a glass electrode-saturated calomel electrode combination. For both the 
titrations, same initial volume of the mixture and same standard alkali is used. 
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The titration curves obtained in the above two titrations are designated as the 
reagent or ligand titration curve and the acid titration curve respectively.  
          The possible hydrolysis reactions are ignored because (i) fresh reagent 
solutions were used in pH titrations, (ii) titration times were of the order of one 
hour, (iii) there were no observable drifts with time in the meter readings and 
(iv) the concentrations of the mineral acid or alkali in the solutions were small.  
         Usually, a pH-meter calibrated with an aqueous buffer is used for 
aqueous solutions only. However, for the mixed aqueous media, especially 
aqueous dioxane solutions, van Uitert and Haas gave a relation between the 
glass electrode reading pH in dioxane-water medium and the stoichiometric 
hydrogen ion concentration of the same in mixture of varied composition and 
ionic strength. They reported the relation: 
                                0log log log HH pH f U
+⎡ ⎤− = + +⎣ ⎦                              ... (3.4.7) 
where f is the activity coefficient of the hydrogen ions in the solvent mixture 
under consideration at the same temperature and ionic strength, and 0HU  is a  
correction  factor  at  zero ionic strength,  which depends only on the solvent 
composition and temperature. 0HU is taken as unity in aqueous media. The 
meter reading in any aqueous dioxane solution can, therefore, be converted 
into hydrogen ion concentration using equation (3.4.7), provided that 
correction factor for the appropriate solvent, salt medium, and temperature, 
has been determined. Equation (3.4.7) can be written as: 
                             01 log [ ] Hanti pH H fU
+=                                  ... (3.4.8) 
                               [ ] 0
1
log H
H
anti pH fU
+⎡ ⎤∴ =⎣ ⎦ ⎡ ⎤⎣ ⎦
                          ... (3.4.9) 
Substituting for [H+] in equation (3.4.5) we get, 
Hn  = (K1H/f U0H)[1/antilog pH] +....+ ((JK1H K2H...KJH) /(f U0H)J)[1/antilog 
pH]J/(1+K1H/f U0H))[1/antilog pH]+..+((K1HK2H...KJH)/(f U0H)J)[1/antilog pH]      
                                                                                                             ...(3.4.10) 
0 .H Hj H jK fU pK=                                         ... (3.4.11) 
0 .H Hj H jfU pβ β=                                          ... (3.4.12) 
         The proton-ligands constant, pKjH can be obtained by the following 
methods: 
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1.   Interpolation at half Hn  values: 
           At the following Hn  values, log K1 and log K2 can be determined: 
 ( )1 0.5log HK n=                                        …  (3.4.13) 
                                     ( )2 1.5log HK n=                                         ..... (3.4.14) 
2.    Mid point slope method: 
 For H2L type ligands: 
                                            21 2[ ] 1K K L =  
            or                           1 2 1log 2K K pL=                                         ... (3.4.15) 
From the measured mid-point slope, D, the ratio K1/K2 can be 
calculated by eq. (3.4.16): 
           
1
2
4.606
2
D
K
K
−= ⎛ ⎞⎛ ⎞+ ⎜ ⎟⎜ ⎟⎝ ⎠⎝ ⎠
                                ...  (3.4.16) 
          The individual values of K1 and K2 were obtained by using K1/K2 values 
and relation (3.4.15).  
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( )log 1H Hn n −
RESULTS AND DISCUSSION 
 Figure 3.4.1 shows that typical titrations curve of the acid in the 
absence and presence of compound RAT-1 at [A] 298.15K, [B] 308.15K and 
[C] 318.15K. It can be seen that for the same volume of NaOH added the 
compound titration curves showed a lower pH value than the titration curve of 
free acid.  
 From these titration curves, the average number of protons associated 
with the ligand ( Hn ) can be calculated by the following equation given by 
Irving and Rossotti44.  
           ( )( ){ } ( ){ }0 0 0 0'' ' 'H Ln Y V V N E V V T= − − + +                 … (3.4.17) 
where Y is the number of displaceable protons per ligand molecule. For RAT-
5 and RAT-10, Y is taken as two whereas other compounds Y is equal to one. 
V’ and V” are the volume of alkali required at the same pH for both acid and 
ligand titration curves respectively. V0 is the initial volume of the test solution.  
N0, E0 and T0L are the initial concentration of the alkali, acid and ligand 
respectively.  
 The calculated values of Hn  for all the studied compounds are given in 
Tables 3.4.1 to 3.4.3 for all temperature systems. It is evident from Tables that 
the values of Hn  are found to be between 0 to 1 for all the compounds except 
RAT-5 and RAT-10 where Hn   values are between 0 to 2. The value of Hn   
between 0 and 2 suggests that compound have two replaceable protons 
whereas Hn   value between 0 and 1 is due to one replaceable proton.      
 Figure 3.4.2 shows the plot of Hn  values against pH for RAT-1. The 
pK1H value was evaluated at Hn =0.5 i.e., by half-integral method for all the 
compounds with Y=1. However, for compound RAT-5 and RAT-10 where 
Y=2, pK1H value was evaluated at Hn =0.5 and Hn =1.5.  
Further, the                        values are plotted against B as shown in Figure  
3.4.3. The plots are straight lines from which 1log
HpK  values were calculated 
at several pH values, by the following equation: 
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Figure 3.4.1: The plot of pH (B) against volume of NaOH for RAT-1 in  
                      DMF at [A] 298.15K [B] 308.15K and [C] 318.15K. 
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Table 3.4.1: The pH, nH, pK1H and other terms for RAT series in DMF at 
                     298.15K.  
 
pH V’ V’’ V’’-V’ nH log nH/(1-nH)  pK1H 
RAT-1 
11.7 4.5578 4.6936 0.1358 0.6657 -0.5286 11.9992 
11.8 4.5656 4.7106 0.1450 0.6432 -0.5371 12.0560 
11.9 4.5734 4.7319 0.1585 0.6102 -0.5503 12.0946 
12.0 4.5812 4.7532 0.1720 0.5772 -0.5645 12.1352 
12.1 4.5891 4.7745 0.1854 0.5445 -0.5796 12.1775 
12.2 4.5969 4.7957 0.1988 0.5118 -0.5958 12.2205 
12.3 4.6130 4.8400 0.2270 0.4431 -0.6347 12.2007 
12.4 4.6348 4.8900 0.2552 0.3746 -0.6818 12.1775 
12.5 4.6565 4.9615 0.3050 0.2538 -0.7980 12.0316 
12.6 4.6783 4.9904 0.3121 0.2369 -0.8196 12.0920 
12.7 4.7006 5.0230 0.3224 0.2122 -0.8546 12.1303 
RAT-2 
11.2 4.5487 4.6600 0.1113 0.7252 -0.5078 11.6214 
11.3 4.5266 4.6800 0.1534 0.6210 -0.5459 11.5145 
11.4 4.5344 4.7002 0.1658 0.5905 -0.5587 11.5589 
11.5 4.5422 4.7250 0.1828 0.5486 -0.5777 11.5846 
11.6 4.5500 4.7500 0.2000 0.5062 -0.5988 11.6107 
11.7 4.5578 4.7750 0.2172 0.4638 -0.6223 11.6370 
11.8 4.5656 4.8002 0.2346 0.4209 -0.6489 11.6615 
11.9 4.5734 4.8238 0.2504 0.3821 -0.6762 11.6912 
12.0 4.5812 4.8476 0.2664 0.3427 -0.7076 11.7171 
RAT-3 
10.4 4.2777 4.3787 0.1009 0.7493 -0.5000 10.8754 
10.5 4.2804 4.4002 0.1198 0.7024 -0.5155 10.8729 
10.6 4.2831 4.4217 0.1386 0.6557 -0.5324 10.8798 
10.7 4.2858 4.4435 0.1577 0.6083 -0.5511 10.8912 
10.8 4.2886 4.4652 0.1766 0.5614 -0.5717 10.9072 
10.9 4.2913 4.4870 0.1957 0.5140 -0.5947 10.9243 
11.0 4.2940 4.5031 0.2091 0.4807 -0.6126 10.9665 
11.1 4.2967 4.5109 0.2142 0.4681 -0.6198 11.0445 
11.2 4.2995 4.5187 0.2192 0.4557 -0.6271 11.1228 
11.3 4.3096 4.5396 0.2300 0.4290 -0.6437 11.1759 
11.4 4.3217 4.5627 0.241 0.4019 -0.6619 11.2273 
RAT-4 
9.7 4.2796 4.3875 0.1079 0.7320 -0.5056 10.1363 
9.8 4.2833 4.3979 0.1146 0.7153 -0.5111 10.2002 
9.9 4.2870 4.4174 0.1304 0.6761 -0.5248 10.2196 
10.0 4.2907 4.4391 0.1484 0.6314 -0.5418 10.2338 
10.1 4.2944 4.4609 0.1665 0.5865 -0.5604 10.2518 
10.2 4.2981 4.4826 0.1845 0.5419 -0.5809 10.2729 
10.3 4.3053 4.5050 0.1997 0.5042 -0.5998 10.3073 
10.4 4.3158 4.5300 0.2142 0.4683 -0.6197 10.3449 
10.5 4.3263 4.5550 0.2287 0.4325 -0.6415 10.3819 
10.6 4.3368 4.5800 0.2432 0.3966 -0.6656 10.4178 
10.7 4.3474 4.6029 0.2555 0.3663 -0.6883 10.4619 
10.8 4.3579 4.6171 0.2592 0.3572 -0.6955 10.5449 
10.9 4.3684 4.6314 0.2630 0.3480 -0.7031 10.6273 
           Continue......  
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………Continue 
pH V’ V’’ V’’-V’ nH log nH/(1-nH)  pK1H 
RAT-5 
7.1 4.0717 4.2008 0.1291 1.6778 0.6974 7.8166 
7.2 4.0780 4.2187 0.1407 1.6489 0.6185 7.8717 
7.3 4.0843 4.2300 0.1457 1.6364 0.5884 7.9533 
7.4 4.0906 4.2482 0.1576 1.6068 0.5238 8.0114 
7.5 4.0969 4.2677 0.1708 1.5739 0.4623 8.0675 
7.6 4.1019 4.2852 0.1833 1.5428 0.4119 8.1282 
7.7 4.1059 4.3012 0.1953 1.5129 0.3692 8.1922 
7.8 4.1093 4.3110 0.2017 1.4970 0.3484 8.2737 
7.9 4.1130 4.3424 0.2294 1.4280 0.2705 8.2973 
8.0 4.1167 4.3605 0.2438 1.3921 0.2364 8.3599 
8.1 4.1204 4.3801 0.2597 1.3525 0.2025 8.4199 
8.2 4.1241 4.4075 0.2834 1.2935 0.1582 8.4626 
8.3 4.1278 4.4378 0.3100 1.2272 0.1151 8.5009 
8.9 4.1500 4.5990 0.4490 0.8813 -0.0490 8.7964 
9.0 4.1537 4.6209 0.4672 0.8361 -0.0668 8.8563 
9.1 4.1574 4.6533 0.4959 0.7647 -0.0943 8.8917 
9.2 4.1611 4.6958 0.5347 0.6681 -0.1315 8.9004 
9.3 4.1648 4.7205 0.5557 0.6159 -0.1521 8.9484 
9.4 4.1685 4.7488 0.5803 0.5548 -0.1771 8.9842 
9.5 4.1722 4.7785 0.6063 0.4902 -0.2051 9.0114 
9.6 4.1759 4.7882 0.6123 0.4753 -0.2118 9.0938 
9.7 4.1796 4.7963 0.6167 0.4645 -0.2169 9.1808 
9.8 4.1833 4.8213 0.6380 0.4116 -0.2427 9.2135 
9.9 4.1870 4.8512 0.6642 0.3465 -0.2784 9.2213 
10.0 4.1907 4.8808 0.6901 0.2822 -0.3199 9.2156 
10.1 4.1944 4.9012 0.7068 0.2408 -0.3515 9.2363 
10.2 4.1981 4.9183 0.7202 0.2076 -0.3810 9.2637 
RAT-6 
10.1 3.6276 3.7766 0.1490 0.6243 -0.5446 10.3206 
10.2 3.6621 3.8235 0.1614 0.5934 -0.5574 10.3641 
10.3 3.6966 3.8711 0.1745 0.5607 -0.5720 10.4060 
10.4 3.7220 3.9065 0.1845 0.5358 -0.5838 10.4623 
10.5 3.7463 3.9452 0.1989 0.4999 -0.6021 10.4998 
10.6 3.7707 3.9837 0.2130 0.4647 -0.6218 10.5386 
10.7 3.7951 4.0210 0.2259 0.4326 -0.6414 10.5822 
10.8 3.8195 4.0522 0.2327 0.4159 -0.6523 10.6524 
10.9 3.8439 4.0860 0.2421 0.3926 -0.6685 10.7105 
RAT-7 
10.8 3.8195 3.9413 0.1218 0.6942 -0.5183 11.1561 
10.9 3.8439 3.9802 0.1363 0.6580 -0.5315 11.1843 
11.0 3.8683 4.0167 0.1484 0.6279 -0.5432 11.2272 
11.1 3.8927 4.0532 0.1605 0.5978 -0.5556 11.2721 
11.2 3.9184 4.1017 0.1833 0.5409 -0.5813 11.2712 
11.3 3.9447 4.1443 0.1996 0.5004 -0.6019 11.3006 
11.4 3.9711 4.1800 0.2089 0.4774 -0.6145 11.3607 
11.5 3.9974 4.2179 0.2205 0.4487 -0.6313 11.4106 
11.6 4.0474 4.2869 0.2395 0.4019 -0.6619 11.4273 
11.7 4.1000 4.3490 0.2490 0.3789 -0.6786 11.4854 
11.8 4.1313 4.3889 0.2576 0.3579 -0.6950 11.5462 
Continue...... 
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……..Continue 
pH V’ V’’ V’’-V’ nH log nH/(1-nH)  pK1H 
RAT-8 
9.4 3.4765 3.6208 0.1443 0.6349 -0.5404 9.6403 
9.5 3.4961 3.6530 0.1569 0.6032 -0.5533 9.6819 
9.6 3.5160 3.6834 0.1674 0.5768 -0.5647 9.7346 
9.7 3.5360 3.7240 0.1880 0.5250 -0.5891 9.7434 
9.8 3.5560 3.7508 0.1948 0.5080 -0.5978 9.8140 
9.9 3.5760 3.7892 0.2132 0.4618 -0.6235 9.8335 
10.0 3.5960 3.8190 0.2230 0.4373 -0.6384 9.8906 
10.1 3.6276 3.8593 0.2317 0.4158 -0.6524 9.9523 
10.2 3.6621 3.9087 0.2466 0.3787 -0.6787 9.9850 
RAT-9 
9.6 3.5160 3.6730 0.1570 0.6031 -0.5533 9.7818 
9.7 3.5360 3.6999 0.1639 0.5859 -0.5607 9.8507 
9.8 3.5560 3.7302 0.1742 0.5601 -0.5723 9.9048 
9.9 3.5760 3.7591 0.1831 0.5378 -0.5828 9.9658 
10.0 3.5960 3.7878 0.1918 0.5161 -0.5937 10.0279 
10.1 3.6276 3.8272 0.1996 0.4967 -0.6038 10.0943 
10.2 3.6621 3.8701 0.2080 0.4760 -0.6153 10.1582 
10.3 3.6966 3.9083 0.2117 0.4671 -0.6204 10.2427 
10.4 3.7220 3.9464 0.2244 0.4354 -0.6396 10.2872 
10.5 3.7463 3.9833 0.2370 0.4041 -0.6604 10.3313 
10.6 3.7707 4.0173 0.2466 0.3803 -0.6776 10.3879 
10.7 3.7951 4.0494 0.2543 0.3613 -0.6923 10.4525 
RAT-10 
8.6 3.3783 3.4518 0.0735 1.8136 1.3872 8.6021 
8.7 3.3836 3.4838 0.1002 1.7459 0.9527 8.8001 
8.8 3.3889 3.5237 0.1348 1.6583 0.6427 8.9244 
8.9 3.3942 3.5579 0.1637 1.5850 0.4821 8.9921 
9.0 3.3995 3.5979 0.1984 1.4971 0.3485 9.1235 
9.1 3.4176 3.6398 0.2222 1.4370 0.2797 9.2354 
9.2 3.4373 3.6908 0.2535 1.3580 0.2070 9.3649 
9.3 3.4569 3.7554 0.2985 1.2444 0.1257 9.3956 
9.4 3.4765 3.8040 0.3275 1.1714 0.0829 9.5024 
10.0 3.5960 4.0884 0.4924 0.7576 -0.0970 10.1842 
10.1 3.6276 4.1563 0.5287 0.6670 -0.1320 10.2375 
10.2 3.6621 4.2219 0.5598 0.5897 -0.1627 10.3465 
10.3 3.6966 4.2897 0.5931 0.5070 -0.1976 10.3995 
10.4 3.7220 4.3485 0.6265 0.4238 -0.2365 10.4563 
10.5 3.7463 4.4051 0.6588 0.3434 -0.2802 10.6231 
10.6 3.7707 4.4544 0.6837 0.2818 -0.3201 10.6982 
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Table 3.4.2: The pH, nH, pK1H and other terms for RAT series in DMF at 
                     308.15 K. 
 
Continue...... 
 
pH V’ V’’ V’’-V’ nH log nH/(1-nH) pK1H 
RAT-1 
11.7 4.6248 4.6788 0.0540 0.8671 -0.4660 12.5144 
11.8 4.6343 4.6906 0.0563 0.8614 -0.4675 12.5935 
11.9 4.6438 4.7074 0.0636 0.8435 -0.4723 12.6316 
12.0 4.6533 4.7444 0.0911 0.7760 -0.4917 12.5397 
12.1 4.6629 4.7815 0.1186 0.7087 -0.5134 12.3861 
12.2 4.6724 4.8278 0.1554 0.6187 -0.5469 12.2102 
12.3 4.6819 4.8833 0.2014 0.5064 -0.5987 12.0111 
12.4 4.6914 4.9636 0.2722 0.3341 -0.7150 11.7004 
12.5 4.7062 4.9966 0.2904 0.2901 -0.7571 11.6113 
12.6 4.7898 5.0906 0.3007 0.2664 -0.7831 11.5600 
12.7 4.8714 5.1850 0.3136 0.2366 -0.8200 11.4912 
RAT-2 
10.8 4.519 4.5846 0.0656 0.8379 -0.4738 11.5134 
10.9 4.5316 4.6286 0.0970 0.7604 -0.4965 11.4015 
11.0 4.5443 4.6643 0.1200 0.7037 -0.5151 11.3756 
11.1 4.5570 4.7003 0.1433 0.6462 -0.5360 11.3617 
11.2 4.5696 4.7313 0.1617 0.6009 -0.5542 11.3778 
11.3 4.5823 4.7625 0.1802 0.5554 -0.5744 11.3966 
11.4 4.5949 4.7938 0.1989 0.5094 -0.5971 11.4163 
11.5 4.6057 4.8089 0.2032 0.4989 -0.6026 11.4981 
11.6 4.6152 4.8200 0.2048 0.4951 -0.6047 11.5914 
11.7 4.6248 4.8311 0.2063 0.4915 -0.6067 11.6852 
11.8 4.6343 4.8422 0.2079 0.4876 -0.6088 11.7785 
11.9 4.6438 4.8533 0.2095 0.4838 -0.6109 11.8719 
12.0 4.6533 4.8644 0.2111 0.4800 -0.6130 11.9652 
RAT-3 
10.1 4.3632 4.6139 0.2507 0.3784 -0.6790 9.8844 
10.2 4.3895 4.6278 0.2383 0.4095 -0.6567 10.0410 
10.3 4.4146 4.6417 0.2271 0.4375 -0.6382 10.1909 
10.4 4.4390 4.6556 0.2166 0.4638 -0.6223 10.3371 
10.5 4.4634 4.6694 0.2060 0.4904 -0.6073 10.4833 
10.6 4.4878 4.6833 0.1955 0.5166 -0.5934 10.6289 
10.7 4.5063 4.6972 0.1909 0.5282 -0.5876 10.7490 
10.8 4.5190 4.7048 0.1858 0.5409 -0.5813 10.8712 
10.9 4.5316 4.7107 0.1791 0.5576 -0.5734 11.0005 
11.0 4.5443 4.7167 0.1724 0.5743 -0.5658 11.1300 
11.1 4.5570 4.7226 0.1656 0.5912 -0.5584 11.2602 
RAT-4 
9.7 4.3460 4.6195 0.2735 0.3216 -0.7263 9.3758 
9.8 4.3660 4.6248 0.2588 0.3583 -0.6946 9.5470 
9.9 4.3860 4.6339 0.2479 0.3856 -0.6736 9.6978 
10.0 4.4073 4.6431 0.2358 0.4159 -0.6523 9.8525 
10.1 4.4317 4.6523 0.2206 0.4539 -0.6282 10.0196 
10.2 4.4561 4.6615 0.2054 0.4918 -0.6065 10.1857 
10.3 4.4805 4.6706 0.1901 0.5299 -0.5867 10.3520 
10.4 4.5038 4.6798 0.1760 0.5650 -0.5700 10.5135 
10.5 4.5226 4.6790 0.1564 0.6136 -0.5490 10.7008 
10.6 4.5415 4.6802 0.1387 0.6575 -0.5317 10.8832 
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……..Continue                                                                                   
pH V’ V’’ V’’-V’ nH log nH/(1-nH)  pK1H 
RAT-5 
7.1 4.1756 4.3175 0.1419 1.6467 0.6130 7.7684 
7.2 4.1837 4.3354 0.1517 1.6223 0.5564 7.8330 
7.3 4.1919 4.3545 0.1626 1.5953 0.5012 7.8957 
7.4 4.2000 4.3845 0.1845 1.5408 0.4089 7.9258 
7.5 4.2048 4.4001 0.1953 1.5140 0.3706 7.9935 
7.6 4.2097 4.4138 0.2041 1.4922 0.3423 8.0681 
7.7 4.2145 4.4576 0.2431 1.3952 0.2391 8.0630 
7.8 4.2193 4.4953 0.2760 1.3134 0.1725 8.0817 
7.9 4.2242 4.5128 0.2886 1.2822 0.1504 8.1519 
8.9 4.2725 4.7835 0.5110 0.7304 0.6130 7.7684 
9.0 4.2773 4.8253 0.5480 0.6386 0.5564 7.8330 
9.1 4.2821 4.8523 0.5702 0.5836 0.5012 7.8957 
9.2 4.2870 4.8746 0.5876 0.5405 0.4089 7.9258 
9.3 4.2918 4.8952 0.6034 0.5014 0.3706 7.9935 
9.4 4.2966 4.9125 0.6159 0.4706 0.3423 8.0681 
9.5 4.3066 4.9357 0.6291 0.4381 0.2391 8.0630 
9.6 4.3260 4.9670 0.6410 0.4093 0.1725 8.0817 
9.7 4.3460 4.9914 0.6454 0.3991 0.1504 8.1519 
RAT-6 
10.0 3.8610 4.0265 0.1655 0.5849 -0.5611 10.1490 
10.1 3.8732 4.0475 0.1743 0.5630 -0.5709 10.2100 
10.2 3.8854 4.0675 0.1821 0.5436 -0.5800 10.2759 
10.3 3.8976 4.0867 0.1891 0.5261 -0.5886 10.3455 
10.4 3.9242 4.1250 0.2008 0.4971 -0.6036 10.3950 
10.5 3.9545 4.1598 0.2053 0.4862 -0.6095 10.4761 
10.6 3.9848 4.2013 0.2165 0.4586 -0.6254 10.5279 
10.7 4.0071 4.2293 0.2222 0.4446 -0.6338 10.6033 
10.8 4.0214 4.2557 0.2343 0.4145 -0.6532 10.6501 
RAT-7 
10.7 4.0071 4.1529 0.1458 0.6356 -0.5401 10.9415 
10.8 4.0214 4.1783 0.1569 0.6079 -0.5513 10.9905 
10.9 4.0357 4.2068 0.1711 0.5726 -0.5666 11.0270 
11.0 4.0500 4.2310 0.1810 0.5480 -0.5779 11.0837 
11.1 4.0643 4.2543 0.1900 0.5257 -0.5888 11.1447 
11.2 4.0786 4.2831 0.2045 0.4897 -0.6076 11.1820 
11.3 4.0929 4.3122 0.2193 0.4529 -0.6288 11.2179 
11.4 4.1104 4.3388 0.2284 0.4304 -0.6428 11.2784 
11.5 4.1312 4.3679 0.2367 0.4100 -0.6563 11.3419 
RAT-8 
9.1 3.7184 3.8614 0.1430 0.6402 -0.5383 9.3502 
9.2 3.7388 3.8910 0.1522 0.6172 -0.5475 9.4075 
9.3 3.7592 3.9203 0.1611 0.5950 -0.5567 9.4671 
9.4 3.7796 3.9516 0.1720 0.5678 -0.5687 9.5186 
9.5 3.8000 3.9834 0.1834 0.5394 -0.5820 9.5686 
9.6 3.8122 4.0103 0.1981 0.5026 -0.6007 9.6046 
9.7 3.8244 4.0315 0.2071 0.4802 -0.6129 9.6655 
9.8 3.8366 4.0528 0.2162 0.4575 -0.6260 9.7260 
9.9 3.8488 4.0773 0.2285 0.4268 -0.6451 9.7719 
10.0 3.8610 4.0983 0.2373 0.4049 -0.6598 9.8327 
10.1 3.8732 4.1204 0.2472 0.3802 -0.6776 9.8878 
           Continue...... 
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……..Continue 
pH V’ V’’ V’’-V’ nH log nH/(1-nH)  pK1H 
RAT-9 
9.4 3.7796 3.9166 0.1370 0.6558 -0.5323 9.6799 
9.5 3.8000 3.9459 0.1459 0.6336 -0.5409 9.7378 
9.6 3.8122 3.9665 0.1543 0.6126 -0.5494 9.7990 
9.7 3.8244 3.9872 0.1628 0.5914 -0.5583 9.8605 
9.8 3.8366 4.0100 0.1734 0.5649 -0.5701 9.9134 
9.9 3.8488 4.0348 0.1860 0.5334 -0.5850 9.9581 
10.0 3.8610 4.0590 0.1980 0.5034 -0.6002 10.0060 
10.1 3.8732 4.0820 0.2088 0.4765 -0.6150 10.0591 
10.2 3.8854 4.1026 0.2172 0.4556 -0.6272 10.1226 
10.3 3.8976 4.1236 0.2260 0.4337 -0.6407 10.1841 
10.4 3.9242 4.1616 0.2374 0.4055 -0.6594 10.2338 
10.5 3.9545 4.2027 0.2482 0.3789 -0.6786 10.2853 
10.6 3.9848 4.2427 0.2579 0.3550 -0.6973 10.3407 
RAT-10 
8.6 3.6539 3.7693 0.1154 1.7092 0.8006 8.8231 
8.7 3.6652 3.8073 0.1421 1.6420 0.6017 8.9540 
8.8 3.6764 3.8451 0.1687 1.5751 0.4644 8.9991 
8.9 3.6876 3.8831 0.1955 1.5078 0.3623 9.0420 
9.0 3.6989 3.9270 0.2281 1.4258 0.2683 9.1204 
9.1 3.7184 3.9826 0.2642 1.3352 0.1889 9.2284 
9.2 3.7388 4.0415 0.3027 1.2387 0.1221 9.4573 
9.9 3.8488 4.3470 0.4982 0.7502 -0.0999 9.9783 
10.0 3.8610 4.3851 0.5241 0.6856 -0.1247 10.0173 
10.1 3.8732 4.4231 0.5499 0.6213 -0.1499 10.1538 
10.2 3.8854 4.4835 0.5981 0.5008 -0.2003 10.2239 
10.3 3.8976 4.5260 0.6284 0.4253 -0.2358 10.3315 
10.4 3.9242 4.5754 0.6512 0.3692 -0.2654 10.4548 
10.5 3.9545 4.6331 0.6786 0.3017 -0.3064 10.5496 
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Table 3.4.3: The pH, nH, pK1H and other terms for RAT series in DMF at 
                     318.15 K. 
 
pH V’ V’’ V’’-V’ nH log nH/(1-nH) pK1H 
RAT-1 
11.7 4.746 4.8563 0.1103 0.7295 -0.5064 12.1309 
11.8 4.7575 4.8875 0.13 0.6814 -0.5229 12.1302 
11.9 4.769 4.94 0.171 0.5814 -0.5626 12.0428 
12.0 4.7805 5.01 0.2295 0.4391 -0.6372 11.8937 
12.1 4.792 5.0225 0.2305 0.4368 -0.6387 11.9897 
12.2 4.8158 5.0899 0.2741 0.3313 -0.7175 11.8950 
12.3 4.8684 5.1605 0.2921 0.2885 -0.7587 11.9080 
12.4 4.95 5.2535 0.3035 0.2623 -0.7879 11.9508 
RAT-2 
10.8 4.6324 4.8138 0.1814 0.5529 -0.5756 10.8923 
10.9 4.6459 4.8310 0.1851 0.5439 -0.5799 10.9765 
11.0 4.6596 4.8483 0.1887 0.5352 -0.5841 11.0613 
11.1 4.6730 4.8655 0.1925 0.5260 -0.5886 11.1452 
11.2 4.6865 4.8828 0.1963 0.5168 -0.5933 11.2292 
11.3 4.7001 4.9000 0.1999 0.5081 -0.5978 11.3140 
11.4 4.7115 4.9200 0.2085 0.4870 -0.6091 11.3775 
11.5 4.7230 4.9350 0.2120 0.4786 -0.6138 11.4627 
11.6 4.7345 4.9498 0.2153 0.4706 -0.6183 11.5488 
11.7 4.7460 4.9623 0.2163 0.4683 -0.6197 11.6448 
11.8 4.7575 4.9803 0.2228 0.4876 -0.6291 11.7171 
RAT-3 
9.9 3.9712 4.0879 0.1167 0.7081 -0.5136 10.2848 
10.0 4.0007 4.1375 0.1368 0.6580 -0.5315 10.2842 
10.1 4.0212 4.2000 0.1788 0.5532 -0.5755 10.1928 
10.2 4.0501 4.2313 0.1812 0.5475 -0.5781 10.2828 
10.3 4.0765 4.2625 0.1860 0.5358 -0.5838 10.3623 
10.4 4.0999 4.2938 0.1939 0.5163 -0.5935 10.4284 
10.5 4.1000 4.3074 0.2074 0.4827 -0.6115 10.4699 
10.6 4.1352 4.3467 0.2115 0.4729 -0.6170 10.5528 
10.7 4.1785 4.3959 0.2174 0.4587 -0.6253 10.6281 
10.8 4.1805 4.4152 0.2347 0.4156 -0.6525 10.6520 
10.9 4.2057 4.4544 0.2487 0.3811 -0.6769 10.6895 
RAT-4 
9.5 4.2836 4.4207 0.1371 0.6594 -0.5310 9.7870 
9.6 4.2973 4.4552 0.1579 0.6079 -0.5513 9.7904 
9.7 4.3267 4.4867 0.1600 0.6029 -0.5534 9.8814 
9.8 4.3600 4.5350 0.1750 0.5661 -0.5695 9.9154 
9.9 4.3933 4.5885 0.1952 0.5163 -0.5935 9.9284 
10.0 4.4421 4.6425 0.2004 0.5040 -0.5999 10.0069 
10.1 4.4947 4.7038 0.2091 0.4831 -0.6113 10.0706 
10.2 4.5200 4.7423 0.2223 0.4507 -0.6301 10.1142 
10.3 4.5422 4.7808 0.2386 0.4108 -0.6558 10.1433 
10.4 4.5644 4.8039 0.2395 0.4088 -0.6571 10.2398 
10.5 4.5867 4.8360 0.2493 0.3850 -0.6741 10.2965 
        Continue...... 
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  …..Continue                                                                                   
pH V’ V’’ V’’-V’ nH log nH/(1-nH) pK1H 
RAT-5 
6.9 3.5956 3.7120 0.1164 1.7063 0.7901 7.6642 
7.0 3.6024 3.7372 0.1348 1.6599 0.6472 7.6885 
7.1 3.6073 3.7645 0.1572 1.6035 0.5171 7.7068 
7.2 3.6121 3.7821 0.1700 1.5712 0.4577 7.7640 
7.3 3.6170 3.8135 0.1965 1.5044 0.3579 7.7823 
7.4 3.6218 3.8562 0.2344 1.4089 0.2519 7.7772 
7.5 3.6267 3.8894 0.2627 1.3376 0.1907 7.8052 
7.6 3.6316 3.9173 0.2857 1.2797 0.1487 7.8496 
7.7 3.6364 3.9305 0.2941 1.2586 0.1347 7.9299 
8.7 3.6850 4.1945 0.5095 0.7171 -0.1126 8.4474 
8.8 3.6898 4.2115 0.5217 0.6865 -0.1244 8.5182 
8.9 3.6947 4.2435 0.5488 0.6184 -0.1511 8.5509 
9.0 3.6995 4.2790 0.5795 0.5413 -0.1827 8.5695 
9.1 3.7148 4.3089 0.5941 0.5051 -0.1984 8.6287 
9.2 3.7311 4.3382 0.6071 0.4729 -0.2130 8.6909 
9.3 3.7475 4.3683 0.6208 0.4390 -0.2290 8.7491 
9.4 3.7639 4.4002 0.6363 0.4007 -0.2484 8.7988 
9.5 3.7803 4.4247 0.6444 0.3809 -0.2589 8.8716 
RAT-6 
9.8 3.8302 3.9827 0.1525 0.6173 -0.5474 10.0076 
9.9 3.8419 4.0057 0.1638 0.5890 -0.5593 10.0563 
10.0 3.8535 4.0277 0.1742 0.5630 -0.5709 10.1101 
10.1 3.8651 4.0469 0.1818 0.5441 -0.5798 10.1768 
10.2 3.8767 4.0675 0.1908 0.5217 -0.5908 10.2377 
10.3 3.8884 4.0893 0.2009 0.4965 -0.6039 10.2939 
10.4 3.9000 4.1128 0.2128 0.4668 -0.6205 10.3422 
10.5 3.9125 4.1347 0.2222 0.4434 -0.6346 10.4012 
10.6 3.9250 4.1588 0.2338 0.4145 -0.6532 10.4500 
10.7 3.9375 4.1800 0.2425 0.3929 -0.6683 10.5110 
10.8 3.9500 4.2032 0.2532 0.3663 -0.6883 10.5619 
RAT-7 
10.5 3.9125 4.0633 0.1508 0.6222 -0.5454 10.7168 
10.6 3.9250 4.0862 0.1612 0.5963 -0.5562 10.7694 
10.7 3.9375 4.1069 0.1694 0.5759 -0.5651 10.8329 
10.8 3.9500 4.1305 0.1805 0.5482 -0.5778 10.8841 
10.9 3.9625 4.1535 0.1910 0.5221 -0.5906 10.9384 
11.0 3.9750 4.1752 0.2002 0.4992 -0.6025 10.9986 
11.1 3.9875 4.1993 0.2118 0.4703 -0.6185 11.0484 
11.2 4.0000 4.2222 0.2222 0.4445 -0.6339 11.1032 
11.3 4.0172 4.2498 0.2326 0.4187 -0.6504 11.1576 
11.4 4.0345 4.2755 0.2410 0.3980 -0.6647 11.2202 
11.5 4.0517 4.3031 0.2514 0.3722 -0.6837 11.2730 
RAT-8 
8.9 3.7135 3.8643 0.1508 0.6205 -0.5461 9.1136 
9.0 3.7270 3.8898 0.1628 0.5905 -0.5587 9.1589 
9.1 3.7405 3.9157 0.1752 0.5594 -0.5726 9.2037 
9.2 3.7541 3.9375 0.1834 0.5389 -0.5823 9.2678 
9.3 3.7676 3.9601 0.1925 0.5162 -0.5936 9.3281 
9.4 3.7811 3.9825 0.2014 0.4940 -0.6053 9.3895 
9.5 3.7946 4.0080 0.2134 0.4640 -0.6222 9.4373 
9.6 3.8070 4.0315 0.2245 0.4363 -0.6390 9.4887 
9.7 3.8186 4.0560 0.2374 0.4040 -0.6604 9.5312 
9.8 3.8302 4.0769 0.2467 0.3809 -0.6771 9.5890 
                                                                                                                             Continue……   
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  …..Continue 
pH V’ V’’ V’’-V’ nH log nH/(1-nH) pK1H 
RAT-9 
9.4 3.7811 3.9371 0.1560 0.6081 -0.5512 9.5907 
9.5 3.7946 3.9593 0.1647 0.5863 -0.5605 9.6515 
9.6 3.8070 3.9810 0.1740 0.5631 -0.5709 9.7102 
9.7 3.8186 4.0004 0.1818 0.5436 -0.5800 9.7760 
9.8 3.8302 4.0227 0.1925 0.5169 -0.5932 9.8293 
9.9 3.8419 4.0429 0.2010 0.4957 -0.6044 9.8925 
10.0 3.8535 4.0650 0.2115 0.4695 -0.6190 9.9469 
10.1 3.8651 4.0871 0.2220 0.4433 -0.6346 10.0011 
10.2 3.8767 4.1072 0.2305 0.4221 -0.6482 10.0636 
10.3 3.8884 4.1294 0.2410 0.3960 -0.6661 10.1166 
10.4 3.9000 4.1511 0.2511 0.3708 -0.6848 10.1704 
RAT-10 
8.5 3.6714 3.7781 0.1067 1.7312 0.8869 8.5247 
8.6 3.6810 3.8118 0.1308 1.6706 0.6766 8.6249 
8.7 3.6905 3.8482 0.1577 1.6030 0.5161 8.7750 
8.8 3.7000 3.8882 0.1882 1.5263 0.3876 8.9173 
8.9 3.7135 3.9409 0.2274 1.4278 0.2703 9.0011 
9.0 3.7270 3.9775 0.2505 1.3698 0.2169 9.1591 
9.1 3.7405 4.0269 0.2864 1.2798 0.1487 9.2805 
9.8 3.8302 4.3136 0.4834 0.7868 -0.0858 9.8834 
9.9 3.8419 4.3665 0.5246 0.6838 -0.1254 9.9935 
10.0 3.8535 4.4069 0.5534 0.6119 -0.1537 10.1935 
10.1 3.8651 4.4539 0.5888 0.5235 -0.1904 10.2604 
10.2 3.8767 4.4856 0.6089 0.4735 -0.2127 10.3007 
10.3 3.8884 4.5198 0.6314 0.4175 -0.2397 10.4285 
10.4 3.9000 4.5621 0.6621 0.3410 -0.2817 10.4952 
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                                  log pK1H = pH + log[ Hn /( Hn -1)]                       … (3.4.18) 
 The calculated pk1H values are reported in Tables 3.4.1 to 3.4.3 for all 
compounds along with those obtained by half-integral method. From these log 
pK1H values, the average value of pK1H was calculated. Further, It is evident 
from Tables 3.4.1 to 3.4.3 that these pk1H values are in agreement with that 
obtained by half-integral method.  
For RAT-5 and RAT-10, the proton-ligand constants were calculated by 
solving equation (3.4.1). For all the points below Hn =1, the following equation 
was used 
                                       ( )H H H1log pK = pH +log n n -1                      … (3.4.19)                     
where as for all the points above Hn =1, the equation used was: 
                                  ( ) ( )HlogpK = pH +log n -1 2 - n2 ⎡ ⎤⎣ ⎦H H                   … (3.4.20)           
 From the various values of H1log pK  (or log pK2
H) calculated for a 
system, the average value was calculated.  
 Table 3.4.4 shows the dissociation constant of compounds by both 
average and half-integral method at different temperatures. It is observed that 
the pKH value decreases with increasing temperature, i.e. the acidity of the 
compounds increases, independently of the nature of the substituent46. 
Further, 1
HpK is minimum in RAT-5 and maximum in RAT-1 suggesting 
thereby maximum dissociation in RAT-5 which contains hydroxy group. RAT-1 
contains –OCH3 group which decreases dissociation. RAT-5 is found to be 
more acidic than other compounds as expected as it contains –OH group. 
Overall, RAT-1 is more basic and RAT-5 is most acidic. Thus, presence of 
different substituents influences the dissociation of the compound due to 
inductive effect.  
Further, some thermodynamic parameters such as enthalpy of solution, 
Gibb’s energy change and entropy of solution have also been evaluated from 
dissociation constants at different temperatures for these systems. 
The enthalpy changes (∆H) for the dissociation process were 
evaluated47 from the slope of the plot pK1H vs. 1/T. 
 
 
Studies on some bio-active……. 
                                                                                               Section-IV Dissociation Constants 
   188
Figure 3.4.2: The plot of nH against pH for [A] RAT-1 and [B] RAT-2 in  
                       DMF at different temperatures.  
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Figure 3.4.3: The plot of log nH/(1-nH) against B for [A] RAT-1 and [B] 
                      RAT-2 in DMF at different temperatures.                         
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Table 3.4.4: The pK1H values for all the studied compounds calculated by 
  different methods in DMF at different temperatures. 
 
Comp. 
code T/K 
Half-
intergal 
method 
pK1H 
Average 
method 
pK1H 
Comp.
code T/K 
Half-
intergal 
method 
pK1H 
Average
method 
pK1H 
RAT-1 298.15 12.12 12.11 RAT-6 298.15 10.50 10.50 
 308.15 12.11 12.00  308.15 10.41 10.40 
 318.15 11.99 12.01  318.15 10.27 10.28 
RAT-2 298.15 11.62 11.62 RAT-7 298.15 11.35 11.33 
 308.15 11.55 11.50  308.15 11.14 11.34 
 318.15 11.31 11.33  318.15 11.00 10.99 
RAT-3 298.15 10.98 11.03 RAT-8 298.15 9.82 9.88 
 308.15 10.57 11.50  308.15 9.64 9.62 
 318.15 10.47 10.47  318.15 9.37 9.38 
RAT-4 298.15 10.33 10.30 RAT-9 298.15 10.09 10.12 
 308.15 10.11 10.20  308.15 10.00 10.01 
 318.15 10.01 10.02  318.15 9.87 9.89 
RAT-5 298.15 
8.18 
(nH=1.5) 
9.05 
(nH=0.5) 
8.00 
(nH=1.5) 
9.20 
(nH=0.5) 
RAT-10 298.15
9.14 
(nH=1.5) 
10.47 
(nH=0.5) 
9.10 
(nH=1.5) 
10.42 
(nH=0.5) 
 308.15 
7.96 
(nH=1.5) 
8.85 
(nH=0.5) 
7.80 
(nH=1.5) 
8.80 
(nH=0.5) 
 308.15
9.10 
(nH=1.5) 
10.20 
(nH=0.5) 
9.09 
(nH=1.5) 
10.24 
(nH=0.5) 
 318.15 
7.75 
(nH=1.5) 
8.64 
(nH=0.5) 
7.68 
(nH=1.5) 
8.62 
(nH=0.5) 
 318.15
8.96 
(nH=1.5) 
10.18 
(nH=0.5) 
8.90 
(nH=1.5) 
10.22 
(nH=0.5) 
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Table 3.4.5.  Thermodynamic parameters for the dissociation of RAT series in  
                      DMF-Water mixture at different temperatures.     
compounds T/K ∆GHal kJ mol-1 
∆GAve 
kJ mol-1 
∆HHal 
kJ mol-1 
∆HAva 
kJ mol-1 
-∆SHal 
J mol-1 K-1 
-∆SAval 
J mol-1 K-1 
RAT-1 298.15 67.045 67.101 187.73 192.33 
 308.15 70.802 71.451 188.34 194.59 
 318.15 73.160 73.039 
12.764 11.488 
189.84 193.47 
RAT-2 298.15 64.332 64.332 129.79 130.80 
 308.15 67.852 68.147 133.21 135.12 
 318.15 69.018 68.896 
26.805 26.511 
132.68 133.23 
RAT-3 298.15 61.066 60.789 45.65 46.55 
 308.15 61.952 62.424 45.71 48.98 
 318.15 63.779 63.779 
47.807 47.330 
50.02 51.70 
RAT-4 298.15 57.190 57.190 101.47 98.46 
 308.15 60.181 59.650 104.92 100.38 
 318.15 61.038 60.977 
27.850 28.720 
104.32 101.39 
RAT-5 298.15 
44.291 
50.934 
45.287 
50.104 
6.03 
48.13 
20.29 
35.33 
 308.15 
46.021 
50.921 
46.965 
52.213 
11.27 
48.37 
24.49 
40.01 
 318.15 
46.783 
52.510 
47.210 
52.632 
42.549 
37.017 
39.420 
39.889 
13.31 
48.70 
24.49 
40.05 
RAT-6 298.15 58.132 58.132 130.94 131.88 
 308.15 61.421 61.362 133.54 134.23 
 318.15 62.561 62.622 
60.704 
 
60.705 
 
132.93 133.97 
RAT-7 298.15 62.838 62.727 100.18 106.58 
 308.15 65.728 66.908 103.39 113.58 
 318.15 67.008 66.947 
65.191 
 
65.527 
 
104.16 110.13 
RAT-8 298.15 54.367 54.699 46.16 40.19 
 308.15 56.877 56.759 51.46 44.39 
 318.15 57.078 57.139 
56.108 
 
56.199 
 
50.48 44.19 
RAT-9 298.15 55.862 56.028 118.70 102.71 
 308.15 59.001 59.060 121.57 106.22 
 318.15 60.124 60.246 
58.329 
 
58.445 
 
121.28 106.61 
RAT-10 298.15 50.602 
57.966 
50.381 
57.689 
129.89 
129.54 
115.13 
129.83 
 308.15 53.691 
60.181 
53.632 
60.417 
131.89 
128.74 
118.59 
130.69 
 318.15 54.581 
62.013 
54.215 
62.256 
13.05 
20.51 
 
17.09 
20.15 
 
130.54 
130.45 
116.69 
132.35 
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Using the following equation, Gibbs energy changes (∆G) have been 
evaluated47.  
                                              ∆G = 2.303 RT pKH                                             … (3.4.21) 
From these ∆G and ∆H values, entropy values (∆S) were calculated 
using the relationship47, assuming ∆H to be independent of temperature48  
                                      ∆S = (∆H - ∆G) / T                             …. (3.4.22) 
All these thermodynamic parameters are reported in Table 3.4.5 for both 
average and half-integral methods. It is observed that for both methods, 
values are in good agreement with each other.  
 The positive value of ∆H indicates that dissociation process is 
endothermic and is accompanied by absorption of heat. Further, ∆G values 
are positive indicating thereby that the dissociation process is not 
spontaneous. However, negative value of ∆S is due to the increased order.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Studies on some bio-active……. 
                                                                                               Section-IV Dissociation Constants 
   193
LITERATURE CITED 
1. Y. H. Zhao, L. H. Yuan and L. S. Wang; Quantative structure activity relationship of 
organic acid and bases, Contam. Toxicol., 57, 242-249 (1996).   
2. H. Rochester; Acidity functions Academic press, New York. (1971). 
3. L. P. Hammet; Phy. org. chemi., (1940)    
4. K. N. Mehrotra and S. K. Upadhyaya; Micellization and conductometric investigation 
on some lanthanide metal oleates., J. Chem. Eng. Data, 33, 465-468 (1988). 
5. M. Uhrova, I. Miksik, Z. Deyl, S. Bellini; Determination of dissociation  constants by 
separation methods (HPLC and CE). Theoretical background and guidelines for 
application, Proc. Con.  Qua., 10, 151-67 (1997). 
6. H. Tanaka, K. Aritsuka, T. Tachibana, H. Chuman and K. P. Dasgupta; Determination 
of dissociation constants of weak acids by feedback-based flow ratiometry, Analytica 
Chimi.  Acta, 499, 199-204 (2003).  
7. A. Lebron-Paler, J. E. Pemberton, B. A. Becker, W. H. Otto, C. K. Larive, and R. M. 
Maier; Determination of the acid dissociation constant of the biosurfactant 
monorhamnolipid in aqueous solution by potentiometric and spectroscopic methods, 
Ana. Chem., 78, 7649-7654 (2006).  
8. Y. E. Zevatskii, D. V. Samoilov and N. S. Panina; Calculations of dissociation 
constants of carboxylic acids by empirical and quantum-chemical DFT methods, Rus. 
J. Gen. Chem., 79, 944-952 (2009).  
9. J. P. Mercier, P. Morin, and A. Tambute; Determination of weak (2.0-2.5) dissociation 
constants of non-UV absorbing solutes by capillary electrophoresis, 
Chromatographia., 48, 529-34 (1998). 
10. L. Fielding; NMR methods for the determination of protein-ligand dissociation 
constants. Prog. in NMR Spect., 51, 219-42 (2007). 
11 H. S. Seleem, B. A. Shetary, S. M. Khalil and M. Shebl; Potentiometric and 
spectrometric studies of the complexation of shiff-base hydrazones containing the 
pyrimidine moiety, J. Serb. Chem. Soc., 686, 759-748 (2003).   
12. A. S. Albert and E. P. Serjeant, “Ionization Constants of Acids and Bases”, Methuen 
and Co., Ltd. 
13. A. L. Agafonova; Second dissociation constant of selenic acid, Z. Obsh. Khi., 17, 
1055-1060 (1947).  
14. E. Treiber, H. Koren, W. Felbinger and W. Lang; Viscose decomposition the 
dissociation constant of cellulose xanthate, Monatshefte fuer Chemie, 83, 259-270 
(1952). 
15. Robinson and R. Anthony; Dissociation constant of 3,5-dinitrophenol in deuterium 
oxide at 25oC, J. Chem. Eng. Data, 14, 247-248 (1969). 
16. T. N. Matskevich, E. P. Trailina and I. A. Savich; Determination of acid dissociation 
onstants for Schiff's bases. Khimiya, 11, 333-336 (1970).  
 
Studies on some bio-active……. 
                                                                                               Section-IV Dissociation Constants 
   194
17. O. W. Edwards, T. D. Farr, R. L. Dunn, J. D. Hatfield, C. D. Div, V. A. Tennessee and 
S. Muscle; Dissociation constants of pyro- and tripolyphosphoric acids at 25 oC, J. 
Chem. Eng. Data, 24, 24-28 (1973). 
18. L. Yang and Z. Yuan; Determination of dissociation constants of amino acids by 
capillary zone electrophoresis, Electrophoresis, 20, 2877-2883 (1999). 
19. H. Tanaka, K. Aritsuka, T. Tachibana, H. Chuman and P. K, Dasgupta; Dissociation 
constants of weak acids by feedback-based flow ratiometry, Ana. Chimica Acta, 499, 
199 -204 (2003).   
20. J. Ghasemi, S. Ghobadi, B. Abbasi and M. Kubista; Spectrophotometric determinatio 
-n of acidity constants of group B vitamins in different ionic strengths at 25oC , J. Kor. 
Chemi. Soc., 49, 269-277 (2005). 
21. A. Bzowska and L. Magnowska; Simple and universal method to determine 
dissociation constants for enzyme/ligand complexes, Nucleic Acids Symposium 
Series, 52, 669-670 (2008).  
22. Y. E. Zevatskii, D. V. Samoilov and N. S. Panina; Calculations of dissociation  
constants of carboxylic acids by empirical and quantum-chemical DFT methods, 
Russ. J. Gen. Chem., 79, 944-952 (2009). 
23. R. P. Bell and M. B. Jensen; Dissociation constant of formic-d acid, DCO2H, in 
aqueous solution, the Chemi. Soc., 307, 307-308 (1960). 
24. K. C. Ong, B. Douglas and R. A. Robinson; Dissociation constants of 
pyridinepentacarboxylic acid and other pyridinecarboxylic acids, J. Chem. Eng. Data, 
11, 574-576 (1966).  
25. B. Perlmutter-Hayman and E. Tapuhi; The dissociation constants of di- and 
trichloroacetic acids measured by a distribution method, J. Chem. Eng. Data, 22, 22-
24 (1977). 
26. F. Corradini, A. Marchetti, M. Tagliazucchi, L. Tassi and G. Tosi; Dissociation 
constants of picric acid in mixtures of N,N-dimethylformamide + ethane-1,2-dio, J. 
Chem. Eng. Data, 37, 191-194 (1992). 
27. K. Thipyapong and V. Ruangpornvisuti; Isomers of various species of 1-hydroxy-2-
pyridinone-6-carboxylic acid, their proton dissociation and complexes with Cr(III) and 
Zn(II), J. Mol. Str.,  891, 1-10 (2008). 
28. P. D. Bolton and F. M. Hall; Substituent effects on the thermodynamic functions of 
proton dissociation of para-substituted anilinium ions, J. Ind. Chem. Soc., 3, 259-263 
(1969). 
29. A. E. Alegria, R. Concepcion and G. R. Stevenson; Equilibrium studies by electron 
spin resonance. X. Thermodynamics of ion-pair dissociation by the use of time-
averaged coupling constants, J. Phy. Chem., 79, 361-365 (1975). 
30. M Sengupta, K. Pal, A. Chakravarti and P. Mahapatra; Dissociation constants of 
toluic acids in aqueous solution at different temperatures and study of related 
thermodynamic parameters, J. Chem. Eng. Data, 23, 103-107 (1978). 
 
Studies on some bio-active……. 
                                                                                               Section-IV Dissociation Constants 
   195
31. S. K. Chakravarty and S. C. Lahiri; The thermodynamics of ionization of glycine in 
methanol + water mixtures and the determination of single ion thermodynamics, 
Thermochimica Acta, 99, 243-251 (1986). 
32. M. Niazi and S. Khan; Conductivities and thermodynamic dissociation constants for 
chloroacetic acid in binary mixed solvent systems at 298.15 K, J. Chem. Eng. Data, 
38, 527-530 (1993). 
33. M. A. Rahman, A. R. Chowdhury and M. R. Zaman; Thermodynamic dissociation     
constants of glycine and DL-alanine in water-ethanol mixtures, Ind. J. Chem. Tech., 
9, 212-217 (2002). 
34. M. Meloun, T. Syrovy and A. Vrana; The thermodynamic dissociation constants of 
ambroxol, antazoline, naphazoline, oxymetazoline and ranitidine by the regression 
analysis of spectrophotometric data, Talanta, 62, 511-522 (2004). 
35. S. E. Hamborg, G. F. Versteeg; Dissociation constants and thermodynamic properties 
of Amines and Alkanolamines from (293 to 353) K, J. Chem. Eng. Data,  54, 1318-
1328 (2009). 
36. J. Boodts and L. Lison; New computerized method for the determination of 
thermodynamic dissociation constants from experimental data, Zeit. fuer Physi. 
Chem., 250, 111-118 (1972). 
37. B. Basaran, M. Erginer and A. Gocmen; The determination of the thermodynamic  
dissociation constant on a weak acid with cells without a liquid junction, the ionization 
of chloroacetic acid, Bull. Tech., 39, 143-149 (1986). 
38. H. B. Sallam, I. A. El-Sabbagh, N. S. Badawy and N. S. Moursy; Dissociation  
constants and thermodynamic functions of some associated dyes, Al-Azhar Bull. Sci., 
3, 59-73 (1992). 
39. I. Bari, A. Hafiz and A. W. K. Khanzada; Determination of dissociation constants and 
thermodynamic parameters of 8-aminoquinoline by potentiometry in aqueous and 
mixed organic-water solvent systems, J. Chemi. Soc. Pak., 22, 1-5 (2000). 
40. G. A. El-Naggar. First and second dissociation constants and related thermodynamic 
functions of adipic acid in various binary methanol/solvent systesystems. Elsevier 
Sci., 41, 245-249 (2004). 
41. K. B. Busserolles, J. Sedlbauer and V. Majer. Standard thermodynamic properties of 
H3PO4 over a wide range of temperatures and pressures, J. Phys. Chem., 111, 181-
190 (2007). 
42. S. H. Espen and F. V. Geert. Dissociation constants and thermodynamic properties of 
amines and alkanolamines from (293 to 353) K, J. Chem. Eng. Data, 54, 1318-1328 
(2009). 
43. J. Bjerrum; Metal Ammine Formation in aqueous solution, P. Hease and Sons, 
Copenhagen (1941). 
44. H. Irving and H. S. Rossoti, The calculation of formation curves of metal complexes 
from pH titration curves in mixed solvents, J. Chem. Soc., 12, 2094-2010 (1954). 
 
Studies on some bio-active……. 
                                                                                               Section-IV Dissociation Constants 
   196
45. L. G. Uitert and C. G. Hass; J. Am. Chem. Soc., 75, 451 (1953). 
46. Y. M. Issa, S. A. Abdel-Latif and H. A. Abdel Salam; Spectroscopic studies of some 
 mandelic hydrazone derivatives, Modelling, Measurement & Control, 57, 1-12 (1998). 
47. A. A. El-Bindary, A. Z. El-Sonbati, E. H. El-Mosalamy and R. M. Ahmed; 
 Potentiometric and thermodynamic studies of azosulfonamide drugs, Chem. Pap., 57, 
 255-258 (2003).  
48. S. Glastone; Thermodynamic for chemist, 131, 1942. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Studies on some bio-active……. 
 
                                                                                                      Section-V Thermal Properties 
   197
INTRODUCTION  
 Today, an impressive array of powerful, elegant ant automated tools is 
available with physical and material scientists for obtaining qualitative and 
quantitative information about the composition, structure and characteristics of 
materials. Among the several instruments and techniques, thermal analysis 
has grown rapidly in recent years.   
 Thermal analysis is the generic name used to describe a series of 
analytical techniques which measure physical and chemical changes in 
materials as a function of temperature and time. These thermal properties can 
be studied by various thermal techniques which are among the most powerful 
experimental tools developed during the last century. These techniques are 
able to characterize a wide range of materials and material properties1,2.  
Some of the most commonly used techniques are Differential Scanning 
Calorimetry (DSC), Differential Thermal Analysis (DTA), Thermo Gravimetric 
Analysis (TGA), Evolved Gas Detection (EGD), Evolved Gas Analysis (EGA) 
etc. 
Thermogravimetric analysis (TGA) is one of the most widely used 
thermal analysis techniques which specifically measure the weight changes 
(gains and losses) in materials. In TGA, the mass of sample is recorded as a 
function of temperature or time. The plot of mass change versus temperature 
is known as thermogram or TG curve. TG curves are characteristic for a given 
compound because of unique sequence of physicochemical reactions which 
occur over definite temperature ranges and at rates that are a function of 
molecular structure3. The changes in weight are due to various physical and 
chemical changes. Such measurements provide information about the 
material’s thermal stability4 as well as the material’s composition5. TGA 
technique is used to estimate the product’s life time6-8. The TGA 
decomposition kinetics method9 uses the data from experiments run at 
several heating rates to calculate kinetic parameters10-13 including activation 
energy and specific rate constant.  
Literature survey shows that thermal analysis of various types of 
compounds such as polymers14,15, geological materials16, electronic circuit 
boards17, coals18, drugs19, pharmaceutical material20,21, catalyst22,23, nuclear 
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fuel24-27, dyes28,29, fertilizers30-32, inorganic33-35 and organic36-41 compounds 
have been reported. Current areas of applications include environmental 
measurements42, composition analysis, product reliability43 and dynamic 
properties44. Further, various reversible and non-reversible reactions45, the 
decomposition of compounds at definite conditions46, the decomposition of 
molecules adsorbed on a surface, phase transitions47 etc. can also be 
studied.  
This method can not distinguish the actual nature of the material 
evolved in the course of the process and is also handicapped in resolving 
overlapped thermal events48. This is the limitation of this technique. 
In the present section, thermal properties of some dihydropyrimidin 
thiones (RAT series) have been studied TGA technique. 
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THEORY 
From TGA curves, various kinetic parameters can be evaluated by 
several methods. In all these methods, it is assumed that thermal and 
diffusion barriers are negligible because small quantity of material is used. 
The shape of any TGA curve depends on the nature of apparatus and the way 
in which it is used. Further, Arrhenius equation is valid in all these methods. 
 The kinetic treatments are generally based on the relationship of the 
type: 
      dC/dt = K f (C)       ... (3.5.1) 
where C is the degree of conversion, t is time and K is rate constant. f(C) is a 
temperature independent function of C. 
The constant K is assumed to have the Arrhenius form: 
        K = A e -E/RT       ... (3.5.2) 
C can also be defined as: 
        C = 1-(W/W0)                        ... (3.5.3) 
where W0 and W are the initial weight at t=0 and weight at any time t of the 
material. 
Equation (3.5.3) can be written as: 
        (W/W0) = (1-C)                 ... (3.5.4) 
W/ W0 is known as residual weight fraction. 
Thus, the rate of conversion is, 
    dC/dt = - (1/W0) (dW/dt)    ... (3.5.5) 
For homogeneous kinetics, the conversion is assumed to be of the 
form: 
       f (C) = (1-C)n     ... (3.5.6) 
where n is the order of the reaction. 
Substituting the values from equation (3.5.2) and (3.5.6) in equation 
(3.5.1) gives: 
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          dC/ dt = A e -E/RT (1-C)n 
       or    dC/dt = (A/β) e -E/RT (1-C)n                  ... (3.5.7) 
where A is the frequency factor, β is the rate of heating and E is the energy of 
activation. 
Various methods for single and multiple heating rates have been 
reported. The methods of single heating rate are as follows: 
1.  Freeman-Carroll49 and Anderson-Freeman Method50: 
At a single heating rate, Freeman and Carroll gave the following 
relation to analysis TGA data : 
   ln (dC/dt)/ln (1-C) = n-E/R [(1/T/(Δln(1-C)]     ... (3.5.8) 
A plot of left hand side against (1/T)/(Δln(1-C)) gives a straight line with 
a slope equal to -E/R and the intercept is equal to n.  
Above equation (3.5.8) is modified by Anderson and Freeman in the 
following form: 
     (Δln[dC/dt]) = n (Δln(1-C)) - E/R Δ(1/T)                ... (3.5.9) 
The plot of (Δln[dC/dt]) against (Δln(1-C)) for equal intervals of Δ(1/T) 
gives a straight line with slope equal to n and intercept -E/RΔ(1/T). 
2. Sharp-Wentworth method51: 
For order kinetics (n=1), Sharp and Wentworth gave the relation: 
 log [(dC/dt)/(1-C)] = log (A/β) – (E /2.303R).(1/T)  ... (3.5.10) 
The plot of log [(dC/dt)/(1-C)] against 1/T would be a straight line with 
slope equal to - (E/2.303R) and intercept equal to log (A/β). 
3. Chatterjee Method52: 
Chatterjee gave the following relation to determine the order of reaction 
(n). 
 n = [log(dW/dt)1-log(dW/dt)2] / (log W1-log W2)              ... (3.5.11) 
where W1 and W2 are the sample weights.  
 
Studies on some bio-active……. 
 
                                                                                                      Section-V Thermal Properties 
   201
4. Horowitz and Metzger method53 : 
In this method, the value of energy of activation E can be determined 
from a single TG curve by the relation: 
         ln [ln(1-C)-1] = (E/RTs2)θ                                    ... (3.5.12) 
where θ = T-Ts. Ts is the temperature at which the rate of decomposition is 
maximum. The frequency factor A and entropy change ΔS can be determined 
by the following equations: 
    ln E - ln (RTs2) = ln A - lnβ - E/RTs                 ... (3.5.13) 
       A = (kbT / h) e ΔS/R                                  ... (3.5.14) 
where kb is Boltzmann constant and h is Planck’s constant. 
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EXPERIMENTAL 
     Thermo gravimetric analysis (TGA) made on the instrument “Pyris-1, 
Perkin Elmer Thermal Analysis” at the heating rate of 10°C/min in nitrogen 
atmosphere for all the RAT series. 
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RESULTS AND DISCUSSION 
 
 The TGA thermo grams of are given in Figure 3.5.1. Various thermal 
properties such as initial decomposition temperature (IDT), the decomposition 
temperature range and the maximum degradation along with the percentage 
weight loss are reported in Table 3.5.1. 
 For most of the compounds, degradation is single step process. 
However, for compounds RAT-1 and RAT-6, multi step degradation takes 
place.  
The thermal stability can not be decided by weight loss for RAT-1 and 
RAT-6, because degradation is multi step process (Figures 1 and 3). Further, 
the variation in the trend of thermal decomposition might be interpreted by 
taking into account some interactions (structural as well as electronic) and 
also because of several experimental factors.  
Looking to the initial decomposition temperature in Table 3.5.1, RAT-10 
is most unstable and RAT-2 is most stable. RAT-10 contains 2-OH group 
whereas RAT-2 is without substitution. Thus, the absence of any functional 
group to aryl ring increases the stability.  
The decomposition continues up to approximately 800 and up for RAT-
2, RAT-3 and RAT-4. RAT-2 is without any functional group. Whereas RAT-3 
and RAT-4 contain 4-methyl and 4-fluoro groups respectively which increase 
the decomposition temperature.  
 Comparison of RAT-5 and RAT-10 shows that RAT-5 is more stable 
than RAT-10. Both these compounds contain hydroxyl group. In RAT-5, it is at 
4 position whereas in RAT-10, it is at 2-position. RAT-6 and RAT-8 contain 
chloro group at 4- and 2- positions respectively. The initial decomposition 
temperature is higher for RAT-8 but decomposition range is higher for RAT-6 
containing 3-chloro group. Similarly, RAT-7 and RAT-9 contain nitro group at 
4- and 2- positions respectively. In this case, RAT-9 is unstable than RAT-7. 
Again, decomposition range is higher for RAT-7 containing 3-nitro group. This 
suggests that position of functional groups also affect the stability. Thus, the 
presence of group at ortho (2-) position decreases the stability. 
From thermograms, various kinetic parameters, such as order of the 
degradation (n), energy of activation (E), frequency factor (A) and entropy  
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Figure 3.5.1: The TGA graphs of RAT-3 and RAT-6. 
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Table 3.5.1: TGA data for synthesized RAT series. 
 
 
Comp. 
Code 
Amt. 
mg. 
Initial 
Decomp. 
Temp. 
(oC) 
Decomp. 
range 
(oC) 
% Wt. 
loss 
Residual 
Wt. 
Loss 
mg. 
Max 
Degrad. 
Temp 
(oC) 
RAT-1 2.230 188 188-621 99.74 2.222 1051.65 
RAT-2 5.827 280 280-792 98.75 5.754 739.15 
RAT-3 1.490 255 255-824 98.80 1.472 718.15 
RAT-4 2.727 230  230-665 99.21 2.705 717.15 
RAT-5 2.916 167   167-820 81.76 2.384 710.15 
RAT-6 4.922 125 125-548 86.24 4.244 691.15 
RAT-7 9.423 200 200-600 61.31 5.777 717.15 
RAT-8 7.493 178 178-400 79.74 5.974 641.15 
RAT-9 4.406 146 146-400 65.44 2.883 540.65 
RAT-10 5.800 98 98-500 64.94 3.766 611.15 
 
Studies on some bio-active……. 
 
                                                                                                      Section-V Thermal Properties 
   206
Table 3.5.2: The kinetic parameters of RAT series. 
 
Comp. code n 
E 
kJ.mol-1 
A 
s-1 
ΔS 
J.mol-1.K-1 
RAT-1 1st step 
RAT-1 2nd step 
1.98 
1.96 
97.4230 
58.7213 
3.4511 X 103 
24.3891 
-34.5081 
-76.6816 
RAT-2 2.90 25.9388 1.8345 -94.2612 
RAT-3 2.68 82.4707 9.0470 X 104 -4.1805 
RAT-4 2.02 49.3677 2.1480 X 102 -54.4111 
RAT-5 4.08 14.8903 0.2086 -112.0020 
RAT-6 1st step 
RAT-6 2nd step 
RAT-6 3rd step 
 
1.19 
15.31 
4.09 
 
98.6705 
37.4961 
3.3015 
3.3603 X 106 
30.3864 
0.0069 
26.1914 
-70.3638 
-95.6127 
RAT-7 2 34.0375 11.3220 -78.8791 
RAT-8 1.95 64.0843 1.4720 X 104 -18.3345 
RAT-9 6.95 18.9933 0.0056 -139.776 
RAT-10 7.75 46.4652 6.6107 X 102 -43.7351 
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change (ΔS) have also been evaluated for each step and are reported in 
Table 3.5.2. 
It is evident from Table 3.5.2 that order of reaction is quite different for 
all the compounds. For single step decomposition, order of reaction varies 
from 1.95 to 7.75. For RAT-1 compound, the order of reaction is almost same 
for both steps, difference is only of 0.02. However, much change is observed 
for different steps in RAT-6.  
For single step degradation, energy of activation (E) is maximum for 
RAT-3 and minimum for RAT-5. The values of frequency factor (A) are also 
showed variation in first step. The frequency factor is maximum for RAT-3 and 
minimum for RAT-9. For multi step degradation, in both RAT-1 and RAT-6, 
energy of activation and frequency factor is higher for the first step. 
Further, change in entropy (ΔS) for all the compounds are calculated 
by equation 3.5.14. It is observed that entropy change is negative for all 
compounds except RAT-6 for the first step. The negative ΔS values indicate 
that the activation compound has a more ordered or more rigid structure than 
the reactants and reaction is slower than the normal. Whereas the positive ΔS 
values indicate that the transition state is in less ordered state54. 
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INTRODUCTION 
Electrical conductance of an electrolyte solution is a measure of the 
solution’s ability to conduct electricity and it is based on Ohm’s law. It is a 
property of ionic solutions. From a macroscopic point of view, ionic 
conductance of solution is similar to electron or hole conductance through 
solid object. In the latter cases, electrons are moving without ion cores, while 
in the former, charges are moving as ions. 
 Although water itself is a very poor conductor of electricity, the 
presence of ionic spices in solution increases the conductance considerably. 
The conductance of such electrolytic solutions depends on the concentration 
of the ions, nature of the ions presents (though their charges and mobility), 
temperature and viscosity of the medium.        
The conductometry is widely applicable for acid-base titration reactions 
for determine relative strength of the two weak acids or bases1, solubility of 
sparingly soluble salt2, for determination of the dissociation constant3 of weak 
electrolytes, and in determining equilibrium constant, rates of reactions that 
proceed with the formation or disappearance of ions and also used to 
determined interionic forces etc4-6.  
This technique is also useful to various biological processes7-10. 
D’Errico11 used this technique for regulation of the osmotic pressure in the 
animal organism. Poole12 have studied the conductivity of glass. The specific 
conductivity of hydrogen clay sols have also been reported by Mitra and 
Ghosh13. The interactions of Gum karaya (neutral salts) and nonelectrolytes14 
and of sucrose with some multivalent ions15 have also been studied by this 
technique.          
 Literature survey shows that conductance of many inorganic and 
organic compounds have been measured in aqueous and non-aqueous 
solvents16-27. Karelson and Kuura28 have reported the conductivity of lithium 
chloride solutions in ethanol. Toshmatov et al.29 have reported the diffusion of 
fluoride ions in a potassium yttrium fluoride crystal and sodium fluoride-yttrium 
fluoride solid solutions at high temperatures by this technique. Liu and 
coworkers30 have studied the conductance of sodium ethanolate. The thermal 
conductivity of various other materials has also been measured31-33. 
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Further, Calinescu et al.34 have reported conductivity of 4-hydroxy-5-
methoxy-isophthaldehyde-bis(dimethylhydrazone) complexes. The conductan- 
ce of o-nitrophenol, 1-nitroso-2 naphthol and 8-hydroxyquinoline complexes 
were studied by Prakash and Eqbal35. Zhang and coworkers36 studied the 
thermal decomposition reaction kinetics of complexes of [Sm(o-MOBA)3 
bipy]2H2O and [Sm(m-MOBA)3bipy]2H2O by conductometry. Macinnis et al.37 
have measured the conductance of sodium dihydroxybenzoates of aqueous 
solutions. The electrolysis method for producing 4-aminophenol was reported 
by Zan38. Zhao and coworkers39 studied the characterization of Schiff bases 
derived from adamantine amine and o-vanillin. Doyle40 have reported the 
conductance of thiazole derivatives. 
In the present section, conductance of all the synthesized 
dihydropyrimidinthiones (RAT series) were measured in N, N-dimethyl 
formamide (DMF) and tetrahydrofuran (THF) at 308.15 K.   
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EXPERIMENTAL 
The solvents DMF and THF were purified by fractionally distillation by 
the method reported in the literature41.  
The solutions of different concentrations were prepared for each 
compound in DMF and THF and the conductance of each solution was 
measured by using Elico Conductivity Meter (Model No. CM 180) at 308.15 K. 
The measured conductance was corrected by subtracting the conductance of 
pure solvent. 
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where k and k0 are the electrolytic conductivity of the solutions and solvent 
respectively. c is the equivalent concentration and the function Φ(c) denotes 
the effect of interionic interactions.
RESULTS AND DISCUSSION 
 The measured conductance (k) of each solution after correction was 
used to determine the specific conductance (κ), which is then used for the 
calculation of equivalent conductance (λc).  
The equations used for calculating specific conductance ( ) and 
equivalent conductance (λc) are: 
κ
k                                             κ θ=        …(3.6.1) 
                                     1000c C
κλ =
( )0 0 cc c
extrapolation method. These values are compared with those determined by 
an alternate procedure using the following equation. 
 For weak electrolytes, it is difficult to determine λ0. However, in 
the studied solutions of compounds, λ0 values are evaluated approximately by  
The equivalent conductance (λc) is plotted against √C for all 
compounds as shown in Figures 3.6.3 and 3.6.4. For all the dihydropyrimi- 
denthiones (RAT series) derivatives, the equivalent conductance increases 
with concentration in both the solvents. It is obvious from figures that all 
derivatives behave as weak electrolytes in both the solvents.  
 These equivalent conductance values of all the RAT series derivatives 
in DMF and THF are reported in Tables 3.6.1 and 3.6.2 along with measured 
conductance (k). In THF, the relatively low conductivities are due to greater 
electro relaxation effect owing to the higher permittivity of THF, which 
contributes interionic repulsions to a larger extent42. It is observed that for all 
the systems studied, conductance increases with concentration (as also 
shown in Figures. 3.6.1 and 3.6.2).  
where θ is the cell constant and c is the concentration (g.equi./lit.) of solution. 
For DMF solutions, cell constant θ was 0.96 cm-1 where as for THF, it was 
0.98 cm-1. 
                                      k k=
               … (3.6.2) 
λ φ+ +   ….. (3.6.3) 
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Table 3.6.1: The conductance (k) and equivalent conductance (λC) of RAT series in DMF at 308.15 K. 
 
 
Conc. 
M 
k.105 
mho 
λC 
mho.cm2.equi.-1 
k.105 
mho 
λC 
mho.cm2.equi.-1 
k.105 
mho 
λC 
mho.cm2.equi.-1 
k.105 
mho 
λC 
mho.cm2.equi.-1 
k.105 
mho 
λC 
mho.cm2.equi.-1 
 RAT-1 RAT-2 RAT-3 RAT-4 RAT-5 
0.000 0.200 - 0.200 - 0.200 - 0.200 - 0.200 - 
0.001 0.325 1.2250 0.420 2.1560 0.380 1.7640 0.715 5.0470 1.200 9.5616 
0.002 0.391 0.9359 0.624 2.0776 0.480 1.3720 0.910 3.4790 2.040 8.8128 
0.004 0.550 0.8575 0.997 1.9527 0.605 0.9923 1.320 2.7440 3.720 8.4384 
0.006 0.656 0.7448 1.340 1.8620 0.610 0.6697 1.580 2.2540 5.000 7.6736 
0.008 0.790 0.7228 1.700 1.8375 0.612 0.5047 1.820 1.9845 5.410 6.2472 
0.010 0.900 0.6860 1.910 1.6758 0.630 0.4214 2.090 1.8522 5.700 5.2762 
0.020 1.500 0.6370 3.350 1.5435 1.030 0.4067 3.500 1.6170 8.800 4.1261 
0.040 2.500 0.5635 5.900 1.3965 1.740 0.3773 5.900 1.3965 14.800 3.5030 
0.060 3.500 0.5390 8.450 1.3475 2.410 0.3610 6.300 0.9963 19.300 3.0554 
0.080 4.300 0.5023 10.800 1.2985 2.820 0.3210 6.800 0.8085 23.500 2.7955 
0.100 4.900 0.4606 12.800 1.2348 3.300 0.3038 7.200 0.6860 24.000 2.2844 
 RAT-6 RAT-7 RAT-8 RAT-9 RAT-10 
0.001 0.900 6.8208 0.568 3.4944 0.817 5.8848 0.418 2.0544 0.665 4.4256 
0.002 1.420 5.9584 0.614 1.9680 1.020 3.9168 0.577 1.7904 1.000 3.8208 
0.004 1.780 3.8612 0.728 1.2576 1.080 2.1024 0.752 1.3152 1.610 3.3744 
0.006 1.830 2.6558 0.880 1.0816 1.380 1.8816 0.830 1.0016 2.120 3.0656 
0.008 1.900 2.0776 0.980 0.9312 1.410 1.4472 0.980 0.9312 2.570 2.8392 
0.010 2.050 1.8091 1.090 0.8506 1.620 1.3594 1.000 0.7642 2.980 2.6650 
0.020 3.190 1.4631 1.630 0.6845 2.500 1.1021 1.500 0.6221 3.530 1.5965 
0.040 4.800 1.1260 2.240 0.4886 4.000 0.9110 2.500 0.5510 4.970 1.1438 
0.060 5.620 0.8846 3.000 0.4474 5.000 0.7674 3.400 0.5114 6.390 0.9898 
0.080 6.010 0.7112 3.130 0.3511 5.500 0.6355 4.500 0.5155 7.680 0.8971 
0.100 6.600 0.6268 3.440 0.3107 6.250 0.5804 5.600 0.5180 8.270 0.7743 
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Table 3.6.2: The conductance (k) and equivalent conductance (λC) of RAT series in THF at 308.15 K. 
 
 
Conc. 
M 
k.105 
mho 
λC 
mho.cm2.equi.-1 
k.105 
mho 
λC 
mho.cm2.equi.-1 
k.105 
mho 
λC 
mho.cm2.equi.-1 
k.105 
mho 
λC 
mho.cm2.equi.-1 
k.105 
mho 
λC 
mho.cm2.equi.-1 
 RAT-1 RAT-2 RAT-3 RAT-4 RAT-5 
0.000 0.024 - 0.024 - 0.024 - 0.024 - 0.024 - 
0.001 0.098 0.7003 0.101 0.7595 0.185 1.5181 0.169 1.3677 0.132 1.0199 
0.002 0.101 0.3643 0.107 0.4092 0.318 1.3842 0.181 0.7403 0.224 0.9424 
0.004 0.146 0.2879 0.133 0.2683 0.425 0.9435 0.209 0.4359 0.385 0.8495 
0.006 0.177 0.2405 0.173 0.2442 0.498 0.7434 0.285 0.4097 0.507 0.7575 
0.008 0.192 0.1980 0.195 0.2101 0.535 0.6010 0.341 0.3731 0.551 0.6198 
0.010 0.207 0.1726 0.200 0.1730 0.580 0.5231 0.390 0.3445 0.570 0.5137 
0.020 0.377 0.1661 0.320 0.1453 1.030 0.4731 0.620 0.2804 0.880 0.4026 
0.040 0.701 0.1592 0.590 0.1388 1.740 0.4034 1.010 0.2318 1.480 0.3423 
0.060 0.886 0.1351 0.860 0.1366 2.410 0.3739 1.260 0.1937 1.930 0.2987 
0.080 0.955 0.1095 1.080 0.1294 2.840 0.3309 1.590 0.1841 2.350 0.2734 
0.100 1.180 0.1087 1.280 0.1231 3.340 0.3118 1.900 0.1764 2.400 0.2234 
 RAT-6 RAT-7 RAT-8 RAT-9 RAT-10 
0.001 0.187 1.5369 0.127 0.9729 0.367 3.2289 0.282 2.4299 0.287 2.4769 
0.002 0.292 1.2620 0.144 0.5664 0.594 2.6814 0.454 2.0234 0.450 2.0046 
0.004 0.380 0.8378 0.168 0.3396 0.972 2.2290 0.729 1.6579 0.684 1.5522 
0.006 0.504 0.7528 0.188 0.2577 1.240 1.9059 0.828 1.2604 0.853 1.2996 
0.008 0.595 0.6715 0.210 0.2191 1.540 1.7819 0.945 1.0828 0.972 1.1145 
0.010 0.660 0.5983 0.235 0.1988 1.670 1.5477 1.040 0.9555 1.010 0.9273 
0.020 1.120 0.5154 0.372 0.1638 2.650 1.2345 1.520 0.7034 1.720 0.7974 
0.040 1.720 0.3987 0.561 0.1263 3.940 0.9204 2.690 0.6266 2.220 0.5162 
0.060 2.270 0.3520 0.725 0.1099 4.210 0.6559 3.420 0.5321 2.860 0.4444 
0.080 2.730 0.3180 0.878 0.1004 4.970 0.5812 4.280 0.5001 3.440 0.4014 
0.100 2.990 0.2789 1.000 0.0918 5.550 0.5195 5.070 0.4744 3.510 0.3277 
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Figure 3.6.1: The variation of conductance with concentration for RAT   
                       series in DMF at 308.15 K. 
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Figure 3.6.2: The variation of conductance with concentration for RAT 
                       series in THF at 308.15 K. 
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Figure 3.6.3: The variation of equivalent conductance with √C for RAT  
                      series in DMF at 308.15 K. 
 
0.0
2.0
4.0
6.0
8.0
10.0
0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35
√c
Eq
ui
. C
on
d.
 (m
ho
.c
m
2 .e
qu
i-1
)
RAT-1 RAT-2 RAT-3 RAT-4 RAT-5
 
 
 
 
0.0
2.0
4.0
6.0
8.0
0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35
√c
Eq
ui
. C
on
d.
 
(m
ho
.c
m
2 .e
qu
i-1
)
RAT-6 RAT-7 RAT-8 RAT-9 RAT-10
 
 
 
 
 
 
Studies on some bio-active……. 
 
                                                                                                               Section-VI Conductance 
 221 
Figure 3.6.4: The variation of equivalent conductance with √C for RAT  
                      series in THF at 308.15 K. 
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The limiting conductivity can be determined accurately from the slope, dk/dc 
of plot of k verses c, provided other derivatives (dk0/dc) and d[cΦ(c)]/dc in 
differential form of equation (3.6.3) are neglected as compared to λ0, which 
can be determined from differential form of equation (3.6.3) is  
               ( )0 0
cd cdkdk
dc dc dc
φλ
⎡ ⎤⎣ ⎦= + +                ….. (3.6.4) 
 These λ0 values are reported in Table 3.6.3 along with those 
determined by extrapolation. 
 From Table 3.6.3., it is observed that in both the solvents, calculated 
values of limiting equivalent conductance (λ0) are in good agreement with 
those evaluated graphically suggesting thereby that equation 3.6.3 is 
applicable for the studied systems. 
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Table 3.6.3: The limiting equivalent conductance (λ0) of RAT series in  
                     DMF and THF at 308.15 K. 
 
 
λ0 
mho.cm2.equi.-1
from graph 
λ0103 
mho.cm2.equi.-1
from eq. (3.6.4) 
λ0 
mho.cm2.equi.-1 
from graph 
λ0103 
mho.cm2.equi.-1
from eq. (3.6.4) 
Compound 
Code 
DMF THF 
RAT-1 - 0.67 0.18 0.16 
RAT-2 - 1.73 0.14 0.15 
RAT-3 0.56 0.48 0.54 0.50 
RAT-4 1.75 1.73 0.33 0.31 
RAT-5 5.67 5.65 0.57 0.55 
RAT-6 1.55 1.54 0.58 0.59 
RAT-7 0.75 0.75 0.24 0.26 
RAT-8 1.12 1.14 1.62 1.61 
RAT-9 0.71 0.75 0.92 0.95 
RAT-10 2.60 2.72 0.90 0.95 
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INTRODUCTION 
 
Biological activity is an expression describing the beneficial or adverse 
effects of a drug on living matter. Biological Activity Spectrum of a compound 
represents the pharmacological effects1, physiological2 and biochemical 
mechanisms3 of action, specific toxicity which can be revealed in compounds 
interaction with biological system. Further, it describes the intrinsic properties 
of the compound which depends on its structure. Most of known biologically 
active substances have many biological activities such as antibacterial4-6, anti-
inflammatory7-9, antifungal10-12, anti-HIV13,14, antipyretic15,16, antitumor17-19 etc.  
When the drug is a complex chemical mixture, this activity is exerted by 
the substance's active ingredient or pharmacophore but can be modified by 
the other constituents. The main kind of biological activity is a substance's 
toxicity. Activity is generally dosage-dependent and it is not uncommon to 
have effects ranging from beneficial to adverse for one substance when going 
from low to high doses.  
 As mentioned in Chapter 2, dihydropytrimidinones and dihydropyrim- 
idinthiones are known for a wide variety of biological activities. In the present 
chapter, the antibacterial and antifungal activities of the synthesized 
dihydropytrimidinones and dihydropyrimidinthiones (RAT series) have been 
screened against some Gram positive, Gram negative bacterial stains and 
fungus.  
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EXPERIMENTAL 
 The antibacterial and antifungal activities of dihydopyrimidinethiones 
(RAT series) and dihydropyrimidinones were studied in DMF and DMSO.  
All the compounds were recrystallized prior to use. The solvents, DMF 
and DMSO were also purified before use by standard method20.  
 For all the compounds, agar well diffusion method was used. 
 
Test Microorganisms: 
The compounds were tested for its antibacterial and antifungal 
activities against Gram positive bacteria viz. Bacillus cereus ATCC11778 
(BC), Micrococcus flavus ATCC10240 (MF), Gram negative bacteria viz. 
Proteus mirabilis NCIM2241 (PM), Escherichina coli NCIM 2241 (EC) and 
Fungus viz. Cryptococcus Iuteolus ATCC 32044 (CL), Candida tropicalis 
ATCC 4563 (CT). 
Microorganisms and Fungus were obtained from National Chemical 
Laboratory (NCL), Pune, India and were maintained at 4°C on nutrient agar 
slants. 
 
Preparation of test compounds: 
The solutions were prepared at a concentration of 1 mg/μl for all the 
compounds. 
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Preparation of the plates and microbiological assay: 
The antibacterial and antifungal evaluation was done by agar well 
diffusion method21,22 using Mueller Hinton Agar No.2 as the nutrient medium. 
The agar well diffusion method was preferred to be used in this study because 
it was found to be better than the disc diffusion method as suggested by 
Parekh et al.3 The bacterial strains were activated by inoculating a loop full of 
test strain in 25 ml of N-broth and the same was incubated for 24 h in an 
incubator at 37o C. 0.2 ml of the activated strain was inoculated in Mueller 
Hinton Agar. Mueller Hinton Agar kept at 45oC was then poured in the Petri 
dishes and allowed to solidify. After solidification of the media, 0.85 cm ditch 
was made in the plates using a sterile cork borer and these were completely 
filled with the test solution. The plates were incubated for 24 h at 37oC. The 
mean value obtained for the three wells was used to calculate the zone of 
growth inhibition of each sample. The controls were maintained for each 
bacterial strain and each solvent. The inhibition zone formed by these 
compounds against the particular test bacterial and fungal strain determined 
the antibacterial activities of these synthesized compounds.  
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RESULTS AND DISCUSSION 
Dihydropyrimidinonthiones (RAT series) : 
  Figure 4.1 shows inhibition against Gram positive bacteria in DMF and 
DMSO. It is observed that against B. cereus, in DMF all the compounds 
exhibited inhibition whereas in DMSO, RAT-10 showed no inhibition at all. 
Further, against B. cereus, in DMF, RAT-5 shows maximum inhibition 
whereas in DMSO, RAT-9 exhibited maximum inhibition. However, for M. 
flavus, RAT-10 showed maximum inhibition in both the solvents. 
 The inhibition depends on type of bacterial strain, solvent as well as 
structure of compound. All the compounds in RAT series contain the same 
central moiety with different side chains. So, in a particular solvent, for a 
particular strain side chain plays important role in inhibition.  
 In the present study, against B. cereus, p-hydroxy group is most 
effective in inhibition which is present in RAT-5. Whereas p-methyl is least 
effective which is present in RAT-3. However, for M. flavus, in DMF solution, 
o-hydroxy ( as in RAT-10) is most effective and no substitution ( as in RAT-2) 
had no effect at all. 
 In DMSO, o-hydroxy ( as in RAT-10) is most effective against both B. 
cereus and M. flavus. Again, p-methyl ( as in RAT-3) and no substitution ( as 
in RAT-2) had no effect at all against M. flavus. Thus, M. flavus is the resistant 
bacteria in DMSO. 
Figure 4.2 shows inhibition against Gram negative bacteria in DMF and 
DMSO. It is observed that against E. coli, in DMF, RAT-1 and in DMSO RAT-
9 showed maximum inhibition. In DMSO, most of the studied compounds had 
no effect against E. Coli. RAT-1 contain p-OCH3 group and RAT-9 contain o-
nitro group. Thus, these groups increase inhibition against E. coli in DMF and 
DMSO respectively.  
     For P. mirabills, In DMF, RAT-2, RAT-3 and RAT-8 showed almost 
same inhibition. Rest of the compounds had no effect at all. Whereas in 
DMSO, only RAT-6 showed no inhibition. RAT-5 and RAT-10 showed same 
maximum inhibition. As mentioned above, RAT-2 and RAT-3 contain no  
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Figure 4.1: Antibacterial activity of dihydropyrimidinthiones (RAT series)   
                   against Gram positive bacteria in DMF and DMSO. 
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Figure 4.2: Antibacterial activity of dihydropyrimidinthiones (RAT series)  
                   against Gram negative bacteria in DMF and DMSO. 
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substitution and p-methyl group respectively whereas RAT-8 contain o-
chloro group. This indicates that these groups, which were not effective 
against Gram positive bacteria is effective against Gram negative bacteria. 
Further, in DMSO against P.mirabills, p-fluoro (as in RAT-4) and o-hydroxyl 
group ( as in RAT-10) is most effective. 
Thus, in DMF, P. mirabills is most resistant bacteria whereas in DMSO, 
E. Coli is resistant. 
Figure 4.3 shows inhibition against fungus in DMF and DMSO. For C. 
luteolus, inhibition is maximum in both DMF and DMSO. RAT-9 showed the 
maximum inhibition in both DMF and DMSO. RAT-2 and RAT-3 showed 
minimum inhibition in DMF whereas in DMSO, RAT-1 and RAT-2 exhibited no 
inhibition at all. Thus, o- nitro group is effective for this fungal strain in both the 
solvents. Whereas compound with p-methoxy group (RAT-1) and compound 
having no substitution group (RAT-2) is not effective in DMSO. 
For C. tropicalis, all the compounds have showed almost same results 
of inhibition in DMF and DMSO. However, in DMSO, RAT-5 has slightly more 
inhibition than others. Thus, all compounds exhibited activity against C. 
tropicalis and activity is maximum for p-hydroxyl group and minimum for 
compound which not having substitution group in DMSO. 
Thus, in DMF the presence of p-hydroxyl and p-methoxy groups are 
most effective against Gram positive and Gram negative bacteria.  Whereas 
in DMSO, o-nitro group increased inhibition against both Gram positive and 
Gram negative bacteria in the studied compounds. Against studied fungal 
strains also, o-nitro group increased inhibition. 
Overall, in case of RAT series, although there is slight change in 
inhibition in the two solvents, the presence of substituent groups affects 
inhibition and inhibition is maximum for compounds having hydroxyl, methoxy 
and nitro groups. Minimum inhibition is observed for compounds having chloro 
group and compounds having no substitution. 
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Figure 4.3: Antifungal activity of dihydropyrimidinthiones (RAT series) in  
                    DMF and DMSO. 
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Figure 4.4: Antibacterial activity of dihydropyrimidinones against Gram  
                    positive bacteria in DMF and DMSO. 
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Dihydropyrimidinones: 
 
Figure 4.4 shows the zone of inhibition against Gram positive bacteria 
in DMF and DMSO. It is evident that for both solvents, RAU-2 showed 
maximum inhibition against B. cereus. Minimum is observed by RAU-4 in 
DMF and RAU-9 in DMSO. RAU-2 contains p-chloro group which is found to 
be most effective against B. cereus in comparison to other groups. RAU-4 and 
RAU-9 contain p-hydroxy and p-methyl groups respectively. Thus, B. cereus 
is more resistant against hydroxyl and methyl group.  
For M. flavus, RAU-10 in DMF and RAU-1 showed maximum inhibition. 
This bacteria is most resistant against RAU-6 in DMF and RAU-2, RAU-3, 
RAU-5 and RAU-6 in DMSO. 
Against Gram negative bacteria, RAU-8 and RAU-10 exhibited 
maximum inhibition against E. coli (as shown in Figure 4.5) in DMF and 
DMSO respectively. RAU-3 and RAU-6 in DMF and RAU-4 and RAU-5 in 
DMSO exhibited no inhibition against E. coli. Thus, no substitution ( as in 
RAU-8) and p-bromo group ( as in RAU-10) is most effective against this 
bacteria. m-chloro (as in RAU-3) and p-fluoro ( as in RAU-6) could not affect 
in DMF whereas p-hdroxy ( as in RAU-4) and 2,5-dichloro ( as in RAU-5) 
groups had no effect in DMSO. 
For P. mirabilis, RAU-7 and RAU-10 showed maximum inhibition in 
DMF and DMSO respectively. Rau-1, RAU-3 and RAU-5 had no effect on P. 
mirabilis in DMF Whereas in DMSO all compounds exhibited inhibition. Thus, 
E. coli is more resistant bacteria in DMSO and P. mirabilis is more resistant 
bacteria in DMF. 
Figure 4.6 shows zone of inhibition against fungal strains in DMF and 
DMSO. RAU-1 observed maximum inhibition against C. luteolus in both DMF 
and DMSO. Whereas RAU-6 showed minimum inhibition against C. luteolus 
in DMF. In DMSO, RAU-4 and RAU-6 showed no inhibition at all. RAU-1 
contains p-methoxy group which is found to be most effective against C. 
luteolus. 
For C. tropicalis, inhibition is much less than C. luteolus in both the 
solvents. In both the solvents, RAU-10 containing p-bromo group exhibited  
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Figure 4.5: Antibacterial activity of dihydropyrimidinones against Gram  
                    negative bacteria in DMF and DMSO. 
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Figure 4.6: Antifungal activity of dihydropyrimidinones in DMF and 
DMSO. 
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maximum inhibition. In DMF, all the compounds showed inhibition whereas in 
DMSO, RAU-3, RAU-4, RAU-5 and RAU-6 had no effect at all.  
 Overall, the studied compounds exhibited more inhibition against 
fungal strains than bacterial strains.  
 In both the solvents, p-chloro group increases the inhibition against B. 
cereus whereas p-bromo in DMF and p-methoxy in DMSO is most effective 
against M. flavus. P-fluoro group had no effect at all in DMF whereas in 
DMSO, p-chloro, m-chloro, p-fluoro groups are found to be ineffective. Against 
Gram negative bacteria E. Coli, when there is no substitution, inhibition is 
highest in DMF whereas in DMSO, p-bromo increases the inhibition. For this 
bacteria, the presence of m-chloro and p-fluoro groups shows no effect in 
DMF whereas in DMSO, p-hydroxy and 2,5-dichloro groups had no effect.  
Against P. mirabilis, in DMSO again p-bromo increases the inhibition whereas 
in DMF p-nitro is most effective. P-methoxy, m-chloro and 2,5-dichloro groups 
had no effect against this bacteria in DMF.   
 In case of fungal strains, p-methoxy for C.luteolus and p-bromo for C. 
tropicalis is found to be most effective in both the solvents. Against C. 
luteolus, all compounds exhibited inhibition in DMF whereas in DMSO, p-
hydroxy and p-fluoro groups are not effective at all. Against C. tropicalis, 
again all compounds exhibited inhibition in DMF whereas in DMSO, p- 
hydroxy, m-chloro, 2,5-dichloro and p-fluoro groups showed no inhibition at 
all.   
 Thus, in the studied bacterial and fungal stains, in the studied 
compounds, overall, p- hydroxy, m-chloro, 2,5-dichloro and p-fluoro groups 
had little or no effect at all in both the solvents.  
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A COMPREHENSIVE SUMMARY OF THE WORK 
 
 The present work is divided into four chapters. 
CHAPTER-1: This chapter deals with the general introduction of heterocyclic 
compounds. The importance of heterocyclic compounds in pharmaceutical 
and biological field is given along with the aims and objective of the present 
work. 
 
CHAPTER-2: This chapter deals with the synthesis of azomethines, 
benzothaizole derivatives, dihydropyrimidinones, dihydropyrimidinthiones and 
thiazolidinones. All the synthesized compounds are characterized by IR, mass 
and NMR spectral data.  
   
CHAPTER-3: For the synthesized dihydropyrimidinthiones (RAT series), 
some physicochemical properties such as acoustical properties, solubility, 
density, refractive index, dissociation constants, thermal propertied, 
conductance etc. are studied in this chapter over a wide range of 
concentration. For all physicochemical properties, DMF and THF are used as 
solvent. The various properties are given in different sections. 
 
Section-I: This section deals with the acoustical properties of RAT series at 
308.15K in solutions of DMF and THF over a wide range of concentration.  
From the various evaluated acoustical parameters, it is concluded that in the 
studied compounds, solute-solvent interactions dominate. 
 
Section II:  This section describes that solubility of all studied compounds in 
DMF and THF at different temperatures (303.15-323.15 K). It is observed that 
the solubility of all the compounds increases linearly with temperature in both 
the solvents. Overall, solubility is greater in DMF than that in THF. The 
dielectric constant and dipole moment of DMF (36.71, 3.86) are greater than 
that of THF (7.58, 1.75). Thus, these properties of solvent play an important 
role on the solubility. Further, some thermodynamic parameters such as  
enthalpy (∆Hsol), Gibb’s energy (ΔGsol) and entropy (∆Ssol) of different 
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solutions have been evaluated. For all the compounds ∆Hsol , ΔGsol and ∆Ssol 
values are positive. The positive value of ∆Hsol indicates absorption of energy 
i.e. endothermic dissolution of compounds. The positive ∆Hsol and ∆Ssol values 
in both solvents, suggest that solubility of compounds is entropy driving 
process. Further, the positive values of ΔGsol indicate that the dissolution 
process is not spontaneous. 
 
 Section III: In this section, density and refractive index of the solutions of 
compounds of RAT series were measured at 308.15 K. The evaluated 
experimental densities are found to be different than those calculated 
theoretically, which may due to solvation of ions. Further, densities of same 
compound are different in both the solvents. This may be due to different 
interactions in different solvents, as discussed in section I. 
 
Section IV: In this section, the dissociation constant of compounds of RAT 
series were studied in DMF : water (60:40) system at different temperatures 
(i.e., 298.15, 308.15 and 318.15). The dissociation constants were evaluated 
by average and half-integral method. The results obtained by these two 
methods are in good agreement. The dissociation constant is observed to 
decrease with increase in temperature. Further, dissociation constant is found 
to be maximum for RAT-5 containing p–OH group and minimum for RAT-1 
which contains p–OCH3 group. Thus, RAT-5 is more acidic and RAT-1 is 
more basic. 
 Further, from dissociation constant data, some thermodynamic 
parameters such as enthalpy (∆H), Gibb’s energy (ΔG) and entropy (∆S)   
were evaluated for both the methods. The values are in good agreement for 
both the methods. Again, positive ∆H indicates that the dissociation process is 
endothermic whereas positive ∆G indicates that dissociation process is not 
spontaneous. The negative values of ∆S is due to increased order.  
 
Section V:  The thermal properties of compounds, measured by TGA were 
discussed in this section. From the thermograms of the all compounds, it is 
 
Studies on some bio-active……. 
 
                                                                                     A Comprehensive Summary of the Work 
 241 
observed that for RAT-1 and RAT-6, multi steps degradation takes place 
whereas for other compounds, degradation is single step process.  
 Further, RAT-2 is found to be more stable whereas RAT-10 is most 
unstable. RAT-10 contains 2-OH group whereas there is no substitution group 
in RAT-2. Thus, absence of any functional group to aryl ring increases the 
stability. The position of functional groups also affects the stability and it is 
observed that the presence of groups at 2-position decreases the stability. 
Various kinetic parameters such as order of reaction, energy of activation, 
frequency factor, entropy etc., were also calculated from thermograms. It is 
observed that order of reaction is quite different for all the compounds. For 
single step, energy of activation is maximum for RAT-3 and minimum for RAT-
5. For RAT-1 and RAT-6, energy of activation and frequency factor is higher 
for the first step. The positive ∆S values indicated that the activation 
compounds has a more ordered or more rigid structure than the reactant and 
reaction is slower than the normal. 
 
Section VI: This section deals with the conductance of solution of compounds 
of RAT series at 308.15 K in DMF and THF over a wide range of 
concentration. The equivalent conductances for all the compounds were also 
evaluated. All the compounds are found to exhibit weak electrolytic nature in 
both the solvents. However, the limiting equivalent conductances (λ0) were 
evaluated by both extrapolation of plot of λc versus √C and by theoretical 
method. The values are found to be in good agreement.               
 
CHAPTER-4: The antibacterial and antifungal activity of dihydropyrimidin 
thiones (RAT series) and dihydropyrimidinones (RAU series) in DMF and 
DMSO are studied in this chapter. Different bacterial strains behave differently 
in different solvents. Further, the presences of different substituents also 
affect inhibition. 
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